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Abstract 
As population growth, climate change, and urbanization strain drinking water sources, the 
increasingly common use of diverse and impacted water supplies necessitates a better 
understanding of contaminant fate in this setting. Among the human health hazards found in water 
supplies, viral pathogens are of principal concern, because they can be present in elevated 
concentrations, are highly infectious, and are difficult to remove due to their small size. Effective 
viral pathogen removal is of particular importance in direct potable water reuse, in which 
wastewater is transformed into drinking water. A multibarrier approach to treatment is traditionally 
used for contaminant removal, where different treatment processes are placed in series and 
cumulatively reduce virus concentrations to levels that pose no significant public health risk. 
However, the persistence of several important waterborne viruses (e.g., human norovirus) through 
treatment processes is not well characterized due to difficulties in virus culturability. This raises 
questions about whether proposed reuse treatment schemes are sufficient to protect human health. 
In addition, monitoring strategies used to ensure treatment performance in real-time are not 
sufficiently sensitive to validate virus reductions, likely resulting in the design of overengineered 
treatment schemes for virus removal. This dissertation sheds light on alternative molecular and 
predictive modeling approaches for estimating virus fate through disinfection when traditional 
methods are not feasible and evaluates flow virometry as a novel approach to accurately validate 
virus reductions through treatment in real-time. 
Results demonstrate that alternative methods to accurately determine virus susceptibility to UV254 
disinfection treatments can be applied effectively when culture-based approaches are not possible. 
 xv 
Specifically, the UV254 sensitivity of human norovirus was established with these alternative 
approaches and confirmed through use of a novel culture system. The findings show that 
commonly used approaches to estimate infectious human norovirus levels overestimate norovirus 
survival through UV254 disinfection. Further, flow virometry, a high-throughput method for 
detecting and enumerating virus particles, was explored as a sensitive method to ensure virus 
reductions through treatment in real-time. Work revealed that flow virometry could effectively 
detect large dsDNA virus populations, while smaller RNA and DNA viruses were not reliably 
measured. Proof-of-concept experiments evaluating virus removal through ultrafiltration indicated 
that while flow virometry could detect particles in the same size range as viruses, little 
improvement over currently used monitoring approaches was observed due to limitations in the 
detection capabilities of current flow cytometers. Taken together, this dissertation research 
improves our understanding of human norovirus fate through treatment and provides novel 
methods that can be applied to monitor virus behavior through treatment. Ultimately, this research 
aids in the development of a regulatory framework that will make direct potable reuse more 





Viral pathogens pose a significant risk to human health, as evidenced by recent and ongoing 
pandemics, endemic illnesses, and frequent outbreaks.1–4 Viruses can spread by various routes, 
including through food, water, aerosols, fomites, and direct human to human transmission, among 
others.1,5,6 The fate of many pathogenic viruses in these settings is not well understood, and 
questions remain about the most effective ways to monitor and inactivate different viral pathogens 
for exposure mitigation. 
Worldwide, gastrointestinal illnesses are caused largely by viruses, including norovirus, rotavirus, 
adenovirus, and astrovirus.7–9 Ingestion of these enteric viral pathogens can lead to viral infection 
and ultimately gastrointestinal disease. Enteric viruses can be highly infectious, with challenge 
studies demonstrating that ingestion of small numbers of infectious virus particles can result in 
disease.10 These viruses are present in numerous water types, including surface water, drinking 
water sources, and wastewater.11–14 The persistence of infectious viruses in water settings 
necessitates the use of treatment technologies to mitigate viral infection risk. Common water 
treatment disinfection strategies include the use of UV254, chlorine, chloramine, and ozone. 
Physical and biological removal processes, such as membrane filtration, granular media filtration, 
and bioreactors followed by biomass separation steps, are also applied. As regions of the world, 
including many in the United States, become water-stressed due to the effects of climate change, 
population growth, water shortage, and urbanization, they seek nontraditional water sources. 
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Direct potable reuse (DPR), in which wastewater is treated to drinking water standards, is an 
advanced technology capable of meeting the needs of these communities. Adoption of this 
technology has not come quickly, however, largely because of several challenges in reuse 
regulation and implementation. Chief among these difficulties is the assurance of public health, 
including prevention of the public’s exposure to harmful chemical and microbiological 
contaminants.16,17 Specifically, microbiological hazards may pose an acute health risk to DPR 
water consumers if pathogens are not sufficiently removed during treatment. Virus removal is of 
primary concern in DPR because viruses can be present in elevated concentrations in wastewater18 
and are highly infectious.10 
To mitigate the microbial risk associated with drinking water, regulations largely focus on keeping 
the prevalence of illness associated with pathogens in water below a certain threshold.16,19,20 For 
example, in the United States, water reuse and drinking water standards include minimum 
pathogen removal levels created to keep the annual risk of infection at or below 1 person per 
10,000.20–22 To achieve the desired level of pathogen reduction, water systems use a multibarrier 
approach to treatment, in which unit processes are placed in series and cumulatively provide the 
total desired amount of removal for a particular pathogen. The removal of pathogens achieved by 
each unit process is typically determined by research studies at the bench- or pilot-scale. For 
instance, adenovirus 41 inactivation by UV254 has been established in various collimated beam 
experiments as achieving 4-log10 inactivation at a UV254 dose of ~ 186 mJ cm-2.23  
Additionally, these unit processes must be monitored in real-time to ensure unit processes are 
inactivating pathogens as intended. The low concentrations of pathogenic viruses required in 
finished drinking water (e.g., < 2.2 x 10-7 viruses/L)17 makes real-time detection of individual 
pathogens infeasible at present. Consequently, surrogate virus parameters are monitored in real-
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time to validate virus removal. These surrogates vary by unit process, and can include turbidity, 
conductivity, disinfectant concentration times contact time (Ct), or pressure-decay tests, among 
others.16,24,25 When surrogate parameters meet accepted values, log10 pathogen removal credit for 
the unit process is allotted. Treatment processes may not be effective or may not be applied in 
instances where virus susceptibility is not well understood or when virus inactivation cannot be 
validated. In these scenarios, treatment may be overengineered, leading to unsustainable and 
economically infeasible treatment schemes; on the other hand, underengineered treatment 
strategies can result in unsafe practices that put the public at increased risk. 
Inactivation and removal of important enteric viruses through some unit processes have not been 
well studied. This is particularly true for emerging or difficult-to-culture viruses. Human norovirus 
(HuNoV), for example, is an important viral pathogen in water settings because of its large burden 
of disease as the leading cause of gastrointestinal illness in the United States.7 To date, our inability 
to readily culture HuNoV in vitro has limited research focused on infectious HuNoV persistence 
in the environment and infectivity through water treatment processes. In many cases, surrogate 
viruses have been used to approximate inactivation of viral pathogens,26–39 but these viruses may 
not behave in the same manner as the pathogens they are selected to represent.40 Viral genome 
concentrations have also been measured in lieu of culture-based methods,11,12,41–48 but these 
measurements provide no information regarding virus infectivity. These approaches are not ideal, 
because infectious viral pathogen levels may not be accurately estimated with either approach. 
Alternative methods for assessing virus fate are needed for viruses that cannot be readily cultured 
or pose an emerging public health threat. To address these needs, I developed innovative methods 
for estimating virus inactivation through UV254 that do not rely on culture systems and applied 
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these approaches to estimate HuNoV inactivation. I further confirmed the estimated UV254 
susceptibility of HuNoV using a novel cell culture system. 
In addition to better understanding virus fate through water treatment systems, sensitive real-time 
tools for monitoring virus reductions through unit processes are needed. Surrogates for real-time 
monitoring are often not as sensitive as necessary to exhibit the same extent of pathogen removal 
occurring through a particular treatment. In other words, the extent of surrogate removal is often 
much less than the demonstrated virus removal through the same unit process. This is particularly 
true for physical and biological removal processes. For example, bench-scale work has established 
that reverse osmosis can provide over 5-log10 removal of viruses,49,50 but the surrogates commonly 
used to validate performance, namely total organic carbon and electrical conductivity, can only 
ensure 1.5 to 2-log10 removal.16,24 As a result, only the removal achieved by the surrogate can be 
allotted. New methods for real-time monitoring of particles in water have the ability to 
revolutionize the way microbial population reductions are ascertained. 
Flow cytometry (FCM), a high-throughput method for real-time particle detection, has been used 
to rapidly quantify bacteria in water.51 Virus detection using FCM, coined flow virometry (FVM), 
may serve as a more sensitive surrogate monitoring approach because, unlike surrogate parameters 
that measure chemical concentrations or water transparency, FVM measures biological particles 
of the same size range as viral pathogens of interest. Yet FVM studies in water treatment are 
limited, and work has not unequivocally determined whether particle counts by flow cytometers 
indeed measure virus populations.52–54 Research to further validate the capabilities of FVM for 
real-time monitoring of viral populations in environmental matrices would be valuable. To this 
end, I initiated this research by characterizing virus types that can detected using a high sensitivity 
flow cytometer, and I conducted proof-of-concept experiments to establish the feasibility of FVM 
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as an accurate real-time surrogate for monitoring the effectiveness of virus removal by membrane 
processes. 
This dissertation introduces novel tools to study the inactivation of viral pathogens through water 
disinfection strategies and evaluates promising viral monitoring methods. Initial work developed 
and validated two methods, a genome-wide PCR-based extrapolation approach (Chapter 2) and a 
predictive modeling approach (Chapter 3), to accurately estimate UV254 virus inactivation without 
relying on traditional culture systems. These alternative approaches were used to determine UV254 
inactivation of various human viral pathogens, including HuNoV, with no available high-quality 
inactivation data. HuNoV susceptibility to UV254 disinfection was then confirmed using a novel 
enteroid culture system (Chapter 4). Next, I explored the potential applications of FVM for 
monitoring virus removal through DPR processes and identified future directions for FVM in this 
setting (Chapter 5). Information from this work motivated an extensive investigation of FVM 
methods and ultimately led to proof-of-concept experiments assessing FVM’s suitability as a real-
time surrogate for virus removal through microfiltration and ultrafiltration (Chapter 6). Ultimately, 
I summarized the primary findings and implications of this research and presented future research 
areas (Chapter 7). 
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 Abstract 
The removal and inactivation of infectious human norovirus is a major focus in water purification, 
but its fate through disinfection treatment processes is largely unknown owing to the lack of a 
readily available infectivity assay. In particular, norovirus behavior through unit processes may be 
over- or underestimated using current approaches for assessing human norovirus infectivity (e.g., 
surrogates, molecular methods). Here we fill a critical knowledge gap by estimating inactivation 
data for human norovirus after exposure to UV254, a commonly used disinfection process in the 
water industry. Specifically, we used a PCR-based approach that accurately tracks positive-sense 
single-stranded RNA virus inactivation without relying on culturing methods. We first confirmed 
that the approach is valid with a culturable positive-sense single-stranded RNA human virus, 
coxsackievirus B5, by applying both qPCR- and culture-based methods to measure inactivation 
kinetics with UV254 treatment. We then applied the qPCR-based method to establish a UV254 
inactivation curve for human norovirus (inactivation rate constant = 0.27 cm2 mJ -1). Based on a 
comparison with previously published data, human norovirus exhibited similar UV254 
 16 
susceptibility compared with other enteric single-stranded RNA viruses (e.g., Echovirus 12, feline 
calicivirus), but degraded much faster than MS2 (inactivation rate constant = 0.14 cm2 mJ-1). In 
addition to establishing a human norovirus inactivation rate constant, we developed an approach 
using a single qPCR assay that can be applied to estimate human norovirus inactivation in UV254 
disinfection systems. 
 Introduction 
Human norovirus (HuNoV) is a viral pathogen of principal concern in water purification due to its 
large burden of disease, ubiquitous presence in wastewater, and highly infectious nature. HuNoV 
is estimated to cause at least 19 million cases of gastroenteritis in the US each year,1,2 almost 20 
times more than any other enteric pathogen.1 As a result of the high frequency of infection and the 
high viral titers present in the excreta of infected individuals, HuNoV concentrations in raw 
wastewater have been measured as high as 3.4 x 109 genome copies/L via reverse transcription 
quantitative PCR (RT-qPCR).3 In addition, human challenge studies and subsequent dose-response 
models have indicated the infectious dose of HuNoV may be as low as one virus particle,4 although 
other work suggests the infectious dose may be higher.5 HuNoV is a particularly important 
consideration in the planned use of wastewater as a drinking water source (i.e., potable reuse). It 
is unclear whether the current water reuse guidelines, which are based on other human viruses, are 
sufficient to meet acceptable HuNoV public health risks.6,7  
The efficacy of HuNoV inactivation through water treatment processes remains elusive due to the 
historical lack of a HuNoV culture system. Two systems capable of culturing certain HuNoV 
strains in vitro from HuNoV positive stool samples have been reported in recent years8–10 but have 
not been applied to establish inactivation curves. A number of culturable surrogate viruses are 
commonly employed in challenge tests to approximate HuNoV physical removal or inactivation 
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in water treatment processes, but questions remain about their ability to mimic HuNoV behavior 
through these treatments.11 Likewise, HuNoV genomes are often quantified in samples with RT-
qPCR,12 but these measurements do not provide information on virus infectivity. Pretreatments 
such as propidium monoazide,13,14 RNase,14–16 and platinum or palladium compounds17 have been 
suggested to differentiate infectious and noninfectious HuNoV by qPCR; however, these 
approaches are only successful when noninfectious viruses have compromised protein capsids.13,18 
Low-pressure UV disinfection (i.e., UV254) primarily targets the viral genome19–22 and is 
increasingly employed in drinking water, wastewater, and advanced water treatment for potable 
reuse. Previous work has noted that the use of traditional qPCR approaches (i.e., targeting 
amplicons of 100 – 200 base pairs) as a proxy for measuring virus infectivity following UV 
inactivation overestimates infectious virus levels.15,23 This is due to the fact that traditional qPCR 
measures short genome segments, and these segments contain far fewer reactive sites than the 
entire viral genome. Quantifying intact short genome segments through UV treatment therefore 
vastly underestimates virus inactivation.24 Long-range reverse transcription and amplification of 
larger portions of the genome more closely mirror infectious virus concentrations following 
treatment.18,23,25 Measuring entire viral genomes by qPCR before and after UV treatment would 
be a technically challenging approach to measuring infectious viruses. Virus inactivation has, 
however, been effectively tracked through disinfection by targeting a large fraction of the genome 
with qPCR (~50%) and then extrapolating the observed amplicon damage to the damage expected 
in the full-length genome with Poissonian statistics.24,26 Originally developed with bacteriophage 
MS2,24 the technique has not yet been applied to fill critical knowledge gaps on the inactivation of 
nonculturable viruses. It should be noted that while this approach works for some virus types, it 
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may not be applicable for others (e.g., some double-stranded DNA viruses), and in particular those 
viruses for which host genome repair or genome reactivation may complicate UV254 inactivation. 
In the current study, we first validate the genome extrapolation approach with a culturable positive-
sense single-stranded RNA ((+) ssRNA) human enteric virus, coxsackievirus B5 (CVB5), and then 
apply the approach to provide UV254 inactivation data for HuNoV. We then compare HuNoV 
UV254 inactivation kinetics with those of several other (+) ssRNA viruses, including viruses 
commonly used as surrogates for HuNoV. Finally, we propose an easy-to-use qPCR tool for 
measuring HuNoV inactivation through UV254 treatment in wastewater, drinking water, and water 
reuse settings. The inactivation kinetics data and qPCR tool can be applied to current water 
treatment schemes to assess the log10 inactivation of HuNoV achieved by UV254 disinfection 
processes. 
 Materials and Methods 
 Virus stocks and enumeration. 
CVB5 (Faulkner strain; ATCC VR-185) was propagated in buffalo green monkey kidney cells 
(BGMK; kindly provided by the Spiez Laboratory, Switzerland) grown in Minimum Essential 
Media (MEM; Gibco, Waltham, NY), amended with 1% penicillin and streptomycin, and 2% fetal 
bovine serum. Cells were incubated at 37°C in 5% CO2 and 95% humidity and grown to confluence 
in T25 culture flasks (TPP Techno Plastic Products, Trasadingen, Switzerland).27 Confluent cells 
in 96-well plates were infected with concentrated stocks of CVB5 (108-109 most probable number 
(mpn)/mL) at a multiplicity of infection equal to 0.1, and cells were checked daily until full 
cytopathic effect (CPE) was observed.27 Propagated CVB5 was concentrated with polyethylene 
glycol, extracted with chloroform, and then filtered and concentrated using 100 kDa molecular 
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weight cut-off centrifugal filters (Amicon Ultra; Sigma-Aldrich, St. Louis, MO), analogous to a 
procedure previously described for MS2 coliphage.28 Infectious CVB5 were enumerated by the 
mpn method,27 and infectious virus concentrations are reported in mpn/mL. The CVB5 stocks were 
stored in virus dilution buffer (VDB; 5 mM NaH2PO4, 10 mM NaCl, pH7.4) at 4°C until use. Stock 
concentrations were measured prior to experiments to confirm initial virus concentrations. 
A de-identified human stool sample containing HuNoV GII.4 Sydney was obtained from the 
Michigan Department of Health and Human Services. Stool suspensions (10%) were generated by 
spiking the received stool into 1X phosphate buffered saline (PBS; Thermo Fisher Scientific, 
Waltham, MA) followed by filtration through a 0.22 μm sterile polyethersulfone membrane 
(CELLTREAT Scientific, Pepperell, MA). The suspensions (approximately 1.5 x 107 genome 
copies/mL) were stored in 260 μL aliquots at -80°C until use. RNase experiments were conducted 
to assess whether extraviral RNA was present in the HuNoV stool suspensions used for UV 
inactivation experiments. Details of RNase experiments in stool suspensions are described in the 
Supporting Information (SI). 
Bacteriophage MS2 was used in all CVB5 and HuNoV experiments to confirm that applied UV 
doses were consistent with expected doses in the literature, and to allow comparison of data 
between laboratories. Bacteriophage MS2 (ATCC 15597-B1) was propagated in Escherichia. coli 
(ATCC 15597), and concentrated, extracted, and purified, as previously described.28 Infectious 
MS2 was enumerated on double agar layer plaque assays using host E. coli,29 and concentrations 
are reported in plaque forming units (pfu)/mL. The MS2 stocks (~1 x 1011 pfu/mL and ~1 x 1012 
pfu/mL for HuNoV and CVB5 experiments, respectively) were stored at 4°C in VDB. 
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 UV254 experiments. 
UV254 inactivation experiments were carried out with custom-built collimated beam apparatuses. 
Lamp intensities were measured with potassium iodide chemical actinometry.30,31 
The CVB5 experiments were conducted in VDB containing both CVB5 (106 mpn/mL) and MS2 
(109 pfu/mL). Experimental solutions (3 mL) were prepared in triplicate in sterile glass beakers, 
and were optically dilute (> 95% transmittance at 254 nm). The solutions were exposed to 0.15 
mW cm-2 lamps (Philips, TUV F17T8) under constant mixing and at room temperature for UV254 
doses ranging from 0 to 150 mJ cm-2. Following UV254 exposure, the solutions were aliquoted for 
MS2 infectivity, CVB5 infectivity, and RNA extraction. 
The HuNoV experimental solutions consisted of 1% filtered stool suspensions and MS2 
bacteriophage (1 x 109 pfu/mL) in PBS. Aliquots of the experimental solutions (220 μL) were 
placed in a 96-well flat-bottomed plate (Corning, Corning, NY) and continuously mixed at 500 
rpm using a 96-well plate mixer (MixMate; Eppendorf, Hamburg, Germany). Samples were 
exposed to a collimated beam reactor with 0.16 mW cm-2 UV254 lamps (model G15T8, Philips) at 
room temperature. The UV254 exposures were corrected for average irradiance based on UV254 
attenuation of the experimental solutions (~40% transmittance at 254 nm) and the sample depth 
(0.5 cm). The resulting doses ranged from 0 to 152 mJ cm-2. Dark control samples were prepared 
for each experiment. Following exposure to UV254, samples were divided for MS2 infectivity and 
RNA extraction. MS2 plaque assays were carried out immediately after all inactivation 
experiments to verify UV254 exposure.29 
UV254 excitation may transform components in HuNoV stool suspensions into reactive species, 
which may in turn contribute to virus degradation (i.e., indirect photolysis). MS2 experiments were 
also conducted in buffer solution, which does not contain potential sources of indirect photolysis, 
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to confirm that inactivation rates determined with stool suspensions did not differ from those in 
buffer solution. MS2 buffer experiments were conducted in the same manner as the HuNoV stool 
experiments described above, with the exception that only MS2 bacteriophage (1 x 109 pfu/mL) 
was spiked into PBS. Experimental solutions were optically dilute (>95% transmittance at 254 
nm) and therefore correction of the UV254 irradiance was not necessary.  
Inactivation rate constants kinact (mJ-1 cm2) for MS2 and CVB5 were determined according to the 
following equation: 
ln # !!!$ = −'"#$%& ∙ )'("#$ + +,-./0-/       (1) 
where C and C0 are the concentrations of infectious viruses post and prior to UV254 exposure, 
respectively, and DUV254 is the UV dose, in mJ cm-2. 
 RT-qPCR assays. 
RNA from CVB5 inactivation experiments was extracted using Viral PureLink RNA Extraction 
kits (Invitrogen, Waltham, MA), eluted in 50 μL nuclease free water, and stored at -80°C. For 
HuNoV RNA extractions, 300 μL TRIzol reagent (Invitrogen) was added to 100 μL HuNoV 
inactivation experiment aliquots and extracted following the Direct-zol RNA MiniPrep Plus kit 
manufacturer instructions (Zymo Research, Irvine, CA) with no DNase treatment step. The 
extracted HuNoV RNA was eluted in 50 μL nuclease free water and stored at -80°C. 
CVB5 primer sets were developed using Geneious (Version 11.1.4, Biomatters Ltd., Auckland, New 
Zealand; A.2 Tables 
Table ). Seven primer sets were selected, covering approximately 49% of the genome. The HuNoV 
GII.4 Sydney virus genome used in this study was Sanger sequenced using primer walking 
methods to obtain a nearly complete genome (7,469 bases; NCBI accession number MN703761). 
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HuNoV primer sets were designed with PrimerSelect (DNASTAR, Madison, WI). Eight sets of 
primers were selected to cover approximately 50% of the genome (Table ). 
One-step RT-qPCR of CVB5 extracts was performed using the One Step PrimeScript RT-PCR Kit 
(Takara Bio, Inc., Kusatsu, Japan) with SYBR Green reagents. 3 µL RNA template and 0.2 µM 
forward and reverse primers were included in each 15 μL reaction. The same cycling parameters 
were used for all CVB5 primer sets: initial denaturation at 95°C for 15 s, followed by 40 cycles of 
denaturation (95°C for 15 s), annealing (60°C for 30 s), and extension (72°C for 20 s), with a final 
extension step (72°C for 45 s). Each CVB5 run was performed on a magnetic induction cycler 
qPCR machine (Mic qPCR Cycler, Bio Molecular Systems, Queensland, Australia) with technical 
replicates (n = 2) and the average concentrations of replicates were used. When neither duplicate 
amplified, the data point was omitted, and if only one duplicate amplified, that value was used. 
Each run included a standard curve for all primer sets considered. qPCR standards were produced 
from extracted CVB5 RNA. The standard curves consisted of five serially diluted standards and a 
no-template control. The slopes and corresponding efficiencies of each assay are included in Table 
A.1. R2 of all standard curves was greater than 0.98. 
HuNoV RT-qPCR was carried out using a two-step reaction. cDNA synthesis was conducted for 
each sample using the iScript cDNA Synthesis kit (Bio-Rad, Hercules, CA) with 5 μL of RNA 
template in each 20 μL reaction. The qPCR reaction took place with a Mastercycler ep RealPlex 2 
system (Eppendorf, Hauppauge, NY) with technical replicates (n = 3) and the average 
concentration of replicates were included. When the sample concentration was below the limit of 
quantification (LOQ), the data point was not included in analysis. Each 20 μL reaction consisted 
of 2 μL of cDNA template, 1X Fast EvaGreen qPCR Master Mix (Biotium, Inc., Fremont, CA), 
0.5 μM forward and reverse primers, and 0.625 mg/mL bovine serum albumin (BSA). 
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Thermocycling conditions included an initial denaturation at 95°C for 5 min, 40 cycles of 
denaturation (95°C for 20 s), annealing (60°C for 20 s), and extension (72°C for 20 s), and a final 
extension step (72°C for 1 min). qPCR standards consisted of eight different purified gel products 
prepared from the GII.4 Sydney stool sample with each primer set. The amplified product was 
extracted with a QIAquick Gel Extraction kit (Qiagen, Hilden, Germany) and quantified with a 
Qubit fluorometer (Invitrogen). All standard sequences were confirmed with Sanger sequencing. 
Each assay contained a standard curve consisting of ³ five serially diluted standards measured in 
triplicate and a no-template control. The slopes and corresponding efficiencies of each assay are 
included in Table A.2. R2 of all standard curves was greater than 0.99. 
RT-qPCR LOQs for each amplicon (Table A.1 and Table A.2) were defined as the threshold cycle 
(i.e., Ct) associated with the lowest dilution standard that resulted in a relative standard deviation 
of less than 35%32 for ten replicates.33 If after primer design and LOQ determination, a specific 
amplicon assay was not capable of tracking a sufficient amount of degradation in amplicon 
concentration before reaching the LOQ, a new primer set was selected and LOQ determination 
was carried out again. Amplicon degradation could be measured up to at least 0.87-log reduction 
for all HuNoV sample replicates and assays, based on initial experimental concentrations and assay 
LOQs. Based on the assay LOQs and starting concentrations of CVB5 amplicons, up to at least 
2.7-log reduction was observable. 
 Extrapolation to the full genome. 
The log10 reduction in intact genome concentrations following exposure to UV254 was estimated 
with the following relationship:24  
log # ))!$ =
*+#,-+	/+#0&1
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where N0 and N are the concentrations of intact genomes before and after UV254 exposure, 
respectively, n is the number of amplicons measured with RT-qPCR, i is the amplicon number, 
and x0 and x are the concentrations of the intact amplicon measured by RT-qPCR before and after 
UV254 inactivation, respectively. Decay rate constants for each amplicon, ki (mJ-1 cm2), were 
determined according to the following equation: 
ln 5 :%:!,%8 = −'" ∙ )'("#$ + +,-./0-/        (3) 
The amplicons used were not identical in length (Table A.1 and Table A.2). Because larger 
nucleotide sequences have more potential UV254 reaction sites than smaller sequences, amplicon 
decay rate constants cannot be directly compared to identify differential amplicon reactivity. To 
account for differences in amplicon size, ki was normalized by the respective amplicon length (i.e., 
each amplicon decay rate constant was divided by the number of nucleotides in the amplicon), 
yielding the normalized amplicon decay rate constant ki, norm (mJ-1 cm2 base-1). 
The decay rate constant for the full genome, kgenome (mJ-1 cm2), is described by the following 
equation: 
ln #))!$ = −'0+#,-+ ∙ )'("#$ + +,-./0-/       (4) 
 Statistical analyses. 
All statistical comparisons and experimental data regression analyses were conducted in Prism 
version 7.0b (GraphPad, La Jolla, CA). Each rate constant (i.e., ki and kinact) was determined by 
conducting a single linear regression analysis on all experimental data (i.e., ln(xi/xi,0) or ln(C/C0) 
values at all UV doses). The full genome decay rate constant (i.e., kgenome) was determined by 
extrapolating amplicon degradation of each data point to the full genome using Equation 2 and 
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conducting a linear regression analysis on all the resulting genome degradation values. The error 
provided for each rate constant represents the 95% confidence interval (CI) of the linear regression 
slope. 
In some cases, inactivation curves and genome degradation curves exhibited tailing at high UV254 
doses; this effect may be due to the pyrimidine dimer reactions reaching photostationary states.34–
36 In these cases, only the linear portion of the curve was included in determination of kinact, ki, or 
kgenome. The linear portion of the curve was identified as the region for which the inclusion of 
increasing doses did not reduce the R2 value. An Analysis of Covariance was employed to assess 
whether two linear regression slopes were significantly different from each other. 
 Results and Discussion 
This study was undertaken to determine the inactivation of HuNoV through UV254 disinfection 
using a genome-wide PCR-based approach originally developed with bacteriophage MS2 
inactivation by UV254.24 To confirm that the framework accurately estimates the UV254 inactivation 
kinetics of other (+) ssRNA viruses, we first tested the approach on CVB5, a culturable virus, so 
that infectivity through UV254 inactivation could be compared to genome extrapolation results. 
 Framework validation using CVB5. 
UV254 doses for CVB5 experiments were verified with MS2, which was inactivated at similar rates 
(kinact = 0.14 ± 0.01 cm2 mJ-1; mean ± 95% CI; Figure A.1) to those described in the literature 
(average kinact = 0.13 cm2 mJ-1).37 The values of ki, norm for the seven amplicons of the CVB5 
genome measured with RT-qPCR ranged from 3.4 x 10-5 to 6.1 x 10-5 cm2 mJ-1 base-1 (Figure A.2). 
These rate constants are similar to the range of values (1.6 x 10-5 to 4.8 x 10-5 cm2 mJ-1 base-1) 
detected for other (+) ssRNA virus amplicons when normalized by amplicon length.28,34 
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Extrapolation of the data from the seven CVB5 amplicons to the entire genome resulted in a CVB5 
genome decay rate of 0.35 ± 0.07 cm2 mJ-1 (Figure 2.1). Amplicon coverage of 49% of the genome 
was chosen for extrapolation because it alleviates variability in amplicon degradation that arises 
when extrapolating inactivation with a reduced number of amplicons.24 The estimated inactivation 
rate was similar to the inactivation rate constant determined with infectivity assays (kinact = 0.33 ± 
0.03 cm2 mJ-1; Figure 2.1). Our CVB5 results provide further evidence that the qPCR extrapolation 
method, which was originally verified with MS2, is effective at estimating the infectivity of (+) 
ssRNA viruses through UV254 treatment. It is therefore reasonable to assume that this method can 
also be applied to predict the inactivation kinetics of (+) ssRNA viruses that are difficult or not yet 
possible to culture.  
 
Figure 2.1. Degradation of CVB5 genome and loss of infectivity following UV254 exposure. Error bars 
depict standard error of the mean of three independent replicates (N = 3). CVB5 was spiked into VDB at a 
final concentration of 106 mpn/mL. Error bars are present for each symbol but in some cases are smaller 
than the symbol. Data re-used by permission from Springer Nature: Food and Environmental Virology, 
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 Estimation of HuNoV UV254 inactivation. 
Next, we applied this approach to predict the inactivation kinetics of HuNoV. In these experiments, 
MS2 was used to verify the UV254 dose applied to viruses in suspension. The MS2 inactivation 
rate (kinact = 0.14 ± 0.02 cm2 mJ-1; Figure A.3) was similar to values reported in the literature 
(average kinact = 0.13 cm2 mJ-1),37 thus confirming the UV254 doses experienced by HuNoV during 
experimentation. The MS2 kinetics also corresponded with those measured in the CVB5/MS2 
experiments discussed above, indicating that the experimental conditions were similar for all of 
the viruses studied. The HuNoV genome concentrations were similar in RNase-treated and 
untreated HuNoV suspensions used for inactivation experiments (Figure A.4), revealing that there 
was minimal extraviral RNA in the suspensions.  
Constituents of HuNoV stool suspensions may react with photons during UV254 inactivation and 
generate reactive species that result in indirect photolysis of viruses. To ensure that indirect 
photolysis did not occur during UV254 inactivation, MS2 inactivation in PBS (i.e., a 
photosensitizer-free solution) was compared to MS2 inactivation in the stool suspension. Rates of 
MS2 inactivation in buffer (kinact = 0.14 ± 0.02 cm2 mJ-1; Figure A.5) were the same as those in 
stool suspensions (kinact = 0.14 ± 0.02 cm2 mJ-1). The similar rates of MS2 inactivation between 
buffer solution and stool suspensions suggest that indirect photolysis did not contribute to the 
inactivation rates observed in HuNoV experiments. 
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HuNoV UV254 inactivation resulted in normalized decay rate constants ki, norm for the eight 
measured regions in the HuNoV genome ranging from 2.1 x 10-5 to 4.9 x 10-5 cm2 mJ-1 base-1 
(Figure 2.2a). These values are comparable to the rate constants measured for the CVB5 genome 
regions, as well as to RNA rate constants reported in the literature.28,34 The range of observed 
HuNoV amplicon reactivities after accounting for amplicon length is consistent with previous 
studies that have reported varying UV254 reaction kinetics across the genomes of other ssRNA 
viruses.28,34 Individual RNA nucleotides and specific RNA sequences have unique UV 
reactivities.39 Specifically, pyrimidine bases are more photoreactive than purine bases, forming 
both pyrimidine hydrates and pyrimidine dimers. Indeed, the fastest reacting amplicon (i.e., 
Amplicon 1) contained 257 pyrimidines, whereas the slowest reacting amplicon (i.e., Amplicon 4) 
contained 222 pyrimidines. RNA secondary structure can also impact the photoreactivity of 
nucleic acids.40 Consequently, amplifying only a small region of the genome and extrapolating 
damage to the whole genome may under- or over-predict genome reactivity;24 incorporating the 
reactivities of several amplicons covering different portions of the genome seeks to avoid this 
potential bias. 
The reactivities of the eight HuNoV genome regions were used to construct an inactivation curve 
for the entire HuNoV genome (Figure 2.2b). Fitted to equation 2, the resulting inactivation rate 
constant kgenome for HuNoV was 0.27 ± 0.03 cm2 mJ-1. As mentioned above, HuNoV UV254 
inactivation curves generated from infectivity assays are not available due to the lack of a reliable 
and quantitative culture-based infectivity assay. Based on the inactivation rate constant determined 
from our extrapolated genome data, a 4-log inactivation of GII HuNoV would be expected 
following a UV254 dose of approximately 34 mJ cm-2.  
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This finding is a significant departure from previous reports of 0- to 1.5-log inactivation at 
treatment plants and in lab-scale studies after UV254 doses as high as 300 mJ cm-2. 3,15,41 These 
studies also relied on qPCR, but used short regions of the genome (~100 bases) to determine virus 
inactivation.3,15,41 The discrepancy between our HuNoV inactivation results and those reported in 
previous studies lies in the fact that their results represent the reactivity of a small portion (i.e., 
<1%) of the genome, whereas our results represent the reactivity of the entire genome. Such 
discrepancies have been reported for culturable viruses,18,23,25,42 but not for HuNoV. 
 
Figure 2.2 Reactivity of HuNoV following UV254 exposure. Reaction rate constants for HuNoV amplicons, 
normalized by number of bases in each amplicon (a), and estimated HuNoV inactivation using extrapolation 
of genome degradation data from all eight amplicons, following equation 2 (b). Experiments were 
performed in replicate (N = 4) and error bars depict standard error of the mean of four independent 
replicates. HuNoV was spiked into PBS at a final concentrations of 1.5 x 106 gene copies/mL. 
 Comparison of HuNoV and other (+) ssRNA viruses. 
The availability of a HuNoV inactivation rate constant provides an opportunity to compare the 
susceptibility of HuNoV to culturable viruses, especially those commonly used as HuNoV 
surrogates. Feline calicivirus (FCV) and murine norovirus (MNV), for example, are both members 
of the Caliciviridae family and share many traits with HuNoV, including RNA genome 
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organization43,44 and capsids with similar diameters and icosahedral shapes.45 Despite these 
structural similarities, the usefulness of these viruses as surrogates for HuNoV has been 
debated.11,46 A comparison of our HuNoV UV254 inactivation kinetics and published inactivation 
kinetics of FCV and MNV confirms that they are appropriate surrogates for HuNoV in UV254 
disinfection processes (Figure 2.3). Likewise, the enteroviruses CVB5 and echovirus 12, which 
are also (+) ssRNA viruses, have similar inactivation rates. Compared to HuNoV and the other 
ssRNA viruses presented in Figure 2.3, bacteriophage MS2 is not inactivated as quickly by UV254. 
This is likely because MS2 has a smaller genome than the other viruses (3.6 kb versus 
approximately 7.5 kb), thus containing fewer UV254 targets (Table A.3). Our results suggest that 
the HuNoV genome is not more resistant to UV254 than other (+) ssRNA viruses with similarly-
sized genomes, as measured with RT-qPCR. Therefore, culturable (+) ssRNA enteric viruses 
appear to be effective surrogates for tracking HuNoV inactivation with UV254. 
 
Figure 2.3 HuNoV inactivation curve based on amplicon extrapolation approach and inactivation curves 
of other (+) ssRNA viruses (MS2, CVB5, MNV, echovirus 12, and FCV). First-order reaction rate constants 
obtained from Park et al.47 and this study (Table A.3). 





















 HuNoV inactivation monitoring in water treatment settings. 
We used eight primer sets spanning the HuNoV GII.4 Sydney genome to approximate the reaction 
kinetics of the entire genome. This same approach cannot be applied to measure the inactivation 
of environmental HuNoV strains in UV treatment processes because the eight primer sets were 
designed specifically for the HuNoV GII.4 Sydney strain used in our experiments. The large 
sequence diversity in HuNoV genomes does not allow for the design of primers spanning the entire 
HuNoV genome, while also targeting a large portion of known HuNoV strains. 
To evaluate UV254 inactivation of environmental HuNoV, we selected a generic GII HuNoV 
primer set, namely G2SK,48 from the conserved region of the GII HuNoV genome for monitoring 
the UV254 inactivation of environmental GII HuNoV. We note that we cannot assume that the 
reactivity of the 344 base genome region captured with primer set G2SK is representative of the 
reactivity of the entire genome; instead, we can develop a relationship to link the reactivity of the 
G2SK region to the reactivity of the HuNoV genome. Specifically, we measured the UV254 
reaction kinetics of the G2SK amplicon (Figure A.6) in the same samples used to measure the 
eight primer sets and correlated the resulting data with the HuNoV inactivation kinetics obtained 
with our extrapolation approach (Figure 2.4). The resulting relationship can be applied by others 
to assess the UV254 inactivation of environmental HuNoV strains using only G2SK amplicon 
measurements: 
3,4<= #))!$ = 93,:; ∙ 3,4<= #
:
:!
$        (5) 
where, log10(x/x0) refers to the lognormal degradation of the G2SK amplicon through UV254 
treatment, log10(N/N0) refers to the lognormal HuNoV inactivation through UV254 treatment, and 
Slope is equal to 17.6. This approach does not extrapolate the G2SK amplicon results, but rather 
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applies the relationship between the degradation of the G2SK amplicon and the degradation of the 
entire genome. For example, if a 0.5-log removal of the G2SK amplicon is measured through 
UV254 treatment, then the overall GII HuNoV inactivation of 8.8-log (i.e., 17.6 × 0.5) has been 
achieved. It is worth mentioning that this relationship was obtained using estimated UV254 
inactivation data for a GII.4 Sydney HuNoV strain. While we would expect that other GII strains 
behave similarly through UV254 treatment, it is possible that other environmental GII strains may 
deviate slightly from this relationship. Additionally, use of this tool can only monitor HuNoV 
inactivation at levels of 1-log or more, because the G2SK degradation must be sufficient to detect 
a reduction in concentration with qPCR (details and results of a G2SK qPCR sensitivity analysis 
are provided in Appendix A and Figure A.7). 
 
Figure 2.4 Relationship between HuNoV inactivation through UV254 treatment and degradation of the 
conserved amplicon G2SK. The slope of the best-fit linear regression is 17.6 and R2 is 0.99. 
 Environmental implications. 
This study provides a critical HuNoV inactivation rate constant for UV254 disinfection and 


























that used traditional qPCR approaches. Our work underscores the importance of accounting for 
the entire genome when evaluating UV254 inactivation rates and highlights the limitations of 
measuring only a small portion of the genome. Although other approaches for estimating 
infectivity with molecular methods (e.g., sample pre-treatment before qPCR, near full-genome 
amplification) have improved inactivation approximations in the absence of infectivity assays, 
they suffer from multiple sample preparation steps, considerable assay optimization, and the 
inability to accurately track UV254 inactivation.13,18 The correlation developed here between short 
amplicon decay and genome inactivation will be a useful tool for rapidly assessing UV254 
inactivation in real world scenarios.  
One important factor enabling the success of this approach is that UV254 irradiation’s primary 
mode of action is damage to nucleic acid, which is the explicit target of the RT-qPCR assay. While 
the method used in this study could also be adapted for use with other disinfectants, such 
application would need to account for the different inactivation mechanisms of these 
disinfectants.34,49,50 The method would also need to be adapted for the inactivation of dsDNA 
viruses that undergo DNA repair in their host cells. 
Our results suggest that HuNoV behaves similarly to other enteric (+) ssRNA viruses through 
UV254 inactivation, though bacteriophage MS2 is more resistant due to its shorter genome length. 
This is an important finding because MS2 is commonly used to assess the degree of virus 
inactivation through UV254 systems;51 these findings provide confidence that MS2 inactivation can 
be used as a conservative estimator of HuNoV removal. Our findings further suggest that 
surrogates such as FCV and MNV are more appropriate for assessing HuNoV inactivation through 
UV254 treatment. Whether these surrogates are also suitable for estimating HuNoV infectivity 
through other disinfecting treatments (e.g., ozone, chlorine, advanced oxidation) remains to be 
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determined. Ongoing work towards quantitative HuNoV in vitro culture systems8,10 will ultimately 
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 Abstract 
UV254 disinfection strategies are commonly applied to inactivate pathogenic viruses in water, food, 
air, and on surfaces. There is a need for methods that rapidly predict the kinetics of virus 
inactivation by UV254, particularly for emerging and difficult-to-culture viruses. We conducted a 
systematic literature review of inactivation rate constants for a wide range of viruses. Using these 
data and virus characteristics, we developed and evaluated linear and non-linear models for 
predicting inactivation rate constants. Multiple linear regressions performed best for predicting the 
inactivation kinetics of (+) ssRNA and dsDNA viruses, with cross-validated root mean squared 
relative prediction errors similar to those associated with experimental rate constants. We tested 
the models by predicting and measuring inactivation rate constants of a (+) ssRNA mouse 
coronavirus and a dsDNA marine bacteriophage; the predicted rate constants were within 7% and 
71% of the experimental rate constants, respectively, indicating that the prediction was more 
accurate for the (+) ssRNA virus than the dsDNA virus. Finally, we applied our models to predict 
the UV254 rate constants of several viruses for which high-quality UV254 inactivation data are not 
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available. Our models will be valuable for predicting inactivation kinetics of emerging or difficult-
to-culture viruses. 
 Introduction 
Viruses can cause diverse and costly illnesses in humans and other animals.1 A variety of 
approaches have therefore been developed to decontaminate food, water, air, and surfaces that may 
contain infective viruses.2–7 UV254 treatment, in particular, is gaining popularity as an alternative 
to more traditional chemical disinfection strategies.8–10 Viruses can have highly variable UV254 
susceptibilities.11,12 For example, two dsDNA viruses, adenovirus type 40 and bacteriophage T6, 
are inactivated by UV254 at the widely varying rates of ~ 0.06 cm2 mJ-1.13–18 and ~ 5.4 cm2 mJ-1,19 
respectively. 
Viruses have diverse genome types, including double-stranded RNA (dsRNA), single-stranded 
RNA (ssRNA), double-stranded DNA (dsDNA), and single-stranded DNA (ssDNA). UV254 
inactivates by primarily targeting viral genetic material, and the different biochemical structures 
associated with these viral genome types result in distinct sensitivities to UV254.20 Nucleic acid 
primary structure, or nucleotide base sequence, also affects UV254 genome reactivity – pyrimidine 
bases, for instance, are about an order of magnitude more reactive with UV254 than purine 
bases.21,22 The replication modes of viruses differ, and an enzyme of one virus may stall at a UV254 
lesion that does not affect the replication enzyme of another virus. For example, the reverse 
transcriptase enzymes involved in the generation of retrovirus mRNA may have different 
sensitivities to photochemical modifications in nucleic acid compared to the RNA dependent RNA 
polymerase enzymes used by other RNA viruses to synthesize mRNA.23 Additional differences in 
viral infection cycles impact virus sensitivity to UV254.24 dsDNA virus genomes, for example, can 
undergo nucleic acid repair once inside host cells.24–26 This means that a virus may be inactivated 
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by UV254 treatment through base modification, only to be repaired and thus rendered infectious 
again when such repair mechanisms are available. We note these differences in virus genome type 
and mode of mRNA generation are utilized in the Baltimore virus classification system (e.g., 
Group 1: dsDNA viruses, Group IV: (+) ssRNA viruses).1,27 
Virus disinfection methods are evaluated by enumerating infective viruses before and after 
treatment, typically with virus culture systems. Relying on culture-based approaches to evaluate 
inactivation kinetics is often challenging. Most notably, many human viruses that are spread 
through the environment are not readily culturable. For highly pathogenic viruses that are 
culturable, disinfection experiments are complicated by biosafety restrictions. Disinfection 
experiments with severe acute respiratory syndrome (SARS) coronaviruses (SARS-CoV-1 and 
SARS-CoV-2), for example, are limited to biosafety level 3 laboratories and work with 
ebolaviruses require biosafety level 4 facilities. Alternative approaches for determining virus 
inactivation kinetics would be valuable, especially for difficult-to-culture and emerging viruses. 
Earlier studies have worked towards a predictive manner of evaluating UV254 virus inactivation 
based on virus attributes.28,29 Recently developed modeling strategies, an improved understanding 
of virus UV254 inactivation mechanisms, and additional high-quality inactivation data published in 
recent years provide the necessary tools and information to expand upon these initial predictive 
approaches. 
In this study, we develop models to predict rate constants for virus inactivation with UV254 
treatment in aqueous suspension using variables that are expected to play a role in inactivation, 
such as genome sequence composition and genome repair information. We conducted a systematic 
review to gather high quality virus inactivation data from the literature and used the resulting data 
set to train and validate the predictive performance of four different models (i.e., multiple linear 
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regression, elastic net regularization, boosted trees, and random forests). The models developed in 
this research will facilitate rapid evaluation of UV254 inactivation rate constants for a broad class 
of virus types based solely on virus genome sequence and genome repair information. 
 Materials and Methods 
 Systematic review of UV254 virus inactivation data. 
We conducted a systematic literature review to capture high quality UV254 virus inactivation data 
using the PRISMA guidelines.30 Data were extracted from studies if they adhered to all of the 
following criteria: the UV254 lamp fluences were measured and reported; sources emitted UV 
irradiation principally at wavelengths of 253, 253.7, 254, or 255 nm; viruses were irradiated in a 
liquid suspension; infective viruses were enumerated with quantitative culture-based approaches 
(e.g., plaque assay); attenuation through the sample solution was taken into account, or negligible 
UV254 attenuation was reported (transmittance > 95%) or could be assumed based on the reported 
viral stock purification techniques and matrix solution composition; stirring was reported when 
attenuation was significant (transmittance < 95%); first-order kinetics were reported or could be 
confirmed with reported data points for at least two UV254 fluences; the first-order inactivation rate 
constant or log-removal dose (e.g., D99) was provided or could be determined with data presented 
in a plot or table. For publications that contained valuable data, but for which not all criteria could 
be evaluated, corresponding authors were contacted when possible to inquire about the criteria. 
For studies that reported multiple UV254 inactivation experiments for the same virus (e.g., in 
different solutions, with multiple UV254 sources), we combined all data to determine a single 
inactivation rate constant with linear regression analysis. All data were re-extracted by a second 
reviewer and discrepancies were addressed. Additional details of our systematic review process 
are included in Appendix B. 
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 Final data set used in modeling. 
An inactivation rate constant collected in the systematic review was included in the modeling work 
if the virus’ genome sequence was available through NCBI and if the error associated with the 
inactivation rate constant was available. Information on NCBI sequence selection is provided in 
Appendix B. For viruses with three or more inactivation rate constants obtained from the 
systematic review, outlier rate constants (i.e., values lying >1.5 times the interquartile range above 
the third quartile or below the first quartile) were not included in model development. We 
calculated the inverse variance weighted mean inactivation rate constant for each virus using the 
following equation: 




          (1) 
where k<v is the inverse variance weighted mean for the virus, n is the number of experimental rate 
constants for the virus, ki is the inactivation rate constant for experiment i, and wi is the weight for 
experiment i, defined as: 
>" = <BC%"          (2) 
where SE,i is the standard error of the inactivation rate constant for experiment i. The standard 
error of the inverse variance weighted mean, SEv, was evaluated for each virus as: 
9?3 =	@ <∑ A%'%()          (3) 
We estimated the inter-experimental error for viruses with more than one experimental rate 
constant in the literature by determining the residual standard deviation from a weighted least 
squares regression. Virus was the categorical variable in the regression and experimental rate 
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constant was the dependent variable. Weighting was done using the inverse of the squared 
experimental standard error normalized by the mean rate constant for that virus. 
 Predictors. 
For model development, we used predictors related to virus structure and behavior that are known 
or hypothesized to affect UV254 inactivation. The specific predictors incorporated included 
structure of nucleic acid strands (i.e., double-stranded or single stranded), genome length, 
pyrimidine base content in the genome, sequential pyrimidine bases, genome repair mode, and 
host cell type. Our reasoning for inclusion of predictors and the methods used to determine values 
for each predictor are included in Appendix B. A list of the exact predictors as well as the values 
used for each virus are available in Table B.1.  
 Predictive model optimization. 
We used four model classes, namely multiple linear regression, elastic net regularization, boosted 
trees, and random forests, to predict virus inactivation during UV254 disinfection. For each model 
class, we developed individual models using only (+) ssRNA viruses and only dsDNA viruses. We 
also generated a single model developed using all viruses included in the collected data set and 
thus not separated by virus Baltimore classification groups. We assessed model performance using 
leave-one-virus-out cross-validation. Further details of model training, validation, and prediction 
performance evaluation are included in Appendix B. Data manipulation, statistical analyses, and 
modeling work were conducted in R software version 4.0.0.31 The raw data files and the scripts 
for model development and prediction are available in Github at https://github.com/nrockey/uv-
virus-inactivation-prediction. 
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 Multiple linear regression. 
Several of the genomic variables are collinear (e.g., numbers of U and UU). We therefore 
conducted principal component analysis (PCA) on the genomic variables prior to linear modeling 
to reduce variable dimensionality and eliminate collinearity. The predictors nucleic acid type, 
genome repair mode, and host cell type were not included in the PCA. We then developed linear 
regression models containing either the first, first and second, or first, second, and third principal 
components, as well as the other predictors. Only the first through third principal components were 
assessed for inclusion in the linear regression models, because they cumulatively explained 97% 
of the variation in genomic variables. Genomic variables were standardized to unit variance prior 
to PCA to eliminate dissimilarities in the magnitude of variable values. Linear regression can 
include one or more predictors that can affect model accuracy. We therefore used best subset 
selection to evaluate a wide range of potential multiple linear regression models. 
 Elastic net regularization. 
As an alternative to best subset selection, we considered linear regression with parameter 
regularization using L1 (“Lasso”) and L2 (“Ridge”) penalties, a technique known as the elastic 
net. We used the ‘glmnet’ package in R to create models with elastic net regularization. The alpha 
and lambda hyperparameters, which control the relative contribution and overall scale of the L1 
and L2 penalties, respectively, were tuned using a grid search to find the optimal hyperparameters 
for the data set as determined by leave-one-virus-out cross-validation. Specifically, 11 different 
values ranging from 0 to 1 with a step of 0.1 were assessed for the hyperparameter alpha, and 100 
different lambda values were evaluated for each alpha.  
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 Random forests. 
To accommodate the use of the modified inverse variance weights, the random forests model was 
developed in R using the ‘xgboost’ package with a single round of boosting, and other 
hyperparameters were set to match defaults from the ‘randomForest’ package as well as possible.32 
 Boosted trees. 
Boosted trees modeling was conducted using the ‘xgboost’ package in R. The number of boosting 
rounds was selected to minimize the cross-validated error. The hyperparameters for learning rate, 
tree depth, and minimum terminal node weight were 0.3, 6, and 1, respectively.  
 Experimental and predicted UV254 inactivation of murine hepatitis virus (MHV) and 
bacteriophage HS2. 
To consider how well the models may predict inactivation of a virus not already included in the 
collected data set, we determined the UV254 inactivation rate constant of MHV, a virus in the 
Coronaviridae family and Betacoronavirus genus, and of HS2, a marine bacteriophage, and 
compared experimental inactivation to the model’s predicted inactivation. Virus propagation and 
enumeration details are provided in Appendix B. 
 UV254 inactivation of viruses. 
All UV254 inactivation experiments were conducted with a custom-made collimated beam reactor 
containing 0.16 mW cm-2 lamps (model G15T8, Philips). UV254 irradiance was determined using 
chemical actinometry33,34 and Escherichia coli bacteriophage MS2 (ATCC 15597-B1) was 
included in all experimental solutions as a biodosimeter to further confirm UV254 doses. Infective 
MS2 was assessed using the double agar overlay approach with host Escherichia coli (ATCC 
15597).35 For each UV254 exposure, 2 mL of the experimental solution was added to a 10 mL glass 
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beaker and continuously stirred. Sample solution depth (0.8 cm) and transmittance (~ 47% to 53% 
for MHV experiments, ~ 79% to 80% for HS2 experiments) were used to determine the average 
UV254 irradiance of the sample according to the Beer-Lambert law.36 All UV254 inactivation 
experiments were conducted at room temperature (20 to 21°C). Infective viruses were assayed 
immediately following experiments. Dark controls were conducted with each experiment and 
consisted of the virus suspended in experimental solution but stored in the dark on ice for the 
duration of experiments. Three independent replicates were conducted for each inactivation 
experiment. 
For MHV experiments, solutions contained MHV and MS2 diluted in 1X PBS to a final 
concentration of ~ 105 pfu/mL and ~ 1010 pfu/mL, respectively. Samples were exposed to UV254 
for 0 s, 5 s, 15 s, 25 s, and 35 s, which corresponded to UV254 doses of approximately 0 mJ cm-2, 
0.62 mJ cm-2, 1.2 mJ cm-2, 1.9 mJ cm-2, 3.1 mJ cm-2, and 4.3 mJ cm-2. MS2 infectivity was assayed 
after larger UV254 doses due to its slower inactivation kinetics, namely 37 mJ cm-2 and 74 mJ cm-
2. For HS2 experiments, solutions contained HS2 and MS2 diluted in 1X PBS to a final 
concentration of ~ 108 pfu/mL and ~ 109 pfu/mL, respectively. Samples were irradiated for 0 s, 
180 s, 300 s, 480 s, 600 s, and 720 s, which resulted in UV254 doses of approximately 0 mJ cm-2, 
26 mJ cm-2, 44 mJ cm-2, 70 mJ cm-2, 88 mJ cm-2, and 105 mJ cm-2. 
The inactivation rate constant, kexp in cm2 mJ-1, for MHV, HS2, and MS2 was determined by the 
following equation: 
3- # !!!$ = '+:8 ∙ )'(DEF        (4) 
where C0 and C are infectious virus concentrations before and after UV254 exposure, respectively, 
in pfu/mL, and DUV254 is the average UV254 dose, in mJ cm-2. 
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Experimental inactivation rate constants (i.e., kexp) were determined with linear regression analyses 
conducted in Prism version 8.4.2 (GraphPad) to obtain experimental inactivation rate constants 
(i.e., kexp). UV254 inactivation curves for some viruses exhibited tailing at high doses. In these 
situations, only the linear portions of the inactivation curves were included in the linear regression 
analyses. 
 MHV and HS2 inactivation rate constant prediction. 
The UV254 inactivation rate constants of MHV and HS2 were predicted using the best-performing 
inactivation models for (+) ssRNA viruses and dsDNA viruses, respectively. The MHV genome 
sequence was provided by Dr. Leibowitz (Appendix B Text File 1), and the HS2 genome sequence 
is available in NCBI (accession no. KF302036). 
 Predicting UV254 inactivation of emerging or difficult-to-culture viruses. 
The inactivation rates of several emerging and difficult-to-culture viruses, including SARS-CoV-
2, were predicted using the best-performing inactivation model. Sequence data for these viruses 
were obtained from NCBI and all viruses with sequence information are included in Table B.1. 
 Results 
 Numerous UV254 rate constants are available, but only for a limited subset of viruses. 
We conducted a systematic review to collect UV254 inactivation rate constants and used them for 
the training and validation of models developed to predict virus inactivation kinetics. Of 2,416 
initial studies, 531 underwent full text review, and 103 studies were included in the final data set 
(Figure B.1). Only data from studies passing a set of experimental criteria were included to ensure 
collection of high-quality rate constants. These studies produced 224 experimental inactivation 
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rate constants for 59 viruses (Figure 3.1; Table B.2). Viruses of different strains and types were 
considered unique. 
More than 350 studies from the full text review that reported conducting UV virus inactivation in 
aqueous suspension were not included in the final data set. Data were excluded most commonly 
because the article did not address UV254 attenuation in the experimental solution and it could not 
be ruled out based on details in the materials and methods. Nearly 50% of the extracted rate 
constants represented only five different viruses. For example, there were 62 different 
experimental inactivation rates for bacteriophage MS2; in contrast, several viruses, including 
hepatitis E virus, only had one reported inactivation rate constant, and there were many human 
viruses with no data that met the review criteria (e.g., influenza viruses, ebolaviruses, 
coronaviruses, herpesviruses). Ultimately 13, 84, 111, 4, and 12 experimental inactivation rate 
constants were extracted for ssDNA, dsDNA, (+) ssRNA, (-) ssRNA, and dsRNA viruses, 
respectively, representing 3, 26, 22, 2, and 5 unique viruses (Figure 3.1). No rate constants met the 
inclusion criteria for retroviral (+) ssRNA viruses, referred to as RT-ssRNA viruses. The 
inactivation rate constants spanned ~2.5 orders of magnitude (Figure 3.1) and ranged from 0.021 
to 7.6 cm2 mJ-1. The (-) ssRNA viruses had the largest rate constants on average (k = 3.6 cm2 mJ-
1), while dsRNA viruses had the lowest average rate constants (k = 0.15 cm2 mJ-1). dsDNA virus 
constants exhibited the widest range of rate constants, spanning from 0.021 to 5.4 cm2 mJ-1 with a 
mean of 0.55 cm2 mJ-1. The rate constants collected were associated with the linear portion of the 
UV254 virus inactivation curve and did not incorporate regions of the curve where tailing occurred. 
Overall, first-order kinetics were observed up to at least 4-log10 virus inactivation. This suggests 
that our models are applicable up to approximately 4-log10 virus inactivation. Beyond that point, 
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our models could overestimate inactivation levels for viruses that exhibit tailing effects during 
inactivation. 
 
Figure 3.1 Distribution of UV254 inactivation rate constants collected from the systematic literature review. 
Black bars denote arithmetic means of inactivation rate constants for viruses with more than one 
experimental rate constant. Outliers are not included. ssDNA viruses: three viruses, 13 rate constants; 
dsDNA viruses: 26 viruses,* 84 rate constants; (-) ssRNA viruses: two viruses, four rate constants; (+) 
ssRNA viruses: 22 viruses, 107 rate constants (four outlier rate constants removed); dsRNA viruses: five 
viruses, 12 rate constants. Viruses within each Baltimore classification are ordered from highest to lowest 
mean rate constant from left to right. Rate constants are reported in Table B.2. *Considers two viruses (i.e., 
adenovirus 5 and adenovirus 41) assayed in host cells with reduced repair abilities as different from the 
same viruses assayed in wild-type host cells. 
Individual models were developed for the (+) ssRNA and dsDNA virus classes. The limited data 
sets for viruses in the other Baltimore classifications made it infeasible to develop individual 
predictive models for the other groups. The data sets used for (+) ssRNA and dsDNA model 
training and validation included 19 (+) ssRNA viruses with 93 experimental inactivation rate 
constants and 16 dsDNA viruses with 50 inactivation rate constants, respectively (Table B.2). The 
model developed with all viruses from the systematic review included 43 viruses with 168 
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 Rate constants predicted using common modeling approaches. 
We used the data collected in the systematic literature review to develop linear regression, elastic 
net regularization, random forests, and boosted trees models for predicting inactivation rate 
constants based on several predictors (Table B.1). These model classes were selected to cover a 
range of different linear and non-linear approaches that are commonly applied in the predictive 
modeling field.37 
 (+) ssRNA virus model. 
The cross-validated root mean squared relative prediction errors (RMSrPEs) for the four optimized 
models varied from 0.22 to 0.95 (Figure 3.2 and Table B.3), with the top performing multiple 
linear regression resulting in the lowest RMSrPE out of the four optimized model classes. Various 
subsets of genomic variables were included in multiple linear regression development. Because 
these genomic variables are highly collinear, we used principal components that incorporated 
various genomic variable subsets as predictors in the regression models. Ultimately, the multiple 
linear regression model with one principal component that incorporated the numbers of cytosines 
(Cs), uracils (Us), uracil doublets (UUs), and uracil triplets (UUUs) resulted in the lowest RMSrPE 
(0.22 ± 0.23; RMSrPE ± standard error; Table B.3). Other multiple linear regressions performed 
similarly (Table B.4). The optimized elastic net regularization and boosted trees models resulted 
in slightly higher RMSrPEs than the top performing multiple linear regression model 
(RMSrPEelastic net = 0.28 ± 0.26, RMSrPEboosted trees = 0.32 ± 0.28; Table B.3), and the random forests 
model had the largest RMSrPE of the (+) ssRNA virus models (RMSrPErandom forests = 0.95 ± 0.48; 
Table B.3). Model performance was significantly reduced in the elastic net and random forests 
models as compared to the multiple linear regression model (Table B.5). 
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Figure 3.2 Root squared relative prediction error of virus inactivation rate constants using top performing 
models from each model class developed with only (+) ssRNA viruses (left) or dsDNA viruses (right) in 
the training and validation set. Individual symbols indicate the root squared relative prediction error of each 
virus, and the black bar indicates the model’s root mean squared relative prediction error. Distinct colors 
represent different viruses, and the symbol sizes represent the weight of the experimental inactivation rate 
constant used for inverse variance weighting, where a larger symbol indicates a greater weight. MLR = 
multiple linear regression, ELNT = elastic net regularization, XGB = boosted trees, RF = random forests. 
Predicted (+) ssRNA virus rate constants from the top performing model were within 51% of the 
mean experimental virus inactivation rate constants obtained from the systematic review, with the 
exception of the rate constant for Atlantic Halibut Nodavirus (percent error = 182%; Figure B.2a). 
The RMSrPE from the top performing linear regression model was lower than the estimated 
relative inter-experimental error of viruses with multiple rate constants in the literature (RMSrPE 
= 0.22 ± 0.23; relative inter-experimental error = 0.33; Figure 3.3a). In other words, the predicted 
rate constants for new (+) ssRNA viruses would be at least as accurate as the rate constants 
determined through experimental studies. 































Figure 3.3 Experimental and predicted cross-validated inactivation rate constants for (+) ssRNA viruses 
(a) and dsDNA viruses (b) present in the training and validation set. Different colors and symbols represent 
different viruses. Black lines represent the estimated experimental rate constant for each virus. Data 
included in the models were obtained from the literature with a systematic review, and all predicted and 
experimental inactivation rate constants are provided in Tables B.1 and B.6. 
 dsDNA virus model. 
The genomic variables used in dsDNA model development were equivalent to the (+) ssRNA 
models, with the exception that thymines (Ts) were substituted for Us (Table B.1). A major 
distinction of dsDNA viruses is that their genomes can undergo repair in host cells and this impacts 
their susceptibility to UV254.24,38–40 Genome repair can be mediated by the host cell or by viral 
genes,24 and the varied efficacy of host-mediated dsDNA repair41–44 impacts virus UV254 
sensitivity. We included categorical predictors for genome repair mode (i.e., host cell mediated, 
virus-gene controlled using one repair system, or virus-gene controlled using multiple repair 
systems) and host cell type (i.e., prokaryotic host, eukaryotic host with wild type repair, or 
eukaryotic host with reduced repair) in the dsDNA virus inactivation rate constant models. 




















































Genome repair mode and host cell type were assigned based on available information and are 
described in Appendix B. 
The RMSrPE of the four optimized dsDNA model classes ranged from 0.31 to 1.6 (Table B.3), 
and the optimized multiple linear regression model outperformed the three other optimized model 
classes (RMSrPE = 0.31 ± 0.28; Figure 3.2 and Table B.3). The optimized elastic net and boosted 
trees RMSrPEs were slightly higher (RMSrPEelastic net = 0.79 ± 0.46, RMSrPEboosted trees = 0.70 ± 
0.43), though the difference in model performance was not significant (Table B.5), and the random 
forests model performed significantly worse (RMSrPErandom forests = 1.6 ± 0.66). The top linear 
regression model included the genome repair mode and host cell type predictors, as well as one 
principal component comprising the three genomic variables numbers of thymine doublets (TT), 
thymine quintuplets (TTTTT), and Cs. As with the top-performing (+) ssRNA model, many of the 
regressions tested with different genomic variable subsets had similar prediction performance, 
making it difficult to identify which genomic variables were critical for predicting dsDNA virus 
rate constants (Table B.4). A point estimate comparison of the regression coefficients for the 
standardized principal component (bPC1 = 0.46), genome repair mode (bgenome repair mode = 2.7), and 
host cell type (bhost cell type = -0.37) predictors indicates that the genome repair mode predictor is 
approximately 5.9 times more important than the principal component predictor (bgenome repair 
mode/bPC1 = 2.7/0.46). Host cell type was comparable in importance to the genomic variable 
contribution, collectively represented by the principal component. Prediction performance 
dropped significantly without genome repair mode as a predictor (RMSrPEopt = 0.31 ± 0.28, 
RMSrPEno repair = 1.0 ± 0.52; Table B.5), further highlighting the importance of genome repair in 
UV254 inactivation. 
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The multiple linear regression model accurately predicted inactivation rate constants across the 
wide range of dsDNA virus susceptibilities to UV254 (Figure 3.3b). As with the top performing (+) 
ssRNA model, the predicted error for the top performing dsDNA model was lower than the 
estimated inter-experimental error for viruses with more than one experimental rate constant 
(RMSrPE = 0.31 ± 0.28; inter-experimental error of kvirus = 0.45). Predictions were poorest for 
T7M, B40-8, and lambda predicted (percent error = 62%, 63%, and 62%, respectively; Figure 
B.2b), which are bacteriophages with the same form of genome repair mode. The poor prediction 
of viruses from this group indicates that some of the rate constants in the training data for viruses 
with these attributes may be inaccurate, leading to worse performance for bacteriophages with host 
mediated repair. 
 All-virus model. 
Larger data sets generally add predictive power to models, though the increased signal from 
additional data can be attenuated or negated by increased heterogeneity. We therefore compared 
the performance of the separate (+) ssRNA and dsDNA virus models with a model that 
incorporated data from all Baltimore classes. In addition to the genomic variables and repair-
related predictors (i.e., genome repair mode and host cell type) included for (+) ssRNA and dsDNA 
viruses, a categorical predictor for nucleic acid type (i.e., double-stranded or single-stranded) was 
included. Boosted trees models were the top performing models using all viruses (Table B.3); these 
performed significantly worse than the models trained using only (+) ssRNA viruses (RMSrPE(+) 
ssRNA = 0.22 ± 0.23, RMSrPEall = 0.45 ± 0.33; Table B.5) or only dsDNA viruses (RMSrPEdsDNA = 
0.31 ± 0.28 vs RMSrPEall = 0.45 ± 0.35; Tables B.3 and B.5). This suggests that using our modeling 
approach and combining viruses with diverse genome types and infection cycles into one model 
can negatively impact performance of virus predictions, possibly owing to insufficient data from 
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less studied classes. Based on these results, we used the separate (+) ssRNA and dsDNA models 
for subsequent analyses. 
 Predicted rate constants align with new experimental rate constants. 
We applied the optimized (+) ssRNA and dsDNA models to predict the rate constants of one (+) 
ssRNA virus and one dsDNA virus for which experimental data were not available and then 
measured the rate constants experimentally. Specifically, we predicted and measured the rate 
constants for MHV, a (+) ssRNA mouse coronavirus, and HS2, a dsDNA marine bacteriophage. 
Based on its large genome size (i.e., ~ 270% longer than the largest (+) ssRNA virus genome 
included in the training and validation set) MHV provided an opportunity to assess the (+) ssRNA 
model’s predictive power using a virus with attributes outside those in the training and validation 
set (Figure B.3). HS2 bacteriophage has similar genomic attributes to many of the other viruses in 
the data set (Figure B.3), and genome repair-related predictors are the same as those for most of 
the phages.  Bacteriophage MS2 was included in each experimental solution to confirm UV254 
doses; the measured MS2 rate constants were in line with those in the literature (0.12 to 0.14 cm2 
mJ-1; Figure B.4 and Table B.2). 
The predicted inactivation rate constant for MHV (kpred = 2.05 ± 0.88 cm2 mJ-1; mean ± 95% 
margin of error) was not significantly different than the experimental rate constant (kexp = 1.92 ± 
0.17 cm-2 mJ-1), with a percent error of only 7% (Figure 3.4a). The prediction accuracy the model 
achieved despite MHV’s elevated UV254 sensitivity compared with other (+) ssRNA viruses in the 
data set highlights how linear regression approaches are capable of extrapolating predictions to 
values distinct from those used in training and validation. In comparison, the MHV inactivation 
rate constant predicted with the top performing nonlinear approach, boosted trees, was 79% 
different the experimental value, with a rate constant of 0.40 ± 0.25 cm2 mJ-1. The accuracy of the 
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MHV rate constant prediction and the relatively low RMSrPE obtained for the top performing (+) 
ssRNA virus model provide some confidence that the (+) ssRNA model can effectively predict 
UV254 rate constants for emerging or difficult-to-culture (+) ssRNA viruses; additional out-of-
sample validation will be needed, however, to better understand how well the models generalize 
to new viruses.  
The experimental HS2 inactivation kinetics exhibited significant tailing beyond UV254 fluences of 
50 mJ cm-2; we therefore modeled the first ~5-log10 of inactivation to obtain a rate constant from 
the first-order portion of the curve. The resulting dsDNA HS2 bacteriophage experimental rate 
constant of kexp = 0.28 ± 0.08 cm2 mJ-1 was 71% lower than the predicted rate constant of kpred = 
0.48 ± 0.29 cm2 mJ-1(Figure 3.4b). Although the error of this dsDNA estimate was larger than that 
of the (+) ssRNA estimate, the HS2 predicted and experimental constants are not significantly 
different. This result, in combination with the cross-validation results, suggest that the dsDNA 
model can effectively predict if a dsDNA virus is particularly resistant to UV254 treatment.  
 
Figure 3.4 Experimental and predicted UV254 inactivation of MHV A59 (a) and HS2 bacteriophage (b). All 
independent replicates (N = 3) from experiments are shown as individual points. The experimental HS2 
inactivation rate constant was determined using the first two UV254 fluences due to significant tailing 
beyond UV254 fluences of 50 mJ cm-2. 















































 Predictive models estimate inactivation of several emerging and difficult-to-culture 
viruses. 
Our systematic review identified a number of important human viruses that lack published high 
quality UV254 inactivation rate constants in the literature. We therefore applied the (+) ssRNA and 
dsDNA predictive models to estimate the inactivation rates constants for several viruses, including 
human norovirus, dengue virus, SARS-CoV-2, and several herpesviruses (Table 3.1). These 
predictions resulted in a range of inactivation rate constants, from 0.28 for human norovirus to 3.0 
cm2 mJ-1 for human cytomegalovirus. Although these virus rate constants have not been validated 
with experiments, the performance of our models gives us confidence that the predicted values are 
good estimates of the actual inactivation rate constants. 
Table 3.1 Predicted UV254 inactivation rate constants for several viruses without high-quality experimental 
inactivation rate constants. 
Virus NCBI accession number Predicted inactivation rate constant, k (cm2 mJ-1)a 
(+) ssRNA viruses 
SARS-CoV-1 NC_004718 1.9 ± 0.82 
SARS-CoV-2 MN908947 2.0 ± 0.86 
Middle eastern respiratory 
syndrome coronavirus 
(MERS-CoV) 
JX869059 2.1 ± 0.91 
Dengue virus NC_001477 0.38 ± 0.16 
Zika virus NC_035889 0.39 ± 0.17 
Human rhinovirus (B14) K02121 0.34  ± 0.15 
Human norovirus 
(GII.4 Sydney) 
JX459908 0.28 ± 0.12 
dsDNA viruses 
Herpes simplex virus 1 
(strain 17) NC_001806 1.8 ± 1.1 
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Epstein-Barr virus NC_007605 1.9 ± 1.2 
Human cytomegalovirus NC_006273 3.0 ± 1.8 
Variola virus (major) L22579 2.5 ± 1.5 
aError shown represents the 95% margin of error of predicted rate constant, as determined by the 
model’s 95% margin of error, estimated as 1.96 times the standard error, where standard error = 
RMSrPE x virus rate constant. 
 
 Discussion 
Through evaluation of a large set of models from four distinct model classes developed with the 
best currently available data, we identified effective models for predicting UV254 inactivation rate 
constants of (+) ssRNA and dsDNA viruses using simple virus attributes as model predictors. 
UV254 primarily targets viral nucleic acid during irradiation. Pyrimidine bases are more 
photoreactive than purines,45 and pyrimidine dimers, in particular, cause a large portion of the UV-
induced damage to DNA.45–51 Limited research centered on ssRNA photolysis suggests pyrimidine 
hydrates are the primary lesions inducing UV damage.52 Photochemical damage to nucleic acids 
can stall or inhibit enzymes required for productive viral infection of host cells.53–55 Based on this 
a priori knowledge, we included several combinations of pyrimidine bases as predictors in our (+) 
ssRNA and dsDNA models, namely the numbers of U, UU, UUU, UUUU, UUUUU, C, UC, and 
CU in (+) ssRNA models and the numbers of T, TT, TTT, TTTT, TTTTT, C, TC, and CT in 
dsDNA models. 
Ultimately, the top performing (+) ssRNA virus model employed one principal component 
incorporating multiple genomic variables (i.e., numbers of C, U, UU, and UUU), and the top 
performing dsDNA virus model employed repair mode, host cell type, and one principal 
component representing three genomic variables (i.e., numbers of C, TT, TTTTT). The relative 
importance of variables in our top performing predictive models may provide insight into the 
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mechanisms driving UV254 inactivation of viruses. Among the (+) ssRNA models, many of the 
multiple linear regression models that included distinct subsets of genomic variables performed 
similarly. This is likely because these genomic variables are so highly correlated that different 
variable combinations resulted in a similar set of principal components as predictors in modeling, 
ultimately yielding similar performance among different models. Separating the effects of 
individual genomic variables was therefore difficult in the (+) ssRNA model. Although the top 
performing model incorporated multiple genomic variables, several linear regression models using 
as few as one genomic variable as a predictor resulted in similar model performance. This finding 
demonstrates that simple aspects of the (+) ssRNA genome provide all the necessary information 
to accurately predict rate constants for this class of viruses. In the dsDNA model, performance was 
significantly improved when genome repair predictors were included in addition to principal 
components incorporating genomic variables. The importance of genome repair was expected. For 
example, the two dsDNA bacteriophages T2 and T4 have similar genome sizes and composition 
(Figure B.3b and Table B.1) but dissimilar UV254 inactivation rate constants (5.1 cm-2 mJ-1 for T2 
and 1.7 cm-2 mJ-1 for T4; Table B.2). T4 phage’s UV254 resistance is due to an additional virus-
controlled repair gene in the T4 genome not present in the T2 genome.56,57 Interestingly, the 
relative contribution of genomic variables in the dsDNA model was significantly less than the 
genome repair predictors, which suggests that genome repair is a more important factor in dsDNA 
UV254 inactivation than genomic variables.  
Including genome repair as a model predictor presented some limitations. First, the mode and 
extent of genome repair is not known for many viruses and has not been well-studied across virus 
families. A single predictor encompassing the contribution of genome repair was therefore not 
possible. We instead applied multiple categorical predictors. With this approach, only viruses that 
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shared a particular genome repair mode or host cell type with at least one other virus in the dsDNA 
data set could be used in cross-validation. Ultimately, the data set used for dsDNA model 
development and validation lacked numerous forms of dsDNA viruses with distinct repair modes 
and host cell types, resulting in uncertainty in model performance for certain dsDNA viruses not 
represented in the training and validation set. To improve future dsDNA virus models, it is critical 
to have a better understanding of genome repair mechanisms and how they affect UV254 
inactivation. 
Our top performing UV254 virus prediction models provide improvements over earlier prediction 
approaches.28,29 On average, the (+) ssRNA and dsDNA virus models predicted rate constants to 
within ~0.2x and ~0.3x of experimental constants, respectively. A previous approach using 
genome length to determine genome size-normalized sensitivity values for a number of virus 
families expected uncertainties in predicted values of ~2x.28 A more recent approach developed 
predictive models for ssRNA and dsDNA UV254 inactivation using genome dimer formation 
potential, a value that incorporated pyrimidine doublets, genome length, and purines with adjacent 
pyrimidine doublets.29 Their reported error as a coefficient of determination (i.e., R2) was 0.67 for 
ssRNA viruses compared to 0.74 (adjusted R2) for our model, and an R2 value of 0.62 for dsDNA 
viruses compared to 0.99 (adjusted R2) for our model. Several factors can be attributed to the 
improved performance of our models, including extensive curation of data based on quality and 
the incorporation of genome repair into dsDNA modeling. 
In light of the coronavirus disease 2019 (COVID-19) pandemic and the need for effective 
decontamination strategies, our predictive models provided an opportunity to predict rate constants 
for a critical group of viruses with very little published inactivation data. Limited data on UV254 
inactivation for coronaviruses in aqueous suspension are available and the published information 
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did not pass the inclusion criteria of our systematic review.10,58–60 This paucity of information on 
the susceptibility of coronaviruses to UV254 is of critical importance for developing effective 
decontamination strategies. Our predicted rate constants for SARS-CoV-1, SARS-CoV-2, and 
MERS, and our measured rate constant for the mouse coronavirus MHV, suggest that 
coronaviruses are much more susceptible to UV254 inactivation than other (+) ssRNA viruses. A 
recent estimate of SARS-CoV-2 UV254 susceptibility using the previously developed Lytle and 
Sagripanti approach28 is ~ 1.7x greater than our estimate indicates.61 Discrepancies in new 
experimental coronavirus data still persist, likely stemming from a lack of checks on UV254 
attenuation of suspensions. 
More robust models are possible with larger data sets that consist of more diverse viruses. 
Unfortunately, a large portion of UV254 inactivation data found during the systematic review did 
not pass our inclusion criteria. The most common reason for excluding data from our systematic 
review was a failure to report solution UV254 attenuation. An earlier study of SARS-CoV-1 
inactivation by UV254,60 for example, did not account for UV254 attenuation in the experimental 
DMEM suspension. The reported inactivation rate constant of 0.003 cm2 mJ-1 was nearly three 
orders of magnitude lower than our predicted rate constant for SARS-CoV-1 and our measured 
value for MHV, likely in part due to solution attenuation. We estimate that their rate constant 
would be closer to 0.35 cm2 mJ-1 after accounting for solution attenuation. This value more closely 
aligns with our coronavirus values. Similarly, several studies reported UV254 inactivation of 
viruses in blood products without describing how attenuation was considered in their reported 
doses.10,62–64 Although these doses are likely representative for these fluids, they cannot be 
extrapolated to other matrices. More stringent reporting of UV254 experimental conditions,65 
including matrix solution transmission at 254 nm, will facilitate future modeling efforts. Our 
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models predict UV254 inactivation rate constants for solutions with 100% transmittance (e.g., 
purified virus in buffer solution). These rate constants can be adjusted to predict virus inactivation 
in a solution with significant attenuation using the Beer-Lambert law, which takes into account 
sample absorbance.36 
The developed models allow us to predict the effectiveness of current UV254 treatment strategies 
on viral pathogens that are difficult or impossible to culture. For example, human norovirus, which 
causes gastrointestinal disease, is a major target of UV254 disinfection processes in water treatment 
and food processing. Our (+) ssRNA virus model predicts an inactivation rate constant of 0.28 cm2 
mJ-1 for human norovirus GII.4, which is similar to our recently reported rate constant of k = 0.27 
cm2 mJ-1 for human norovirus GII.4 Sydney using RT-qPCR data coupled with a full-genome 
extrapolation approach.66 This finding indicates that current water treatment guidelines for 
adequate UV254 virus inactivation, which are defined to treat adenovirus 41,67 are more than 
sufficient to inactivate human norovirus to acceptable levels. In fact, none of the viruses for which 
we predicted rate constants had UV254 resistance greater than viruses in the Adenoviridae family. 
The limited and unbalanced data set that we obtained from the systematic review and used in 
modeling efforts created challenges in our modeling work. Of primary concern, we could not take 
a commonly used approach to evaluating models, in which a portion of data is held back during 
model development to assess performance. Holding back the typical 10 – 20% of data would 
correspond to holding back only two to four viruses from the (+) ssRNA or dsDNA classes for 
testing. This could result in high variance estimates of prediction performance that would also be 
highly dependent on the viruses withheld during training. We consequently used leave-one-virus-
out cross-validation to more efficiently estimate prediction performance on out of sample data. 
Another limitation of our models is that they were developed and validated for only (+) ssRNA 
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and dsDNA viruses. Although many human viruses are in these two classes, many emerging and 
noteworthy human viruses belong to other classes. In particular, the (-) ssRNA virus class includes 
several important human pathogens, such as lassa virus, nipah virus, influenza virus, and 
ebolavirus. Since only two (-) ssRNA viruses were included in our data set, we were unable to 
assess whether inactivation rate constants for viruses in this group could be accurately predicted 
with our (+) ssRNA model. More high quality UV254 experimental inactivation data for a broader 
set of viruses would facilitate the holdout approach for validating models and the development of 
models for other virus Baltimore classification groups. 
Additional experimental data could also support an expanded set of predictors beyond the primary 
genome structure and genome repair parameters included here. Virus attributes, like the secondary 
structure of single-stranded nucleic acids22 or nucleic acid interactions with viral proteins,68 may 
play a role in virus inactivation by UV254. These structural virus characteristics are not as readily 
available as genome sequence information and were therefore not considered in the present study. 
Future research could incorporate these attributes as additional model parameters when more data 
become available. Another focus of future work could be the expansion of these models to predict 
the tailing of virus inactivation that is often observed during UV254 treatment. Our models focus 
on the first order portion of the UV254 inactivation curve; by understanding the mechanisms that 
underlie tailing kinetics and including the appropriate predictors, this model could be updated to 
predict both the first order and tailing regions of the UV254 virus inactivation curve. 
This research demonstrates the value of predictive models for estimating virus fate in various 
settings. Using readily available viral genome data, we developed models to predict UV254 
inactivation of (+) ssRNA and dsDNA viruses. The benefits of predictive models are underlined 
by the ongoing COVID-19 pandemic: access to the biosafety level 3 laboratories required to work 
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with SARS-CoV-2 has been limited and, as a result, few experimental inactivation studies have 
been performed. Our approach can rapidly determine virus susceptibility to UV254 using available 
genomes, but without relying on culture systems that are often unavailable or difficult to access. 
Other potential applications of our models including identifying outlier UV254 data that are 
published and predicting potential worst-case scenarios for viruses and their susceptibility to 
UV254. Ultimately, we expect that this predictive modeling approach can be applied to estimate 
inactivation of microorganisms with other disinfectants and in different settings, such as on 
surfaces or in air. 
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 Abstract 
Human norovirus is a leading cause of enteric disease worldwide, yet the lack of a readily available 
cell culture system has severely limited our understanding of norovirus fate in the environment 
and through inactivating treatments. Here, we developed an approach to quantify infectious human 
norovirus levels using a novel human intestinal enteroid cell culture system and most probable 
number calculations. We applied the quantitative method to characterize the extent of human 
norovirus inactivation with UV254 disinfection. Our preliminary UV254 inactivation results indicate 
that human norovirus has similar UV254 susceptibility compared with other common enteric (+) 
ssRNA viruses, requiring approximately 27 mJ cm-2 for 4-log10 inactivation. These findings will 
inform effective mitigation strategies for water and food industries, where human norovirus is a 
major concern. The quantitative infectivity method we developed shows promise for future 
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research focused on investigating the persistence of infectious human norovirus in environmental 
settings. 
 Introduction 
Human norovirus (HuNoV) is estimated as the leading cause of gastrointestinal illness in the 
United States and worldwide,1,2 frequently causing vomiting and diarrhea in infected individuals.3 
Possible sources of HuNoV exposure include ingestion of contaminated food or liquids, as well as 
direct human-to-human contact.4–11 HuNoV can be highly infectious, with challenge studies 
revealing that as little as one viral particle may result in infection.12 However, culturing HuNoV 
in vitro has proven difficult since the virus’ discovery in 1968. Numerous attempts to culture the 
virus using distinct cell culture systems have not been effective.13–16 Recent work using novel 
culture systems have been more promising.17–19 Although culturing HuNoV in some of these 
systems has been difficult to reproduce,18 the human intestinal enteroid (HIE) system17 has been 
successfully applied in various laboratories.20–23 Drawbacks of the new HuNoV culture system 
include its technical complexities and costliness; consequently, it is not currently available in most 
laboratories. In addition, the propagation of infectious HuNoV from this culture systems is not yet 
achievable. As a result, researchers must rely on stool samples with high titer HuNoV from 
infected individuals. And with only a fraction of HuNoV positive stool samples resulting in 
productive infection in HIEs,20 research with the HIE HuNoV culture system is limited by the lack 
of readily available virus stocks. 
These challenges have severely limited research focused on evaluating the presence and fate of 
infectious HuNoV in the environment. As a result, little is currently known about the fate of 
infectious HuNoV in environmental matrices, including through water and wastewater treatment. 
Often, studies use other approaches, such as reverse transcription quantitative polymerase chain 
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reaction (RT-qPCR), to detect HuNoV in samples.24–30 These methods, however, only quantify a 
small portion of the virus particle and therefore likely vastly overestimate infectious virus 
concentrations in a sample. 
A better understanding of HuNoV infectivity through unit processes would inform effective 
strategies for mitigating HuNoV risk in various food and environmental settings. In particular, the 
field of direct potable water reuse (DPR), in which wastewater is treated to drinking water 
standards,31 would benefit from an improved understanding of HuNoV infectivity through water 
treatment processes. HuNoV is of principal concern in water reuse, because the starting source 
water in reuse can contain elevated levels of this enteric pathogen (~ 1 – 106 viruses/L).32,33 
However, some DPR risk assessments do not consider HuNoV because of a lack of infectivity 
data34 or rely on assumptions about HuNoV persistence to model exposure risk in finished 
water.35,36 This means that proposed or established reuse schemes may currently be under or 
overengineered for HuNoV treatment. 
In this study, we applied the recently developed HIE culture system to study infectious HuNoV 
through UV254 disinfection. We first developed a quantitative infectivity assay using a most 
probable number (MPN) approach,37 and then used the approach to quantify the infectious HuNoV 
before and after exposure to UV254. Our resulting HuNoV inactivation data will inform future risk 
assessments focused on UV254 disinfection to limit enteric viral pathogen exposure. In addition, 
our quantitative approach for tracking HuNoV infectivity will be a valuable research tool for future 
studies on the fate of infectious HuNoV in various environmental settings.  
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 Materials and Methods 
 Virus stocks. 
A stool sample containing HuNoV GII.4 was obtained from New York (18-20942 NY). The 
sample was diluted 1:100 in sterile 1X phosphate buffer saline (PBS) solution (Cat. No. 10010023, 
Invitrogen) and filtered through a 0.2 µm polyethersulfone membrane (Cat. No. 229747, 
CELLTreat Scientific). Aliquots of the diluted, filtered stock solution were stored at -80°C until 
use. 
 Human intestinal enteroids (HIEs). 
Fetal ileum cells (FI 124) were kindly provided by Dr. J. Spence and the Translational Tissue 
Modeling Laboratory (University of Michigan). HIE maintenance and monolayer preparation were 
conducted as previously described with slight modifications.17,20,38,39 Briefly, 3D HIEs were kept 
in Matrigel basement membrane matrix (Cat. Nos. 354234 and 354623, Corning) and passaged 
every six to seven days. Passaging was conducted by adding 1 mL ice cold CMGF- (Table C.1) to 
each well of a 6-well plate (Cat. No. CC7682-7506, USA Scientific) containing 3D HIEs. Cells 
were dislodged by vigorously pipetting the gel and media solution five or more times, and a 25G 
x 5/8” needle syringe (Cat. No. 26403, Exel International) was used to further break up and collect 
the cells from each well. Wells were rinsed with an additional 1 mL of 1X PBS to collect residual 
cells. Cells were centrifuged at 80 x g for five minutes at 4°C, and the supernatant was removed 
and replaced with Matrigel. 3D HIEs were generated by placing 20 10 µL droplets of Matrigel 
containing cells in each well of a 6-well plate. After allowing Matrigel to solidify, CMGF+ (Table 
C.1) was added. Cells were incubated at 37°C and 5% CO2, and media was replaced every 48 
hours. 
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HIE monolayers were generated from 3D HIEs. Medium on 3D HIEs was replaced with 1 mL of 
0.5 mM ethylenediaminetetraacetic acid (EDTA; Cat. No. 51201, Lonza) in 1X PBS. Cells were 
dislodged, collected, and centrifuged for five minutes at 200 x g and 4°C. The pellet was suspended 
in 0.05% trypsin-EDTA (Cat. No. 25300-054, Gibco) and the solution was incubated for five 
minutes at 37°C. CMGF- medium containing 10% fetal bovine serum (Cat. No. SH30396.03, 
Thermo Scientific) was added to inactivate the trypsin. Cells were gently pipetted at least 50x, and 
the solution was applied to a pre-rinsed 40 µm strainer (Cat. No. 22-363-547, Fisher Scientific). 
The resulting cell suspension was centrifuged at 400 x g for five minutes at 4°C and resuspended 
in CMGF+ medium containing 10 µM Y27632 (Cat. No. 1254, R&D Systems). The cell suspension 
was seeded at a density of 1 to 2 x 105 cells/well into collagen-treated wells in a 96-well flat-
bottomed plate (Cat. No. 353072, Corning). For collagen pre-treatment, 100 µL of 33 µg/mL 
collagen IV (Cat. No. C8919, Sigma-Aldrich) in cold sterile water was added to wells, and the 96-
well plate was incubated at 37°C for at least two hours prior to replacement with HIE cell 
suspension. CMGF+ medium was replaced every 48 hours until HIE monolayers were confluent. 
CMGF+ medium on confluent monolayers was then replaced with differentiation medium (Table 
C.1). Five to six days after differentiation was initiated, we used monolayers in HuNoV infections. 
 HuNoV infectivity assay. 
We used an integrated cell culture RT-qPCR (ICC-RT-qPCR) method to confirm HuNoV infection 
of cells. 
 HuNoV infection of HIEs. 
Medium on HIE monolayers was replaced with differentiation medium supplemented with 500 
µM sodium glycochenodeoxycholic acid (GCDCA; Cat. No. G0759, Sigma) and 10 µM 
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ruxolitinib (Cat No. 11609, Cayman Chemical Company) at least 24 hours before infection. Prior 
to infection, HIE monolayers were washed once with CMGF-. Each HuNoV sample was diluted 
1:20 in CMGF- supplemented with 500 µM GCDCA and 10 µM ruxolitinib. HuNoV samples in 
CMGF- solution were applied to HIE monolayers using 100 µL of inoculum in each well. Infected 
HIE monolayers were incubated for one hour at 37°C, and HIEs were then washed twice with 
CMGF-. 100 µL differentiation medium with GCDCA and ruxolitinib was added to all wells. The 
HIEs were then incubated at 37°C and frozen at -80°C 3 days post infection (dpi). During each 
infection, a subset of HIEs were infected with the original HuNoV sample, incubated, and washed 
as described for the 3 dpi samples. Immediately following washing and replacement with 
differentiation medium, the material from these wells was harvested to confirm the initial 
concentration of HuNoV in the HIE wells at 0 dpi. 
 RNA extraction. 
Samples were thawed at room temperature, and 300 µL of TRIzol reagent (Cat. No. 15596026, 
Invitrogen) was mixed with the contents of each well. The RNA MiniPrep Plus (Cat. No. R2072, 
Directzol) was used to extract RNA as per manufacturer instructions. No DNase I treatment was 
conducted. Extracts were suspended in 50 µL nuclease free water and stored at -80°C or 
immediately quantified. 
 RT-qPCR. 
One-step RT-qPCR was carried out using a Mastercycler ep RealPlex 2 system (Eppendorf). Each 
20 µL reaction consisted of 5 µL RNA template, 0.3 µL probe (QNIFS; Table C.2),40 1 µL each 
of forward and reverse primers (QNIF2d/COG2R; Table C.2),40,41 0.5 µL iScript advanced RT 
(Cat. No. 172-5141, BioRad), 2.2 µL nuclease-free water, and 10 µL iTaq Universal Probes One-
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Step Reaction Mix (Cat. No. 172-5141, BioRad). Cycling conditions included cDNA synthesis at 
50°C for 10 min, initial denaturation at 95°C for 3 min, followed by 40 cycles of denaturation at 
95°C for 20 s, annealing at 60°C for 20 s, and extension at 72°C for 20 s. A purified gel product 
prepared from a GII.4 Sydney stool sample was used for the qPCR standard. Each qPCR assay 
included a standard curve with at least 4 serially diluted standards and a no-template control. All 
samples and standards were run in duplicate. 
 Quantitative MPN approach. 
An MPN approach37 was taken to quantify infectious HuNoV levels in samples. Four to six 
replicates of each HuNoV sample dilution were applied to the HIE wells. Specific dilutions of the 
untreated samples included 10x, 50x, and 100x and dilutions of the UV254-treated samples included 
no dilution, 5x, and 10x. 
 MPN Calculation. 
A sample was considered HuNoV positive when the 3 dpi HuNoV genome copy concentration 
amplified in both RT-qPCR replicates conducted. Any samples with a 3 dpi HuNoV genome copy 
concentration below detection were considered HuNoV negative. The concentration of infectious 
HuNoV in the original HuNoV sample, in MPN/mL, was then calculated using the MPN calculator 
developed by the U.S. Environmental Protection Agency (USEPA).42 
 UV254 irradiation. 
A HuNoV sample was exposed to UV254 using a custom-built collimated beam apparatus. We 
confirmed the lamp’s UV254 irradiance, 0.16 mW cm-2, using potassium iodide chemical 
actinometry.43,44 For the UV254 irradiation experiment, MS2 bacteriophage was added to the 1:100 
filtered HuNoV stock (~107 gene copies/mL) at a final concentration of ~109 plaque forming units 
 86 
(pfu)/mL. The average solution irradiance was determined by the Beer-Lambert law, considering 
sample absorbance at 254 nm (0.26) and sample depth (0.5 cm). 220 µL of the solution was added 
to one well of a 96-well plate for each irradiation time point. During UV254 treatment, the plate 
was shaken using a 96-well plate shaker. The irradiated sample was immediately collected and 
stored on ice until being diluted and applied to HIEs. Two irradiation time points were carried out 
in a single experiment and included an unirradiated sample and an irradiated sample. The sample 
was irradiated for 0 s and 60 s, resulting in average UV254 fluences of 0 mJ cm-2 and ~ 8.2 mJ cm-
2, respectively. One experiment was conducted. MS2 bacteriophage inactivation was evaluated 
immediately following irradiation to confirm the UV254 fluence applied to viruses in the sample. 
 Results and Discussion 
 Quantitative HuNoV infectivity assay. 
Initially, we intended to measure the UV254 inactivation kinetics for HuNoV by measuring the 
HuNoV RNA signal at 3 dpi in both the untreated and UV254-treated HuNoV samples. For this to 
work, the HuNoV RNA signal at 3 dpi would need to scale with the amount of infectious HuNoV 
that was inoculated in the cells. Control experiments, however, demonstrated that the HuNoV 
RNA signal at 3 dpi did not correlate 1:1 with the amount of infectious HuNoV applied to the HIE 
well (Figure 4.1). For dilutions where all replicates had a measurable HuNoV RNA signal at 3 dpi, 
the signal varied by up to 1-log10 among replicates. In certain cases, some replicates of the same 
dilution did not have a detectable HuNoV RNA signal at 3 dpi. This suggests the quantity of RNA 
transcribed over the course of an infection is not representative of how much infectious HuNoV is 
applied to HIEs. This may be due in part to the fact that the time-course of infection varies between 
HuNoV samples and between dilutions of the same HuNoV sample.20 Consequently, halting each 
infection at 3 dpi may not capture RNA copies that are comparable from one sample to another or 
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from one dilution to another.  It is worth noting that other work with the HIE assay has used the 
fold change in HuNoV RNA signal from 3 to 0 dpi to quantify the extent of HIE infection by 
HuNoV.17 However, at the sample dilutions used in our work, most 0 dpi samples were below 
detection by RT-qPCR. We therefore relied only on the HuNoV RNA signal at 3 dpi. 
 
Figure 4.1 Log10 HuNoV RNA signal at 3 dpi for the same HuNoV positive stool sample at dilutions of 
1x, 10x, 50x, 100x, and 500x. Technical replicates vary between 2 and 4, depending on the dilution. 
Samples below detection are shown at a HuNoV RNA signal of 0. 
Due to the issues with using the HuNoV RNA signal at 3 dpi to infer the concentration of infectious 
viruses in a sample, we considered the MPN method as an alternative. The MPN method, which 
relies on Poisson statistics to define the most likely quantity of an organism in a sample, has been 
successfully applied to measure the concentrations of other viruses.45–51 This approach assumes 
that (1) the microorganism is evenly and randomly distributed throughout the sample, and (2) 
microbial growth will result if one or more microorganisms is inoculated with the host.37 To 
effectively determine the MPN, multiple dilutions of the sample and multiple replicates of each 
dilution must be cultured separately such that some replicates will be negative and others will be 
positive. We used various 2x, 5x, or 10x dilutions of each sample and four, five, or six replicates 





























of each dilution to determine which combination of dilutions and replicates was optimal for 
reliably determining the MPN of infectious HuNoV in samples. 
Overall, we found that regardless of the number of replicates and dilutions used, the MPN estimate 
was consistent within the same experiment (Figure 4.2). As the number of replicates increased, the 
margin of error was slightly reduced (Figure 4.2a). This is in line with MPN theory, because as 
additional replicates are included for each dilution, confidence in capturing the true ratio of 
positive and negative samples at a particular dilution increases.37 Expanding the range of sample 
dilutions by an additional 2x to 10x did not greatly affect the MPN estimate or margin of error for 
two different samples (Figure 4.2b). This may be because the additional tested dilutions did not 
provide meaningful information beyond the information provided with the initial dilutions. Use of 
dilutions covering a smaller range than what was tested (e.g., 2-fold, 3-fold) would likely lead to 
improved MPN calculations. For our purposes, the slight increase in confidence observed from 
added dilutions was not as important as obtaining the true MPN concentration. We concluded that 
the confidence intervals achieved by the MPN assay using three dilutions and six replicates each 
















































































































































Figure 4.2 MPN concentrations and 95% margins of error resulting from experiments conducted using 
three dilutions (i.e., 10x, 50x, and 100x) with four, five or six replicates of each dilution (a) and using three, 
four, five, or six dilutions with six replicates of each dilution (b). Error bars indicate margin of upper and 
lower 95% confidence. Dilutions used in (b) are indicated in parentheses beside the number of dilutions 
used. 
 Inactivation of HuNoV by UV254. 
UV254 disinfection was conducted at a single UV254 dose, ~ 8.2 mJ cm-2. Only one irradiated 
sample and one unirradiated sample were included in the same UV254 experiment so the number 
of HIE wells needed for a given experiment was not excessive. The UV254 dose of ~ 8.2 mJ cm-2 
was selected because it was anticipated to result in approximately 1-log10 inactivation of HuNoV 
based on previous estimates of UV254 HuNoV susceptibility.52,53 Log10 inactivation greater than 1-
log10 was avoided to ensure that infectious HuNoV in irradiated samples was not below detection 
limits of the MPN HIE assay. 
Because only UV254 at one dose was used, we assumed first-order virus inactivation kinetics. 
Bacteriophage MS2 inactivation was used to confirm the UV254 dose delivered to viruses in the 
sample during irradiation and resulted in a rate constant of 0.17 cm2 mJ-2, in line with previously 
reported constants.52 HuNoV inactivation with UV254 resulted in a rate constant of 0.34 ± 0.18 cm2 
mJ-1 (mean ± 95% margin of error; Figure 4.3), showing that a UV254 dose of ~ 27 mJ cm-2 is 
required for 4-log10 inactivation of HuNoV. It is important to note that these findings are 
preliminary, as only one experiment was conducted. Difficulties with HIE culturing prevented the 
inclusion of additional HuNoV UV254 inactivation data, although work continues to verify the 
results of this initial experiment. These results suggest HuNoV is similarly susceptible to UV254 
compared with other (+) ssRNA enteric human viruses.52 For example, various human 
enteroviruses, including poliovirus 1, echovirus 11, and coxsackievirus B5, have reported rate 
 90 
constants ranging from 0.21 to 0.43 cm-2 mJ-1.52 The common surrogate bacteriophage MS2 is 
significantly more resistant to UV254 inactivation than HuNoV based on our results. HuNoV 
surrogates murine norovirus (MNV) and feline calicivirus (FCV) have been widely used in studies 
of environmental HuNoV fate because they are in the Caliciviridae family, like HuNoV, and share 
many structural and genomic similarities with HuNoV.54,55 MNV and FCV have UV254 rate 
constants of ~ 0.33 mJ cm-2 and ~ 0.29 mJ cm-2,52 respectively, which are in line with HuNoV 
inactivation. Although these preliminary UV254 findings must be confirmed with additional 
replicates to be certain, MNV and FCV are likely accurate HuNoV surrogates through UV254. 
Beyond UV254 inactivation, use of the culture system work should be conducted to assess HuNoV 
infectivity through other disinfection strategies, such as chlorine or ozone, to confirm that MNV 
and FCV also behave similarly to HuNoV through other treatments. 
Past studies looking at HuNoV levels through UV254 treatment have identified much greater 
HuNoV resistance to UV254 disinfection than we found with the in vitro assay, indicating as little 
as 0 to 1.5-log10 HuNov inactivation with as high a UV254 dose as 300 mJ cm-2.24,56,57 This is likely 
because RT-qPCR methods were applied. Traditional molecular approaches for measuring 
HuNoV gene copies measure only a small portion of the genome, which do not accurately track 
infectious virus particles. Research with various (+) ssRNA viruses has shown that molecular 
approaches using longer regions of the viral genome demonstrate inactivation more similar to that 
of the infectious virus;58,59 however short of amplifying the entire genome or using an alternative 
extrapolation approach, discrepancies remain. 
We recently reported on two alternative approaches to estimate HuNoV inactivation by UV254 in 
the absence of a readily available infectivity assay. The first approach, which detected UV254 
damage to multiple regions of the HuNoV genome using RT-qPCR and extrapolated that damage 
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to the full-length genome, resulted in a rate constant of 0.27 ± 0.03 cm2 mJ-1.53 The second 
approach applied a linear regression model to predict inactivation using genome sequence 
information and resulted in a rate constant of kpred = 0.28 ± 0.12 cm2 mJ-1.52 Both of these 
approaches yielded similar HuNoV UV254 susceptibility (k = 0.34 ± 0.18 cm2 mJ-1) to the 
infectivity analysis conducted here. The preliminary culture-based results obtained here offer 
additional confidence that using a non-traditional qPCR extrapolation approach53,60 or a predictive 
modeling approach52 can accurately predict UV254 inactivation of (+) ssRNA viruses. 
 
Figure 4.3 Inactivation of HuNoV as a function of UV254 dose, in mJ cm-2. One independent replicate is 
shown. Shading indicates the 95% confidence interval of the linear regression. The estimated inactivation 
rate constant, defined as the slope of the linear regression, is displayed, along with the values associated 
with the 95% confidence interval of the rate constant. 
 Freeze-thaw of HuNoV samples. 
Experiments to determine fate and behavior of HuNoV may require a large quantity and high 
concentration of HuNoV positive stool sample that can replicate in the HIEs. Ensuring the 
retention of infectious HuNoV in a sample between freeze-thaws was therefore critical. We 
investigated the effect of freeze-thaw on HuNoV infectivity of HIEs. Results indicate that the same 
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stool sample before a freeze-thaw yielded significantly higher RNA gene copy levels at 3 dpi as 
opposed to the same sample that had undergone one additional freeze-thaw from -80°C to room 
temperature (Figure 4.4). This suggests that levels of HuNoV capable of effectively infecting and 
replicating in HIEs are significantly reduced through freeze-thaw cycles of HuNoV positive 
samples. Past work with HuNoV GII.4 stability through freeze-thaws observed negligible 
degradation of the RNA genome, as measured by RT-qPCR, and capsid proteins, as measured by 
capsid binding to magnetic beads, after as many as 14 freeze-thaws.61 While the study did not 
observe degradation of these two components of the HuNoV particle, infectivity was not evaluated. 
Our findings clearly establish a large reduction in HuNoV infectivity following as little as one 
freeze-thaw. This suggests that HuNoV inactivation is indeed occurring in some form through 
freeze-thaw, although that inactivation may not be detected using assays targeting specific 
components of the virus capsid or genome. Future work should work to determine which specific 
components of the virus particle are degraded through freeze-thaw. 
It is important to note that the sample evaluated in our experiments was a fecal sample that had 
been diluted 1:100 in 1X PBS and filtered through a 0.2 µm PES membrane prior to freezing. This 
dilution and filtration might have impacted HuNoV persistence through the freeze-thaw process 
and HuNoV in raw stool samples may be more or less stable. To date, the mechanism of HuNoV 
inactivation through the freeze-thaw process is not known. A previous report of infectious virus 
degradation through freeze-thaws focused on enveloped viruses.62 In general, more research is 
needed to determine the stability of viruses in stool samples and in purified forms through storage 
and freeze-thaw processes. 
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Figure 4.4 3 dpi HuNoV RNA gene copy levels of the same sample diluted 10x before and after an 
additional freeze-thaw. Three or six technical replicates of the same sample dilution were conducted for 
two independent experiments. The number of positive technical replicates are shown for each independent 
experiment.  
 Implications. 
To date, the lack of a reliable HuNoV cell culture system has hindered studies of infectious HuNoV 
persistence in the environment and through water treatments processes. Here, we provide 
preliminary UV254 inactivation data for HuNoV determined with an in vitro culture system. These 
findings suggest that HuNoV behaves similarly to many other (+) ssRNA viruses through UV254 
disinfection. Adenovirus 41, an enteric dsDNA virus that is highly resistant to UV254 inactivation, 
is almost an order of magnitude more resistant to UV254 than HuNoV. UV254 treatments intended 
to inactivate adenovirus 41 by 4-log10 will inactivate HuNoV by > 20-log10 assuming first order 
kinetics is maintained to these levels of inactivation. Additional work will be needed to confirm 
the HuNoV UV254 susceptibility observed here and establish that first order inactivation kinetics 












































For this work, we used a high-titer GII.4 HuNoV sample that we knew could productively infect 
the HIEs based on past experiments. An important limitation of this cell culture assay for use in 
the environmental setting is its inability to support growth of certain circulating noroviruses. 
Previous work screened over 80 fecal samples containing 12 different genogroups of HuNoV for 
infection in the enteroids, including 65 samples with GII HuNoV, and determined that roughly 
only 20% resulted in productive infection.20 Our preliminary screening of HuNoV stool samples 
revealed a similar inability of certain HuNoV positive stool samples to produce measurable 
increases in viral RNA after 3 days of viral infection. Even in samples that could productively 
infect HIEs, titers had to be sufficiently high to evaluate inactivation and apply the dilutions 
necessary for the MPN approach. Without the ability to propagate HuNoV in vitro, obtaining and 
finding suitable HuNoV positive stool samples for environmental fate studies using HIEs will 
continue to present a major barrier for the field. We do not yet understand what differences from 
sample to sample cause the disparities in productive HIE infection, although strain-specific 
differences likely play a role.17 It has also been suggested that certain cofactors, such as the bile 
GCDCA, can support or enhance HIE infection, depending on the strain.17 It is important to note 
that in this work, bile was always added to HIEs before and during infection, so this parameter 
was eliminated in our study. Some research has indicated that stool samples with elevated 
norovirus gene copy concentrations and that come from young patients more commonly infect 
HIEs successfully,20 while more recent work suggests samples from adults are just as capable of 
productive HIE infection.21 These results have important implications for the environmental 
virology field, because this tool cannot yet reliably be used for monitoring native infectious 
HuNoV in environmental matrices. 
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Several other viruses, including astrovirus or rotavirus, can produce high RNA titers after 
inoculation in HIEs.39,63 Environmental samples such as primary wastewater likely contain a 
variety of different enteric viral pathogens. The HIEs, which are not a specific host for HuNoV, 
would therefore support growth of many different viruses that can grow rapidly in human intestinal 
cell lines. In these cases, it is possible that although HuNoV is present in the sample, no increase 
in viral RNA is measured because other viruses more effectively infect the HIEs and use host cell 
machinery. Future work in the virology field to distinguish methods for selective growth of 
HuNoV could facilitate the use of this tool for monitoring purposes and for better understanding 
the environmental fate of HuNoV. 
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Protecting public health from pathogens is critical when treating wastewater to drinking water 
standards (i.e., planned water reuse). Viruses are a principal concern, yet real-time monitoring 
strategies do not currently measure virus removal through reuse processes. Flow cytometry (FCM) 
has enabled rapid and sensitive bacteria monitoring in water treatment applications, but methods 
for virus and protozoa monitoring remain immature. We discuss recent advances in the FCM field 
and FCM applications for quantifying microorganisms in water. We focus on flow virometry 
(FVM) developments, as virus enumeration methods show promise for water reuse applications. 
Ultimately, we propose FVM for near real-time monitoring across treatment to more accurately 
validate virus particle removal and for pilot studies to characterize removal through understudied 
unit processes. 
 Introduction 
Wastewater is increasingly used as an alternative water source to meet potable needs,1–3 giving 
rise to new challenges in assuring public health. Pathogenic microorganisms are of principal 
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concern in wastewater reuse due to the acute health risks they pose to consumers. Virus removal, 
in particular, is a major driver in the regulation and design of planned potable water reuse because 
they are present in high concentrations in wastewater,1,4–6 and their small size (20 nm to over 200 
nm) makes them difficult to remove.7 Depending on the intended application and project location, 
reuse regulations and guidelines for virus removal range from 8- to 13-logs or more from raw or 
treated wastewater to finished water.4,5,8 
Ideally, pathogens would be monitored directly in finished drinking water to demonstrate the water 
is safe; however, this is infeasible due to the extremely low pathogen concentrations in safe 
finished water (e.g., 10-7 enteric viruses/L 1). Instead, individual unit processes in the treatment 
train are allotted log removal credits for groups of pathogens, and the credits are summed across 
the treatment train. To maintain removal credits, the proper functioning of a unit process is ensured 
in real- or near real-time by monitoring an easy-to-measure surrogate parameter, such as turbidity 
or electrical conductivity. These surrogate parameters often underestimate actual microorganism 
removal. Virus removal credits, in particular, are very conservative. Consequently, potable water 
reuse treatment trains may be over-engineered for pathogen removal because utilities cannot 
demonstrate the actual log reductions for common unit processes (e.g., biofiltration, ultrafiltration, 
reverse osmosis). 
The water treatment field in general, and the wastewater reuse field in particular, would greatly 
benefit from technologies that accurately depict microorganism concentrations in real- or near real-
time and demonstrate their reductions through specific unit processes. We believe flow cytometry 
(FCM), a high-throughput technique that uses light scattering and fluorescence for particle 
detection,9 can fill some of these needs for microbe monitoring and will be increasingly applied 
for wastewater reuse monitoring. The main advantage of FCM over currently used surrogate 
 108 
parameters is that it directly detects microorganisms. The main advantages of FCM for reuse 
applications over other microbial detection techniques are that it is high-throughput, reproducible, 
and can concurrently enumerate different microorganism groups based on size and fluorescence 
properties. In this perspective, we review recent applications and advances in FCM for 
environmental monitoring. We discuss the three main pathogen groups but focus on virus detection 
using FCM, coined flow virometry (FVM), as we see this as an area ripe for advancement in 
coming years. Based on demonstrated capabilities of FCM and FVM, we propose three specific 
applications in potable water reuse.  
 Recent applications and advances in the use of FCM for bacteria and protozoa 
monitoring. 
Bacteria enumeration via FCM is far more advanced than protozoa or virus monitoring in terms of 
experience, automation, and proof-of-concept research.10,11 Bacteria in drinking and surface water 
matrices can effectively be monitored in real-time12–14 using flow cytometers with automated 
modules that routinely sample, stain, and enumerate bacteria with fifteen-minute resolution.15 
Online bacteria monitoring via FCM in full-scale water treatment systems offers improved 
resolution, reproducibility, and statistical power over traditional bacteria monitoring methods such 
as heterotrophic plate counts.11 Bacteria staining techniques aimed at assessing viability are now 
commonly applied to distinguish intact from membrane compromised bacteria 10. Total and viable 
bacteria levels have been enumerated via FCM in various water types (Table 5.1). Total bacteria 
reductions of about 2-logs have been reported across conventional wastewater treatment,16,17 
whereas a microfiltration unit process in a water reclamation facility can remove over 5-logs.18 
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Unlike bacteria monitoring with FCM, measuring total protozoa populations has not been a 
focused area of research. This may be due to the presence of algae or other detrital material of 
similar size or fluorescent intensity19,20 Instead, protozoa FCM research has centered on 
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quantifying the pathogens Cryptosporidium spp. and Giardia spp. in water because of their health 
and regulatory relevance. Depending on the sample matrix, significant concentration steps are 
required prior to FCM analysis to detect them.21,22 Future work to address these limitations would 
help make protozoa monitoring using FCM more realistic as a real-time reuse monitoring strategy. 
 Recent applications and advances in the use of FVM for virus detection 
 Advances in FVM. 
Improvements in sample preparation and FVM instrumentation are enabling quantification of total 
virus populations as well as specific viral strains. Most flow cytometers are unable to differentiate 
biological particles below approximately 300 nm from the background signal (i.e., noise) of the 
instrument based solely on light scattering properties23,24 As a result, virus particles are commonly 
tagged with fluorescent dyes via antibodies, fluorescent proteins, or nucleic acid stains to facilitate 
detection. Even when stained or tagged, however, virus particle signals are at or near the 
background signals of some flow cytometers. The background signal arises from the optical, 
fluidic, and electronic components of the flow cytometer. Increased laser wattage, use of 
photomultiplier tubes (PMTs) or digital focusing systems (DFS) in place of photodiode detectors, 
filtration of sheath fluid used during sample analysis, decreased internal chamber size, and 
continual instrument cleaning are all strategies to help reduce background signals for improved 
nanoparticle detection.25,26 The difficult in distinguishing a single virus particle from multiple virus 
particles in one FVM event27 can be addressed via sample dilution 28, slower flow rates (< 1000 
events per second),29 or smaller internal chamber size 25. Building on these advances, the field of 
medical virology has conclusively demonstrated the utility of FVM to detect specific virus 
particles, including HIV-1,30,31 T4 and lambda phage,32 HSV-1,33 Junin virus,34 and filoviruses.35 
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These studies have used specialized flow cytometers with stringent controls to ensure accuracy in 
distinguishing viral populations. 
 Application of FVM to environmental samples. 
Applications of FVM in medical virology tend to concentrate on the detection and characterization 
of targeted virus species. Antibody-based fluorescent tagging therefore provides advantages in 
these applications due to its specificity. Environmental FVM studies, on the other hand, have 
typically focused on the enumeration of total virus particles. Here, nucleic acid staining is more 
applicable than antibody tagging because it theoretically targets all viruses in the sample. In reality, 
FVM fluorescence signals observed following nucleic acid staining are not consistent among 
viruses with variable genome types, genome sizes, and capsid structures. 
In terms of environmental measurement, FVM has been used most extensively in marine biology 
for the enumeration of native marine virus populations stained with nucleic acid dyes.28,36–38 FVM 
research in the marine biology setting has almost exclusively relied on dyes from the SYBR family. 
These are newer dyes with lower intrinsic fluorescence and improved nucleic acid signals 
compared to older dyes (e.g., DAPI; Table 5.2). SYTO, TOTO, and YOYO dyes, also newer dyes 
commonly employed by the medical virology field, are avoided in marine biology because they 
lose their binding affinity in samples with high ionic strength.39,40 These dyes have yet to be 
explored with viruses in freshwater samples. Prior to analysis, marine virus samples are often 
pretreated with fixation, heat, and flash-freezing to improve virus particle fluorescence signals. 
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Table 5.2 Properties of nucleic acid stains and reference FCM studies that have used the specified stains 
for different analyses. 
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0.34 (DNA)58 358/46158 Bacteria enumeration60 
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TOTO Family    
TOTO-1 0.34 (DNA)58 514/53158 Bacteria diversity69 
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 FVM for water quality monitoring. 
Water quality and water treatment researchers have drawn from procedures used in marine biology 
to enumerate total virus populations in wastewater and reclaimed water samples.16,18,41,42 Overall, 
various combinations of SYBR Gold, SYBR Green I, and SYBR Green II have been employed, 
and pretreatments include sample flash-freezing, heating and incubation, and fixation.16,41,42 In 
complex samples like wastewater, an additional virus disaggregation step, such as Tween 80 and 
sodium pyrophosphate pretreatment can improve virus enumeration.41 An ultrasonication 
pretreatment step did not improve enumeration in activated sludge samples16,41 but did improve 
virus particle counts in settled wastewater samples.16 
FVM has been used to measure virus concentrations and removal rates for a range of treatment 
technologies in wastewater and water reuse systems (Table 5.1). No significant reduction in virus 
concentrations were observed through traditional wastewater processes via FVM.16,18 Of note, total 
detectable virus concentrations were reduced by over 4-logs through the microfiltration process of 
a reclamation facility in a recent study employing FVM.18 Reductions through the subsequent 
reverse osmosis unit processes were not measurable because the detection limit of the method had 
been reached.18 In the same study, over 4-logs of total detectable virus particles were removed 
through a membrane bioreactor process. At this point, infective and non-infective viral fractions 
have not been differentiated with FVM. 
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 Methodological challenges in FVM for water quality monitoring. 
A number of challenges must be addressed before the utilization of FVM for water quality 
monitoring can be fully realized. One primary challenge is in confirming that all or most virus 
particles are actually being measured by FVM (i.e., avoiding false negatives). This is particularly 
difficult when enumerating virus particles with small genomes or single stranded genomes (e.g., 
ssRNA or ssDNA), which tend to emit smaller fluorescence signals. Studies often use transmission 
electron microscopy and/or epifluorescence microscopy to confirm total virus particle counts 
obtained by FVM.16,41,42 Spike additions of pure virus stocks into sample matrices are also critical 
to verify that the FVM method can effectively quantify the virus populations of interest. For 
example, Brown et al.41 measured total virus particle counts in samples with and without spike 
additions of T4 coliphage to assess recovery in activated sludge samples. Realizing the diversity 
of potential virus targets, we propose future studies spike virus cocktails, consisting of several 
different viruses, into samples to more accurately characterize the impacts of genome and structure 
type and size on recoveries. 
Another significant challenge is minimizing false positives. These can be caused by cytometer 
background noise,28 particles that autofluoresce (e.g., colloids),43 and biological particles that 
fluoresce when stained (e.g., microvesicles, gene transfer agents, or extracellular DNA).44 To 
address background noise of the machine, filtered and autoclaved samples are typically run 
through the cytometer and subtracted from stained samples.41,42 Measuring the same sample before 
and after staining can help identify particles that are not virus particles. For biological samples, 
DNAse treatments have been used with limited success to reduce the likelihood of detecting free 
DNA.41 Chloroform treatment of samples prior to the addition of DNAse could also prove 
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beneficial by releasing membrane-associated nucleic acids from biological particles that may 
otherwise results in false positives (e.g., microvesicles, gene-transfer agents). 
 Our vision of FCM in wastewater reuse applications 
Based on previous work in FCM for water monitoring, we envision at least three major applications 
of flow cytometry in the water reuse setting (Figure 5.1). First, we believe FCM will become an 
important near-real time surrogate measurement for validating log reduction values through 
physical treatment processes (e.g., filtration, sedimentation). Specifically, reductions of groups of 
particles with certain fluorescence properties could be used to represent the removal of 
microorganisms with the same FCM properties. For example, if flow cytometer measurements 
show a 99% reduction in detectable virus-like particles across a unit process, then 2-log virus 
reduction will be granted for enteric viruses. Before this is feasible, research will need to establish 
whether reductions measured with FCM correlate with actual virus removal. As an example of our 
proposed approach, the 4-log total virus removal measured by Huang et al.18 through 
microfiltration with FVM is similar to virus removal that has been achieved through 
microfiltration,45 although microfiltration virus removal has been highly variable (i.e., 0 to >5-log 
removal46). Where this approach can be applied in the reuse scheme will depend on detection 
methods for the particular cytometer and native virus particle concentrations. A wide range of 
FVM detection limits has been reported in various matrices, from 80 to 104 particles/ml.16,18,31 
Beyond viruses, we imagine similar approaches could be made for bacteria and protozoa 
reductions across unit processes. 
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Figure 5.1 Three potential applications of FCM in an example advanced water treatment scheme. In the 
first application, log removal credits are maintained through unit processes by real-time particle monitoring. 
In the second application, online influent and effluent FCM monitoring detects aberrations in water quality 
and system performance. In the third application, cocktails of noninfective fluorescent viruses are added to 
water samples before unit processes to characterize virus removal. 
We also envision using FCM to continuously monitor particles of a certain size or fluorescence to 
help inform operators of changes in treatment plant influent or effluent quality. For example, 
potable reuse effluent could be continuously measured with FCM and trends in particle size 
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distributions, fluorescence characteristics, or particle concentrations could be correlated with 
overall system performance. Aberrations in the FCM data would thus serve as an immediate 
warning for failures in the treatment train. This is similar to using turbidity measurements to detect 
changes in water quality, but FCM would provide more relevant and extensive information related 
to microbial water quality. Future research at actual plants should study how variations in FCM 
“fingerprints” correlate with other indices used to assess influent water quality or overall treatment 
train performance. 
Finally, we see FCM as a powerful tool for improved virus removal studies at the bench- and pilot-
scale level. Currently, bench-scale and pilot-scale assessments of unit processes involve spiking 
in one or two surrogate viruses and measuring removal with culture-based methods. These studies 
are not only time consuming, but the selected surrogate viruses do not represent the behavior of 
all viruses of interest in water.47 An alternative approach measures the reduction in spiked 
fluorescent latex bead concentrations,46 but these particles have little in common with virus 
particles. Instead, we propose using cocktails of bacteriophages of various sizes and genome types 
with stained nucleic acids that are readily detected by FVM for bench-scale and pilot-scale 
assessment. Alternatively, lab-synthesized virus-like particles identical to a variety of human 
pathogens in structure but containing nontoxic fluorescent tags instead of nucleic acids can be used 
as a cocktail for spiking experiments.48 In either manner, the virus cocktails could be utilized to 
directly and rapidly measure virus log removals in pilot scale systems with FVM. An exciting 
application of the virus-like particle spike cocktail is in assessing pathogenic virus reductions 
through biological treatment processes, which often also involve physical particle removal. 
Biological treatment likely propagates bacteriophage and thus increases total virus concentrations 
in treated water while pathogenic virus concentrations are concurrently decreasing. Therefore, 
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measuring background total virus concentrations before and after biological processes by FVM 
would not provide an accurate assessment of pathogenic virus removal. Adding fluorescent virus 
particles that do not replicate could alleviate these issues and enable the accurate measurement of 
physical virus removal in unit processes where virus propagation occurs. 
 Conclusions and future implications 
We envision that FCM will revolutionize how microbial monitoring is conducted through potable 
reuse, especially for virus detection. To bring this vision towards reality, research should compare 
instrument performance with different virus particle sizes of variable genome types (i.e., ssDNA, 
dsDNA, ssRNA, dsRNA) and assess fluorescence stains already employed in other applications. 
This research should be conducted in real waters with a range of characteristics, spanning from 
untreated municipal wastewater to finished reclaimed drinking water. Techniques should be 
developed that differentiate infective and noninfective virus particles with FVM, particularly as 
virus particles are inactivated through disinfection unit processes. A potential method for 
distinguishing infective virus particles could include the use of enzymatic pretreatment49 to 
eliminate fluorescence from virus particles with degraded capsids. Research is also necessary to 
establish relationships between total particle concentrations measured with FCM and pathogenic 
microorganism concentrations. Finally, FVM monitoring should be studied through bench-scale 
unit processes, followed by testing at the pilot-scale, and should ultimately be applied in full-scale 
systems with automated monitoring.
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 Abstract 
To validate the effective removal of viruses through water reuse treatment systems, real-time 
monitoring of each treatment process is required. Surrogates that are easy to measure before and 
after a treatment, such as turbidity, are used for this purpose. However, the lack of sensitivity in 
currently applied real-time virus monitoring approaches means that water reuse treatment trains 
are likely overengineered for virus removal. Flow cytometric detection of viruses, termed flow 
virometry (FVM), is gaining popularity as a rapid approach for quantifying or characterizing virus 
particles in the microbiology, medical, marine biology, and environmental engineering fields. 
While FVM is a promising method for use in water treatment virus monitoring, virus detection 
capabilities of high sensitivity flow cytometers are not well-characterized. In this study, we 
evaluate the ability of a high sensitivity flow cytometer to detect viruses with different genome 
types (e.g., large dsDNA genomes, small (+) ssRNA genomes) and conduct proof-of-concept 
experiments to evaluate FVM’s ability to accurately measure virus reductions through bench-scale 
physical treatment processes. Our findings establish that only bacteriophage T4, a dsDNA virus 
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with a large genome, was detected with the cytometer after nucleic acid staining. All other viruses 
were below or within the background noise of the instrument. FVM was able to accurately measure 
up to ~ 4.5-log10 T4 reductions through ultrafiltration, while turbidity was only reduced by 0.5-
log10. However, FVM measurement of native virus populations in secondary wastewater effluent 
yielded no significant improvement in monitoring sensitivity over turbidity measurements. These 
findings indicate that in its current form, FVM cannot accurately detect virus reductions for the 
virus populations native to relevant water matrices and is therefore not a practical real-time 
monitoring approach. Improvements in cytometer technologies will eventually allow for detection 
of viruses with smaller genomes, and as this happens, FVM should be re-assessed as a real-time 
monitoring option. 
 Introduction 
Waterborne viruses pose an acute risk to human health.1 To mitigate the risk of exposure to these 
viruses in water supplies, a multi-barrier approach to water treatment is used, in which numerous 
unit processes are placed in series to cumulatively reduce infectious virus levels to an acceptable 
level. The low concentrations of viral pathogens allowed in finished water (i.e., < 1 x 10-7 viruses/L 
2) makes ascertaining treatment performance by direct pathogen quantification infeasible. Real-
time monitoring of unit processes in the water treatment field is therefore used to ensure that unit 
processes are performing as expected.2 This approach is particularly important in the direct potable 
reuse (DPR) field, where the source water for treatment is wastewater and may contain elevated 
enteric virus concentrations. 
Many currently used monitoring strategies in water reuse scenarios underestimate virus removal, 
particularly through physical treatment processes (e.g., ultrafiltration, reverse osmosis). This is 
because the surrogate parameters used for real-time monitoring through physical treatments are 
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not sensitive enough to demonstrate the full extent of log10 virus reductions that occur. As a result, 
even when a treatment is known to achieve a certain amount of log10 virus reduction, it will only 
be allotted the reductions observed by the surrogate parameter. For example, ultrafiltration 
research at the bench-scale has established > 5-log10 virus removal through treatment,3,4 however 
commonly used unit process surrogates (e.g., turbidity, pressure decay test) cannot detect virus-
sized membrane breaches in the treatment process.5,6 This means that typically no virus removal 
is allotted for ultrafiltration. The lack of sensitive surrogate parameters for real-time monitoring 
leads to overengineered treatment trains for virus removal. Innovative new monitoring methods 
have the capability of transforming how virus removal is allotted through physical treatment 
processes. One promising approach is flow virometry (FVM), a high-throughput method that uses 
flow cytometers for virus detection.7 
Cytometers employ powerful lasers and state-of-the-art fluidics to rapidly and sensitively analyze 
particles.8 Advances in cytometer instrumentation have allowed for the detection of smaller 
biological particles, including some viruses.9–17 FVM is an invaluable tool in the virology field, 
where it is used to rapidly analyze virus particles for various purposes, including vaccine 
development, virus isolation, and virus structure characterization.14,18,19 Virology studies using 
FVM often employ antibodies specific to a viral protein12,19–21 or fluorescently labeled proteins22 
to increase the virus signal and accurately detect a particular virus. In contrast, FVM research in 
the marine and environmental microbiology fields generally seeks to enumerate total virus 
populations in water samples.11,23–28 In these studies, water samples are usually stained with a 
nucleic acid dye to boost the virus signal prior to FVM analysis.  
FVM offers various advantages over traditional virus enumeration techniques (e.g., transmission 
electron microscopy, fluorescence microscopy), which are hindered by slow throughput and 
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quantification biases. Yet many current FVM methods push the limits of cytometer capabilities. 
Approaches to FVM in the environmental microbiology field are inconsistent, and questions 
remain regarding the feasibility of reliably detecting virus particles.29,30 While many 
environmental studies have attempted to optimize FVM sample preparation and analysis, results 
from these experiments often identified different optimized protocols.11,24,26 This is likely due to 
dissimilarities in sample types, cytometer capabilities, and measurement strategies. These 
distinctions, although important to address, are not typically highlighted. To more consistently 
monitor virus concentrations in complex environmental matrices, the limitations and capabilities 
of FVM methods must first be clearly characterized and better understood. For instance, while 
some studies use highly sensitive flow cytometers (e.g., LSR Fortessa, BioRad ZE5) with powerful 
lasers (> 100 mW), others use standard benchtop cytometers (e.g., BD Accuri C6) with much 
reduced laser wattage (~ 20 mW) and no voltage adjustment capabilities. These cytometer 
differences can manifest in detection disparities, allowing sensitive cytometers to successfully 
detect more of the virus signal, while less sensitive instruments may not be able to discriminate 
viruses from the instrument background. Even when using a highly sensitive flow cytometer for 
analysis, the voltage and threshold settings used can significantly impact the instrument’s detection 
abilities. 
Another important consideration with FVM is which virus classes can effectively be detected. In 
environmental matrices, a wide range of viruses have been identified.31,32 Flow cytometric analysis 
of biological particles is typically conducted by using controls, including stained and unstained 
samples, to determine which regions of a cytometer plot confidently characterize particles of 
interest. In bacterial and mammalian cell FCM, the cell populations of interest generally have a 
sufficiently large signal so that the background noise is excluded from analysis. As shown in past 
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work,10,17,33 viruses with large genomes stained with nucleic acid dyes have a sufficient 
fluorescence signal to be separated from the background signal, and in this scenario the traditional 
approach of gating the population of interest is possible to determine accurate virus concentrations. 
When biological particles are much smaller, however, the particle signal may be within the signal 
of the background noise or possibly even below the background noise signal. This is likely the 
case for many viruses, which range in size from ~ 5 – 300 nm and can have genomes as small as 
~ 1.9 kilobases.34 Some custom-built cytometers can separate the light scattering signal of many 
smaller viruses9,35 from the background signal due to improved fluidics and laser power. However, 
this is likely not feasible for the high sensitivity cytometers currently on the market, which may 
not be able to separate all or even most viruses from the instrument background noise. 
Most environmental FVM studies to date have taken the traditional approach of eliminating 
background noise from sample analysis, but this may result in a significant underestimation of 
total virus concentrations. Given the limited detection capabilities of cytometers at present, 
additional approaches for improving virus detection should be considered. Regardless of whether 
FVM is capable of detecting natural virus populations present in water matrices, FVM may still 
prove a useful real-time surrogate parameter for virus removal. Past work has observed 1 – 4-log10 
reduction in the FVM signal through microfiltration,24,25 but more information about how well 
FVM signal reductions correlate with simultaneous infectious virus removal through the same 
treatment is needed. 
In this study, we undertook experiments to identify the combination of fluorescent dye, dilution 
solution, and flow cytometer settings that would result in accurate virus counts while maintaining 
low background noise levels using a large dsDNA virus, T4 bacteriophage. We also assessed the 
FVM signatures of a range of different bacteriophages, including T4, T3, phi6, phiX174, and MS2 
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(Table 6.1), to confirm which virus types are likely to be enumerated using a high sensitivity flow 
cytometer.  
Table 6.1 The structural and molecular characteristics of the bacteriophages used in this study. 
Bacteriophage Family Nucleic acid type 
Nucleic acid 
size (kb or 
kbp) 
Capsid (nm) 
T4 Myoviridae dsDNA, linear ~ 169 ~ 90 x 200 
T3 Autographiviridae dsDNA, linear ~ 38 ~ 60 
phi6 Cystoviridae dsRNA, segmented ~ 13.4 ~ 85 
phiX174 Microviridae ssDNA, circular ~ 5.4 ~ 30 
MS2 Leviviridae (+) ssRNA, linear ~ 3.6 27 
kb = kilobases; kbp = kilobase pairs. 
Ultimately, we assessed how well FVM counts correlate with viruses in water treatment scenarios 
compared to already established real-time monitoring approaches (e.g., turbidity). This work sheds 
light on the capabilities of high sensitivity flow cytometers for virus detection and enumeration. 
Our proof-of-concept analysis has implications for the application of FVM as a real-time 
monitoring tool in water treatment settings. 
 Materials and Methods 
 Virus propagation and purification. 
Bacteriophages T4, T3, phi6, phiX174, and MS2 were included in this work to provide a range of 
different virus types (Table 6.1). Viruses were purified to allow for the reliable designation of 
FVM counts as virus particles. All purified virus stocks were kept at 4°C for short-term storage 
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and -80°C for long-term storage. Infectious bacteriophages were enumerated by plaque assay using 
the double agar overlay method.36 
 Bacteriophage T4. 
E. coli ATCC strain 11303 was the host for bacteriophage T4. T4 was propagated using the soft 
agar overlay method. Propagated virus was purified on a sucrose gradient, which was generated 
by allowing five layers of 10 – 50% sucrose to linearize overnight at 4°C. 3 mL of T4 stock was 
overlaid on the linearized gradient and centrifuged at 28,000 rpm for 40 mins at 4°C. The resulting 
virus band was pulled from the gradient and buffer exchanged > 12x with 1X phosphate buffered 
saline (PBS) solution (Cat. No. 10010023, Invitrogen) using a 100 kDa ultrafilter (Cat. No. 
UFC910008, Amicon). 
 Bacteriophage T3. 
E. coli ATCC strain 11303 was the host for bacteriophage T3. T3 was propagated using liquid 
propagation and concentrated by polyethylene glycol (PEG) 8000 (Cat. No. BP2331, Fisher 
Scientific).37 The virus stock was purified on a linear sucrose gradient using the same approach as 
described for T4. 
 Bacteriophage phi6. 
Bacteriophage phi6 and its host P. syringae pv phaseolicola were kindly provided by Dr. L. Marr 
(Virginia Tech). phi6 was propagated as previously described.38 Following liquid propagation and 
filtration through a 0.22 µm polyethersulfone (PES) membrane (Cat. No. 229747, CELLTreat) to 
remove cell debris, the propagated virus stock was enriched and purified using a sucrose cushion. 
Specifically, 28 mL of propagated virus lysate was overlaid on 5 mL of 30% sucrose and run at 
24,000 rpm for 1.5 hr at 4°C. The pellet was washed one time with 1X PBS and suspended in ~ 4 
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mL 1X PBS. The virus stock was further purified using a sucrose gradient. 3 mL of sucrose cushion 
purified phi6 was overlaid on a sucrose gradient generated by allowing five layers of 10 – 50% 
sucrose to linearize overnight at 4°C. The gradient was centrifuged at 22,000 rpm for 1.5 hr at 4°C, 
and the resulting band was extracted. The phi6 stock was buffer exchanged with > 12 volumes of 
1X PBS through a 100 kDa Amicon ultrafiltration unit. 
 Bacteriophage phiX174. 
Bacteriophage phiX174 and its host E. coli ATCC 13706 were kindly provided by Dr. C. Gerba 
(University of Arizona). phiX174 propagation was conducted by the soft agar overlay method, as 
previously described.39 phiX174 was enriched and purified using a sucrose cushion, according to 
the same conditions described for bacteriophage phi6. 
 Bacteriophage MS2. 
E. coli ATCC strain 15597 was the host for bacteriophage MS2. MS2 was propagated by liquid 
propagation and concentrated through PEG as previously described.40 Propagated MS2 stocks 
were further purified by sucrose gradient (linear gradient resulting from five layers of 10 – 30% 
sucrose). 3 mL of propagated MS2 was laid over the linear gradient and centrifuged for 3 hours at 
30,000 rpm at 4°C. The resulting band was collected and buffer exchanged with > 12 volumes 1X 
PBS by ultrafiltration through a 100 kDa Amicon filter. 
 FVM sample preparation. 
Purified viruses were spiked into dilution solutions in 4 mL polyethylene sterile tubes (Cat. No. 
352063, Corning) for FVM analysis. All samples were subjected to 0.5% glutaraldehyde fixation, 
vortexed, and incubated at 4°C for 15 min in the dark. Samples were then stained with fluorescent 
dyes, vortexed, and incubated at 80°C for 10 min in the dark. Following sample preparation, 
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samples were immediately placed on ice and kept in the dark until FVM analysis. Various dilution 
solutions and fluorescent dyes were used for sample preparation optimization. 
 Dilution solutions. 
1X PBS, 0.2 µm filtered 1X PBS using a PES membrane, autoclaved 1X PBS, and 0.2 µm filtered 
and autoclaved 1X PBS were used to determine which dilution solution provides the clearest virus 
populations while not increasing background noise significantly. 
 Fluorescent dyes. 
Samples were stained with the nucleic acid stains SYBR Green I (SGI), SYBR Green II (SGII), 
and SYBR Gold (SG) to final concentrations of 0.5x or 1x and with SYTO 11 to final 
concentrations of 1 or 2 µM. 
 FVM analysis. 
We used the BioRad ZE5 flow cytometer for all FVM work. The cytometer was equipped with 
100 mW 488 and 405 nm argon lasers. Voltages on the 488 nm laser were set to 600, 500, 530, 
700, 700, and 700 nm for the FSC, SSC, 529 nm, 549 nm, 615 nm, and 692 nm filters, respectively. 
The FSC detector with small particle detector on the 405 nm laser was set to a voltage of 600. 
Events were set to trigger on 529 nm fluorescence channel, with a threshold of 0.03%. Sheath fluid 
was distilled water filtered in-line through a 0.04 µm membrane. 10 µL of each sample was run 
using volumetric intake at a medium flow rate (i.e., 1 µL s-1). Samples were prepared so that viruses 
passed through the cytometer at < 1000 events s-1 to avoid coincident events. During analysis, the 
BioRad ZE5 sample chamber was kept at 4°C. 
When excess background noise was detected prior to sample analysis, 30 µL of 10% bleach was 
run at high flow, followed by 1X PBS samples to ensure that counts were consistent from sample 
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to sample. This process was repeated until five consecutive 1X PBS samples displayed similar 
counts. In between each sample, 10 µL of a detergent (Contrad) was run at high flow, followed by 
30 µL of sterile 1X PBS run at high flow. Counts from the 1X PBS were continuously monitored 
to ensure no unexpected spike in counts from background noise. When a spike in counts from 
background noise was detected, the sample results were not used in analysis. All FVM results were 
analyzed using FCS Express (De Novo Software). 
 Evaluation of enumeration methods through membrane filtration. 
Secondary wastewater effluent from the Ann Arbor Wastewater Treatment Plant was collected and 
stored at 4°C until use in experiments. Purified viruses were spiked into 0.45 µm PES (Cat. No. 
229771, CELLTreat) filtered secondary wastewater effluent samples to a 10% final concentration, 
mixed gently by inversion, and kept at 4°C for 10 minutes before filtration experiments. Spiked 
secondary wastewater effluent samples were passed through 0.2 µm PVDF membranes (Cat. No. 
09-720-3, FisherBrand) and 0.02 µm inorganic membranes (Cat. No. WHA68091002, Whatman) 
to assess the correlation of FVM data with virus removal through microfiltration and ultrafiltration, 
respectively. The filters were wetted with virus spiked solution before filtrate collection to avoid 
introduction of filter-associated particles in FVM measurements. 
 Other surrogate measurements. 
Turbidity was measured before and after treatment of 0.45 µm filtered secondary wastewater 
effluent through ultrafiltration and microfiltration. A 2100N Hach turbidimeter (Hach) was used 
for turbidity measurements. 
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 Statistical analyses. 
All statistical analyses were conducted in R version 4.0.0.41 Figures were generated in Prism 
version 8.4.2 and in FCS Express. 
 Results and Discussion 
 Dilution solutions. 
We determined whether one type of dilution solution was significantly better or worse than 
another. To this end, we evaluated several variations of buffer solution stained with SGI at a 0.5x 
final concentration. No significant differences were found between the counts obtained with 
different dilution solutions (paired t-test, all p > 0.05), suggesting that no components of certain 
solutions contributed more or less to background noise. 
The limit of detection of the instrument when analyzing 10 µL of sample at a flow rate of 1 
µL/second was estimated to be ~ 6 x 104 counts/mL (additional details provided in Appendix D).  
 SGI stain provides optimal virus fluorescence in the 529 nm channel, but SG provides 
elevated signal in 549 nm channel. 
We stained T4 bacteriophage with four different nucleic acid stains (i.e., SG, SGI, SGII, and S11) 
at variable concentrations to determine which stain was best for improving the virus fluorescence 
signal while not adding so much background that the virus signal was overtaken. The T4 
bacteriophage signal in the 529 nm fluorescence channel was distinguishable from the background 
noise for all nucleic acid stains and concentrations tested, however the fluorescence intensity of 
the T4 signal differed (Figure 6.1 and Table 6.2). We also tested the 549 nm fluorescence channel, 
because the nucleic acid stains used exhibit a range of peak emission wavelengths,30 and use of 
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this channel could result in improved virus fluorescence signal. Indeed, the 549 nm fluorescence 
channel offered an increased T4 signal for several of the dyes, particularly for SG. This is not 
surprising, because SG has a right skewed emission spectrum with peak emission at 537 nm, which 
lies between the 529 nm and 549 nm bandpass filters on our BioRad ZE5 instrument. While the 
529 nm fluorescence channel is commonly used in FVM work using nucleic acid stains,29,42,43 our 
findings indicate the importance of evaluating detection in several channels when possible to 
ensure the optimal settings are used for sensitive virus detection. 
 
Figure 6.1 Event counts and fluorescence intensity resulting from FVM analysis of T4 bacteriophage in 
1X PBS solution stained with SGI, SGII, SG, and SYTO 1, where events were captured using (a) the 529 
nm fluorescence channel or (b) the 549 nm fluorescence channel.  
The total T4 bacteriophage population enumerated via FVM yielded statistically similar counts for 
most stains, with only the SYTO 11 dye at a 2 µM concentration resulting in significantly less 
counts than the SGI, SGII, and SG stains at all concentrations (Table 6.2 and Table D.1). This 
reduction in counts is likely due to the minimal separation between the background and T4 signal 
with SYTO 11 dye that may result in uncounted T4 viruses. 








































Table 6.2 Summary of T4 stain experiments, including the T4 concentration, signal-to-noise ratio, and stain 
index for each stain evaluated in the 529 nm and 549 nm fluorescence channels during FVM analysis. 
 
The signal-to-noise ratio, calculated as the difference in median fluorescence intensity between the 
T4 population signal and the background signal, was significantly greater for SGI and SGII stains 
in the 529 nm fluorescence channel compared to the SYTO 11 and SG stains (Table 6.2 and Table 
D.2). However, when analyzing events in the 549 nm fluorescence channel, SG and SGI had the 
best signal-to-noise ratios. Past FVM work has identified SGI and SGII as optimal stains, citing 
increased fluorescence signal compared to SG, although no significant differences in signal were 
observed.26,44 Here, we also saw increased signal from T4 stained with SGI compared with SG in 
the 529 nm fluorescence channel, however when evaluating fluorescence in the 549 nm 
fluorescence channel SG offered elevated fluorescence. 
We also considered the stain index, defined as the difference in T4 signal to background signal 
divided by the spread of the background noise, to identify which stains provided optimal 
fluorescence signal with minimal background. The two stains with the highest signal-to-noise 









SGI (0.5x) 2.8 x 104 ± 8.8 x 103 1.5 x 105 ± 4.7 x 103 7.87 11.7 1.5 x 105 ± 3.6 x 103 25.0 17.3
SGI (1x) 2.8 x 104 ± 8.8 x 103 1.5 x 105 ± 2.7 x 103 9.42 15.5 1.5 x 105 ± 7.9 x 103 33.5 24.1
SGII (0.5x) 2.8 x 104 ± 8.8 x 103 1.8 x 105 ± 1.9 x 104 8.32 12.5 2.0 x 105 ± 3.1 x 104 17.4 12.3
SGII (1x) 2.8 x 104 ± 8.8 x 103 1.9 x 105 ± 2.4 x 104 10.5 15.1 2.2 x 105 ± 3.5 x 104 17.8 12.8
SG (0.5x) 2.8 x 104 ± 8.8 x 103 1.5 x 105 ± 1.1 x 104 4.84 6.34 1.6 x 105 ± 6.5 x 103 41.3 32.2
SG (1x) 2.8 x 104 ± 8.8 x 103 1.6 x 105 ± 8.7 x 103 4.48 5.20 1.7 x 105 ± 4.7 x 103 27.1 22.6
SYTO 11 ( 1 uM) 2.8 x 104 ± 8.8 x 103 1.0 x 105 ± 2.8 x 104 3.30 3.71 1.2 x 105 ± 2.6 x 104 24.7 17.9
SYTO 11 (2 uM) 2.8 x 104 ± 8.8 x 103 4.8 x 104 ± 5.9 x 103 3.21 3.77 6.1 x 104 ± 6.0 x 103 17.9 12.9
aConcentrations shown are arithmetic mean ± standard error of three independent replicate FVM samples.
bCalculated as the ratio of the median fluorescence intensity of the T4 signal to the median fluorescence intensity of the background signal.
cCalculated as the difference between the median fluorescene intensity of the T4 signal and th median fluorescence intensity of the background signal, 
divided by the spread of the background signal (i.e., 2 x the robust standard deviation).










 dsDNA viruses are detectable with FVM but not RNA viruses. 
Five bacteriophages were analyzed to evaluate the class of viruses detectable by a sensitive 
cytometer. Using traditional FVM analysis approaches, no virus signals except that of T4 were 
completely distinguishable from the background noise signal (Table 6.2 and Figure D.1). Analysis 
of the viruses stained with SG at 0.5x final concentration revealed that a portion of the T3 signal 
was separated from the background signal in the 549 nm fluorescence channel, although the counts 
are much reduced from the total expected count (Figure 6.2). This could be because a portion of 
the T3 signal is in the background noise. Our results are in line with other studies that have not 
been able to separate small DNA or RNA viruses from instrument background.29,44 However, work 
using a BD Accuri C6 cytometer indicated that MS2 bacteriophage was effectively enumerated 
via FVM.24 Here, we were unable to detect an MS2 signal from the background signal of the 
instrument, despite using a more powerful laser. This discrepancy could be due to the fact that 
unclean samples were used in that work, so although infectious MS2 concentrations correlated 
with FVM counts, it is possible that those FVM counts were not in fact enumerated MS2 viral 
particles. 
 
Figure 6.2 FVM analysis of (a) 1X PBS stained with 0.5x SG, (b) T4 in 1X PBS stained with 0.5x SG, and 








































































































































































fluorescence channel area are used on the axes. Heat map indicates highest event concentrations in red and 
lowest concentrations in blue. 
The inability to quantify most virus types using the traditional approach to FVM analysis led us to 
evaluate an alternative approach in which we allowed a portion of the background noise in our 
analysis. The stained blank sample was run with the stained virus sample, and the counts from the 
blank samples were subtracted from the virus sample to determine the total virus particle counts 
in the sample. This approach requires that instrument background signal be consistent from sample 
to sample. We evaluated whether this was true for our purified virus solutions by enumerating T4 
using both of the described approaches to FVM analysis. Our results using SGI and SG at 0.5x 
final concentrations demonstrate that the total counts subtraction approach over and 
underestimated true T4 virus counts in the sample, depending on the replicate (Table D.3). On 
average, the subtraction approach for samples stained with SGI or SG at 0.5x concentration 
resulted in ~ 0.1% or ~ 32% error from true counts, respectively. These findings suggest that SGI 
may provide the most accurate counts when using the subtraction approach to FVM analysis. 
Ultimately, we evaluated if smaller viruses with less of a fluorescence signal could reliably be 
enumerated using the alternative approach to FVM analysis. The fluorescent signatures of all five 
bacteriophages (Table 6.1) were assessed using SGI and SG at 0.5x final concentrations. SGI 
stained samples revealed accurate counts for the T4 population but counts below detection for T3, 
phi6, phiX174, and MS2 (Table D.4). SG, in contrast, resulted in increased counts in the virus 
samples for all five bacteriophages (Table D.4). However, T4 counts in these samples using the 
total counts subtraction approach were overestimated compared to using the traditional FVM 
analysis approach (average percent error ~ 94%, n = 2), suggesting that increased FVM counts in 
the other virus samples may not be enumerating true virus particles. In addition, standard error of 
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two independent replicates was nearly as large as FVM counts themselves, suggesting a significant 
degree of variability in FVM counts when analyzing SG stained samples using the FVM 
subtraction approach. Additional replicates should be conducted with SG-stained virus samples to 
ensure that the elevated counts observed were indeed virus counts. 
 Proof-of-concept application of real-time FVM monitoring. 
While our results suggest only large dsDNA viruses are separable from FVM background noise, 
FVM still provides potential as a sensitive real-time monitoring approach to verify log10 virus 
reduction through water treatment processes. We spiked bacteriophages T4 and T3 into secondary 
wastewater effluent and filtered samples through microfiltration and ultrafiltration. Our results 
show that FVM counts of the T4 population correlate better with infectious T4 removal through 
microfiltration and ultrafiltration than do turbidity measurements (Figure 6.3). Specifically, 
infectious T4 levels through ultrafiltration were reduced by greater than 5-log10, and FVM 
demonstrated ~ 4.5-log10 reduction, while turbidity was reduced by less than 1-log10. Reductions 
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Figure 6.3 Log10 reduction of bacteriophage T4 infectivity, bacteriophage T4 FVM counts, and turbidity 
through microfiltration and ultrafiltration membranes. The samples subjected to microfiltration and 
ultrafiltration consisted of bacteriophage T4 spiked into secondary wastewater effluent at a 1:10 final 
concentration (~5 x 109 pfu/mL). Error bars represent the standard error of two independent replicates. 
Arrows above bars indicate log10 reductions beyond detection limits. 
We also evaluated removal of T3 bacteriophage suspended in secondary wastewater effluent 
through membrane treatments using the subtraction approach to FVM analysis. While infectious 
T3 levels were reduced by over 7-log10, only 2.5-log10 reductions could be detected via FVM 
(Figure D.2). A similar trend was observed using secondary wastewater effluent; only 0.5-log10 
reduction of FVM counts resulted through ultrafiltration. In both T3-spiked samples and secondary 
effluent samples, increased FVM background noise was observed, which likely overwhelmed the 
true reduction in signal resulting from virus particles. Future analyses should raise the fluorescence 
threshold to decrease the background signal and in turn increase the signal of the virus population. 
 Conclusions. 
This research focuses on the capabilities of FVM analysis using a high sensitivity flow cytometer. 
Here, we identify that while most stains evaluated provide similar counts of a large dsDNA virus, 
bacteriophage T4, SG provided an increased fluorescence signal when FVM analysis was 
conducted using the 549 nm fluorescence channel. However, this increased sensitivity from 
staining with SG also resulted in increased counts in background noise. The increased noise led to 
greater variability in counts from sample to sample, making it difficult to obtain consistently 
accurate virus counts. As a result, preliminary work using five different bacteriophages stained 
with SG at 0.5x final concentration suggested that small DNA and RNA viruses were measurable 
with this approach, however large variability in counts meant that additional replicates are needed 
before concluding which viruses were truly detected. 
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The proof-of-concept work using bench-scale physical removal processes demonstrated that FVM 
was capable of accurately monitoring virus removal of T4, a dsDNA virus with a large genome. 
Unfortunately, the FVM approach was unable to accurately measure virus removal for viruses with 
smaller genomes. In fact, FVM showed no improvement over turbidity in measuring reductions of 
native virus populations in wastewater effluent through ultrafiltration or microfiltration. This 
indicates that in its current form, FVM is not a practical option for real-time monitoring of virus 
removal through water treatment systems. Despite our current findings for viruses with small 
genomes, the fact that FVM could accurately detect T4 populations indicates that this monitoring 
approach could be applied in the future as cytometer technologies improve for detection of smaller 
particles. In addition, staining technologies and other advances in this area can work to make the 
detection of viruses with small RNA or DNA genomes a reality. It is important to note that our 
work was conducted at the bench-scale using spiked solutions of viruses. Future work in this area 
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Significance and Future Research Directions 
 Overview 
The threat of virus persistence in our water supplies must be balanced with concerns of 
overengineering water treatment systems. These matters are difficult to reconcile when the 
microbial hazards associated with important enteric viral pathogens are unknown or when their 
mitigation through treatment cannot be validated. This dissertation was conducted to better 
understand infectious virus fate through water treatment processes and to improve viral monitoring 
methods in the water treatment setting. The broad objective of this work is to inform water 
treatment regulations that will ultimately support the design and implementation of treatment 
schemes that are cost-effective and sustainable while still protecting public health. 
A primary focus of this research was on the use of novel approaches to assess the inactivation of 
an important enteric viral pathogen, HuNoV, through UV254, a commonly applied disinfection 
treatment (Chapters 2, 3, and 4). While HuNoV is of principal concern in water settings because 
of its large burden of gastrointestinal illness,1 little is known about its fate through treatment 
processes because of the lack of a readily available culture system. Estimation of HuNoV 
inactivation using novel computational and molecular approaches demonstrated that HuNoV has 
similar UV254 susceptibility compared to many other enteric (+) ssRNA viruses, such as 
enteroviruses (Chapters 2 and 3). In contrast, HuNoV was found to be nearly an order of magnitude 
more sensitive to UV254 treatment than enteric viruses within the Adenoviridae family. Work using 
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a culture-based HuNoV infectivity assay (Chapter 4) confirmed the UV254 susceptibilities 
determined via predictive modeling and genome extrapolation approaches. Beyond elucidating the 
UV254 susceptibility of HuNoV, this research developed and validated the use of alternative tools 
for accurately assessing virus behavior through UV254 treatment when traditional approaches are 
not feasible. 
This body of work also centered on developing approaches to accurately and rapidly monitor virus 
levels through water treatment processes. Many of the surrogate parameters monitored in real-time 
to confirm adequate performance of treatment are not sufficiently sensitive to validate the true 
amount of log10 virus reduction occurring through a unit process. As highlighted in Chapter 5, flow 
virometry (FVM) is a promising alternative for real-time validation of virus removal through unit 
processes. However, many aspects of the technology are not yet standardized and questions remain 
about detection capabilities. FVM methods development in Chapter 6 indicated that only large 
dsDNA viruses are entirely separable from the background noise of a high sensitivity flow 
cytometer, while smaller dsDNA viruses are partially separable using SYBR Gold staining, and 
small RNA and DNA viruses are within or below the noise of the cytometer. Proof-of-concept 
experiments (Chapter 6) evaluating bacteriophage T4 removal through microfiltration and 
ultrafiltration showed that infectious T4 reductions through treatments were much more similar to 
reductions in FVM counts than turbidity, a common process surrogate. This suggests that FVM 
shows increased sensitivity over current surrogates in monitoring virus removal through physical 
removal processes. However, FVM measurements of secondary wastewater effluent through 
ultrafiltration did not show significant improvements in monitoring native virus concentration 
reductions as compared to turbidity. 
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 Implications  
This research demonstrated that computational and molecular methods for evaluating infectious 
virus fate are capable of accurately estimating virus persistence. These tools can be applied when 
the use of traditional culture-based methods is not feasible. The value of these methods is 
highlighted by the ongoing COVID-19 pandemic, in which infectious SARS-CoV-2 work has been 
limited due to biosafety concerns. Application of the predictive model developed in this 
dissertation indicated the heightened sensitivity of SARS-CoV-2 to UV254 and suggested the 
suitability of UV254 as an effective mitigation strategy. 
The improved understanding of HuNoV fate through UV254 treatment gained through this work is 
beneficial for evaluating the risk of HuNoV infection in various food and water sources. In 
particular, the results are useful for the potable reuse field, as the lack of information about HuNoV 
infectivity through water treatment has resulted in uncertainties about whether treatment schemes 
are under or overengineered for HuNoV inactivation.2,3 The findings in this dissertation indicated 
that UV254 is an effective treatment for HuNoV, and that at the 186 mJ cm-2 dose required to ensure 
4-log10 adenovirus removal4 through UV254, HuNoV is inactivated by well over 20-log10. While 
this work provides confidence that HuNoV does not exhibit any unique attributes that make it less 
susceptible to UV254 than other enteric (+) ssRNA viruses, future work should evaluate the fate of 
HuNoV in other disinfection processes to ensure that this trend holds true for other treatment 
systems. 
The FVM work in this dissertation demonstrated that some large DNA viruses can be detected 
using state-of-the-art flow cytometers. On the other hand, the quantification of smaller RNA and 
DNA viruses with FVM is not yet a reality. In addition, FVM analysis revealed that tuning of the 
fluorescence channels, voltages, and thresholds used in detection is critical to obtain optimal 
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results. Proof-of-concept experiments with physical removal processes for virus removal 
demonstrated FVM was a more sensitive monitoring approach than traditional surrogates when 
large dsDNA viruses were being monitored. This finding has significant implications for the water 
treatment field: if methods like FVM are eventually permitted as real-time monitoring approaches 
for validating virus removal, treatment schemes could be completely redesigned for virus removal. 
This could in turn lead to far less conservative treatment systems that are better optimized to protect 
public health while also more economically treating water supplies. However, the fact that virus 
reductions in secondary wastewater effluent treated by ultrafiltration could not be measured with 
FVM indicates that native virus populations in secondary wastewater effluent likely have smaller 
genomes that are not currently detectable using a high sensitivity flow cytometer. FVM is therefore 
not a practical approach for real-time monitoring in water reuse at present, although cytometer 
technology advances may change this. 
 Future research directions 
This dissertation work resulted in useful approaches to assess virus fate through UV254 
disinfection. However, the fate of many important pathogens, including HuNoV, is not well-
understood through other water treatment processes. To characterize the persistence of emerging 
or difficult-to-culture viruses through other treatment strategies, future work should expand on the 
computational and molecular approaches developed here for UV254. One major limitation for the 
accuracy of these approaches is the need to understand the mechanisms by which viruses are 
inactivated by these different treatment strategies. For example, predictive models were feasible 
for UV254 disinfection because we understand UV254 inactivation mechanisms (i.e., UV254 
primarily targets the viral genome, and genome repair is possible for dsDNA viruses once inside 
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the host cell). To this end, more research on the mechanisms driving virus inactivation is needed, 
and larger data sets incorporating a broad range of viruses are required to inform modeling efforts. 
This research demonstrated that the novel enteroid culture system can be used to characterize 
HuNoV infectivity through treatment processes. Future work using this approach to investigate 
HuNoV fate in other environmental processes, including in additional water treatment systems and 
in different water types, will be beneficial for better understanding risks of HuNoV in these 
settings. However, several limitations of this cell culture system, including its inability to support 
productive infection of HuNoV from certain stool samples, limit its widespread use in studies of 
environmental fate. Continued efforts to identify the role of various cofactors and strain-specific 
determinants in viral pathogenesis will be invaluable for ultimately developing a HuNoV culture 
system that can selectively grow HuNoV so that the concentration and behavior of native HuNoV 
populations in environmental matrices can be explored. 
FVM monitoring of virus reductions through microfiltration and ultrafiltration was evaluated using 
hand-held syringe filter membranes. These experiments must be scaled up to bench- or pilot-scale 
to ensure that the proof-of-concept results presented in this dissertation will hold in more realistic 
systems. As improvements in flow cytometer capabilities become available, virus detection of 
smaller DNA and potentially RNA viruses will result. These technologies should continue to be a 
focus of future research, because once cytometers are sensitive enough to detect the signal of most 
viruses, monitoring through treatment processes is likely to be significantly improved. While FVM 
shows promise to measure virus reductions through physical removal processes, FVM monitoring 
of biological treatment processes may not be preferred, because the growth of certain 
microorganisms, including bacteriophages, in these processes could result in negligible reductions 
of FVM counts. Instead, spiking and measurement of fluorescent virus-like particles that can be 
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detected using FVM analysis but do not grow in biological systems should be investigated for 
potential use to evaluate the effectiveness of virus removal these processes.
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Appendix A 
Supplementary Information for Chapter 2 
A.1 Supplementary Text 
A.1.1 RNase experiments. 
RNase experiments were conducted to determine whether extraviral RNA was a component of the 
HuNoV/MS2 suspensions used for inactivation experiments. RNase experiments were conducted 
using the same matrix of HuNoV stool suspension and MS2 stock as during UV254 inactivation 
experiments. Triplicate samples with a total volume of 110 μL were treated with RNase ONE 
Ribonuclease (Promega, Madison, WI) by adding 10 units RNase ONE. This amount of RNase 
ONE was recommended by the manufacturer to ensure an excess of RNase ONE. Specifically, 10 
units of RNase ONE degrade 900,000 ng of total RNA when left in the shaking experimental 
solution for 15 minutes at 37°C, per the manufacturer’s specifications. Quantification of the RNA 
in the HuNoV/MS2 suspensions using Nanodrop indicates approximately 2,772 ng of ssRNA in 
the RNase experiment samples, which is over two orders of magnitude less than what could be 
degraded with the RNase present. While we conducted these checks to ensure no significant 
amount of extraviral RNA was in experimental solutions, recent research with UV254 shows that 
extraviral and intraviral RNA degrades at the same rate;1 these results suggest that the presence of 
extraviral RNA in a sample would not change the observed rate of genome degradation. Untreated 
triplicate samples were conducted in parallel. Treated and untreated samples were shaken at 37°C 
for 15 minutes. 1 μL RNasin Inhibitor (Promega) was added to RNase treated samples to inhibit 
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downstream RNase activity and all samples were subsequently shaken at room temperature for 15 
minutes. 
Downstream RNA extraction and cDNA synthesis were carried out as described for the HuNoV 
UV inactivation samples. qPCR was conducted in triplicate (n=3) with the same thermocycling 
instrument as for HuNoV UV inactivation experiments. A 94 base pair region of cDNA was 
amplified using the NV107a forward primer (AGCCAATGTTCAGATGGATG)2 and COG2R 
reverse primer (TCGACGCCATCTTCATTCACA).3 10 μL reactions consisted of 1 μL cDNA 
template, 1X Fast EvaGreen qPCR Master Mix (Biotium, Inc., Fremont, CA), 0.5 μM forward and 
reverse primers, and 0.625 mg/ml bovine serum albumin (BSA). Thermocycling conditions 
included an initial denaturation at 95°C for 10 min, 40 cycles of denaturation (95°C for 20 s), 
annealing (60°C for 20 s), and extension (72°C for 25 s), and then a final extension step (72°C for 
1 min). gBlocks (Integrated DNA Technologies, Coralville, IA) were used as qPCR standards. 
Each assay contained a standard curve with seven serially diluted standards measured in triplicate 
and a no-template control. The slope, efficiency, and R2 of the standard curve were -4.04, 77%, 
and 0.997, respectively. The sequence of the gBlock standard used is as follows: 
5’ – CTG ACC GAT ACC TGC TTC GTT GAG AAC TCA AGC CAA TGT TCA GAT 
GGA TGA GAT TCT CAG ATC TGA GCA CGT GGG AGG GCG ATC GCA ATC TGG 
CTC CCA GTT TTG TGA ATG AAG ATG GCG TCG ATT TTT CGC TGG ATG CGC 
TTC CAT GAC CTC GGA TTG TGG ACA GGA GAT CGC GAT CTT CTG CCC GAA 
TTC GTA AAT GAT GAT GGC GTC TAA GGG CCC ATC ATC TAC TCG CGT CCC 
TGT GGC TC – 3’ 
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A.1.2 G2SK qPCR sensitivity analysis. 
Using the G2SK amplicon to assess HuNoV concentrations through UV254 treatment means that 
amplicon degradation must be sufficient for qPCR to reliably detect a reduction in signal. To 
establish this level of degradation, sensitivity analyses were conducted with G2SK. Three separate 
dilution series of G2SK standards (starting at a concentration of ~2 x 108 gene copies/mL) were 
made, in which dilutions were 89%, 78%, 67%, 56%, and 44% of the original concentration. These 
dilutions were selected to capture the minimum reduction in the target concentration that was 
statistically significant with the qPCR assay. Each set of dilutions was quantified using qPCR as 
described for UV254 experiments. The initial qPCR concentration was compared to qPCR 
concentration of dilutions in the series using a paired t-test to establish which dilution resulted in 
a significant loss of signal (Figure A.7). The starting concentration was significantly different from 
the 89% dilution (p = 0.032). This reduction is a 0.05-log loss in the G2SK amplicon signal, which 




Table A.1 Forward and reverse primer sequences, positions, and amplicon lengths of seven different regions of the coxsackievirus B5 Faulkner 
genome assessed using qPCR. 














1 ATGGAAATTGCGGAGTGTT TCTTGCCTATTTGCGGAATT 272 605 302 35.7 
-4.04 
(-4.11 to  
-3.97) 
77 
(75 to 79) 
2 CTACTTGAGGGACGATGAA TGTCACTGTGATCGGTACAT 1069 613 283 33.8 
-3.99 
(-4.08 to  
-3.90) 
78 
(76 to 81) 
3 AGATTGCGGAGGTGGAT TGACACAAAGCACAAAATCT 1866 512 246 35.5 
-4.69 
(-4.88 to  
-4.51) 
63 
(60 to 67) 
4 AGATCCGCATGTGTTTACTACA TCAAATCTAGCCCATCCATCAT 2654 398 196 33.1 
-3.62 
(-3.73 to  
-3.51) 
89 
(86 to 93) 
5 ACTACCGGAGTGTATTTCTGT TGATTTCTTACCACAATAACCAGT 3470 455 214 35.7 
-4.26 
(-4.52 to  
-4.01) 
72 
(66 to 78) 
6 AGAAAGGCATCTTGTTCACTT AGTTGACCTCAGGAACCAA 4665 513 230 33.7 
-4.20 
(-4.37 to  
-4.04) 
73 
(69 to 77) 
7 TTGAGGAGGCCATATTCTCAA ATCACCGGTATTTTACTCCAAA 6072 511 224 33.1 
-4.40 
(-4.65 to  
-4.14) 
69 
(64 to 74) 
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aCorresponds to nucleotide position of Coxsackievirus B5 Faulkner strain (accession number AF114383.1). bValues are given as cycle threshold. cMean slope 
and efficiency values are the arithmetic mean of all standard curves generated for an assay. The minimum (min) and maximum (max) values of the slope and 
efficiency are the minimum and maximum values taken from all standard curves generated for an assay. dEfficiency is given as a percentage and was calculated 
according to the following equation: E = (10(-1/slope) – 1) x 100%. LOQ = Limit of quantification. 
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Table A.2 Forward and reverse primer sequences, positions, and amplicon lengths of eight different regions of the human norovirus GII.4 Sydney 
genome assessed using qPCR. 













1 TTATTGAAATGTGGGATGGAG CTGCGAAGGTCCAATCAC 390 498 257 28.0 
-3.78 
(-4.04 to  
-3.54) 
84 
(77 to 92) 
2 TGCTTCACCCGATATTGTGGGC AGGGGCTTCTGCGTACACGAG 1360 505 244 29.9 
-3.64 
(-3.79 to  
-3.51) 
88 
(84 to 93) 
3 CCGAGCATCAGGGTTACT GGTCATCTCTTCTGTGTCTTCC 2044 514 228 29.0 
-3.69 
(-3.79 to  
-3.64) 
87 
(84 to 88) 
4 TGGCCACACTGCTCATCAAG TGGTTTTAGCTGGTCCCTCATA 3273 506 222 28.3 
-3.73 
(-3.89 to  
-3.58) 
86 
(81 to 90) 
5 ATGGTAAGATCAAGAAGAGGCT TAGAAGGAGAAAAGGGAGTTGG 4098 496 261 30.1 
-3.66 
(-3.77 to  
-3.57) 
88 
(84 to 91) 
6 TCGAGTGACGCCAACCCATCT CATCGGGTAAGGGAATCAACACAG 5097 469 238 29.5 -3.68 (-3.8 to -3.6) 
87 
(83 to 89) 
7 CCAGCAGTGCCTTTGTTGTCC GGGGCCAGATGCACATTATGAG 5842 502 245 30.7 
-3.66 
(-3.79 to  
-3.56) 
88 
(84 to 91) 
8 GTTACAACAGGAAATGATGAAA CTTTAGGCACGGTTGAGAC 6925 500 249 32.5 
-4.06 
(-4.25 to  
-3.93) 
77 
(72 to 80) 
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(73 to 78) 
aCorresponds to nucleotide position of GII.4 Sydney virus used in this study (accession number MN703761). bValues are given as cycle threshold (Ct). cMean slope 
and efficiency values are the arithmetic mean of all standard curves generated for an assay. The minimum (min) and maximum (max) values of the slope and 
efficiency are the minimum and maximum values taken from all standard curves generated for an assay. d Efficiency is given as a percentage and was calculated 
according to the following equation: E = (10(-1/slope) – 1) x 100%. eConserved GII HuNoV amplicon. LOQ = Limit of quantification. 
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Table A.3 Reaction rate constants and the source of those constants for all (+) ssRNA viruses included in Figure 2.3. 









rate constant, k 
(cm2 mJ-1 base-1) 
Human norovirus 
GII.4 Sydney JX459908.1 7564 3952 3612 0.27
a 3.6 x 10-5 
MS2 NC_001417.2 3569 1762 1807 0.14a 3.9 x 10-5 
Feline calicivirus NC_001481.2 7683 3844 3839 0.37b 4.8 x 10-5 
Murine norovirus EF014462.1 7382 3608 3774 0.32b 4.3 x 10-5 
Echovirus 12 X77708.1 7501 4014 3487 0.31b 4.1 x 10-5 
Coxsackievirus B5 AF114383.1 7400 3931 3469 0.35a 4.7 x 10-5 
aThis study 





Figure A.1 Loss of MS2 infectivity following UV254 exposure during CVB5 experiments. Error bars depict 
standard error of the mean of three independent replicates (N=3). MS2 was spiked into VDB at a final 
concentration of 109 pfu/mL. Error bars are present for each symbol but in all cases are smaller than the 
symbol. The data resulted in an inactivation rate constant of 0.14 ± 0.01 cm2 mJ-1 (mean ± 95% CI).




















Figure A.2 UV254 reaction rate constants for CVB5 amplicons, normalized by number of bases in each 
amplicon. Error bars depict standard error of the mean of three independent replicates (N = 3).





























Figure A.3 Loss of MS2 infectivity following UV254 exposure during HuNoV experiments. Error bars 
depict standard error of the mean of four independent replicates (N=4). MS2 was spiked into the stool 
suspensions at a final concentration of 109 pfu/mL. Error bars are present for each symbol but in some cases 
are smaller than the symbol. The data resulted in an inactivation rate constant of 0.14 ± 0.02 cm2 mJ-1 (mean 
± 95% CI). 




















Figure A.4 HuNoV gene copy concentrations of RNase-treated and untreated HuNoV stool suspension 






































Figure A.5 Loss of MS2 infectivity following UV254 exposure in buffer solution. Error bars depict standard 
error of the mean of three independent replicates (N=3). MS2 was spiked into PBS at a final concentration 
of 109 pfu/mL. Error bars are present for each symbol but in some cases are smaller than the symbol. The 
data resulted in an inactivation rate constant of 0.14 ± 0.02 cm2 mJ-1 (mean ± 95% CI). 




















Figure A.6 Loss of G2SK amplicon signal following UV254 exposure. Error bars depict standard error of 
the mean of four independent replicates (N=4).


























Figure A.7 Sensitivity analysis of G2SK amplicon signal reduction with qPCR. Error bars depict standard 
error of the mean of three independent replicates (N=3). 
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Appendix B 
Supplementary Information for Chapter 3 
B.1 Supplementary Text 
B.1.1 Systematic literature review. The goal of the systematic literature review was to collect 
UV254 inactivation rate constants for viruses in aqueous suspensions so that these data could be 
used to develop models for predicting virus inactivation by UV254. The Web of Science Core 
Collection database was used to obtain records for the systematic literature review. Specifically, 
the database was searched by “Topic” (i.e., search for terms in the title, abstract, author keywords, 
or Keywords Plus) using the following search term: ((UV OR ultraviolet OR UVC) AND 
(inactivat* OR disinfect* OR degradat*) AND (virus OR viral OR phage OR bacteriophage)) in 
August 2019. All records, including conference proceedings and peer-reviewed publications, were 
output for consideration. Any records containing duplicate content (i.e., duplicate publications, 
conference proceedings with information also published in a peer-reviewed journal) were 
removed, and only records in the English language were considered. In addition, any review and 
microbial risk assessment publications were removed; all references of these papers, however, 
were screened and relevant references were included in the full-text review (Figure B.1). 
During the first round of screening, the title and abstract of each result were evaluated and all 
records whose details indicated possible inclusion of UV254 virus inactivation data were kept. The 
text of all records passing the initial screening were then reviewed in full. Any records meeting 
the inclusion criteria were added to the final study set and UV254 virus inactivation data were 
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extracted. For publications that did not allow evaluation of all criteria were not explicitly stated, 
corresponding authors were contacted when possible to confirm whether remaining criteria were 
met. Screening and full-text review were carried out by one reviewer.  
UV254 inactivation rate constants (k), in cm2 mJ-1, defined as the natural logarithm transformed 
reduction in infectious virus concentration per UV254 dose, were extracted from the publications. 
This relationship is described by Chick-Watson kinetics: 
ln # !!!$ = −' ∙ )"#"#$  
where C0 and C are the infectious virus concentrations before and after UV exposure, respectively, 
and DUV254 is the UV254 dose, in mJ cm-2. When available, inactivation plots from the study 
showing the reduction in infectious virus concentrations for varying UV doses were digitized using 
DigitizeIt.1 A linear regression of the digitized data, plotted as the natural logarithm transformed 
reduction in infectious virus concentrations versus UV254 dose, was then conducted using Prism 
version 8.4.2 (GraphPad, La Jolla, CA). The inactivation rate constant was defined as the slope 
resulting from the linear regression analysis. Only data following first-order kinetics were included 
in the linear regression analysis. If multiple different inactivation plots with the same virus were 
conducted in the same study, the extracted data were combined and analyzed in a single linear 
regression. When no inactivation plot was available or was too blurry to digitize accurately, but 
the publication reported some form of the inactivation rate constant, this value was extracted and 
unit conversions were applied as needed. When only the dose required to achieve a specific log-
reduction in infectious virus concentrations was reported (e.g., D90 or D99 values), this value was 
converted into the inactivation rate constant using Equation 1. 
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Standard errors were also collected from studies when possible. For digitized data, the standard 
error of the slope was obtained from the linear regression. When data could not be digitized, but a 
rate constant and an associated error estimate were reported, the error estimate was extracted and 
converted to a standard error. Specifically, if a 95% confidence interval for a rate constant was 
provided, the confidence interval was divided by four to obtain an estimate of the standard error. 
Data extraction was conducted by one reviewer. To ensure the quality of extracted data, a second 
reviewer re-extracted all data from the selected studies. Extracted data were then compared among 
the two reviewers to confirm consistency. 
B.1.2 Genome sequence selection. Genome sequences were determined by searching in NCBI for 
the virus specified in a study. When no details of the exact virus strain or genotype were provided 
in the methods of a study, the corresponding author was contacted when possible to determine 
additional details. Ultimately, the NCBI complete genome sequence with a virus description most 
closely aligned with the virus description from a study was used. We did not include viruses for 
which we could not find a complete genome sequence as close to or more specific than the species 
level described in the study. For example, no full-length genome sequence of the bovine calicivirus 
serotype used by Malley et al.2 was found on NCBI, so the inactivation rate constant data for this 
vesivirus work was not included in model development. Environmental virus isolates without 
available genome information were not used.  
B.1.3 Predictor selection. 
B.1.3.1 Virus nucleic acid type. 
The form of virus nucleic acid, either double-stranded or single-stranded, was included as a 
categorical predictor in the combined models because research has shown that there are significant 
differences in the rate of photoproduct formation with UV254 irradiation.3 For RNA in particular, 
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photoproduct formation with UV254 exposure appears to be suppressed significantly in double-
stranded nucleic acid compared to single-stranded nucleic acid.3,4 
B.1.3.2 Length. 
The length of the viral genome has frequently been associated with UV254 virus inactivation.5,6 
While length is not directly a factor in UV254 inactivation, longer regions of the genome have more 
possible reaction sites for UV254 photoproduct formation, and so longer genomes indirectly lead 
to higher reaction rates. Length was determined using virus genome sequences available in NCBI 
databases. 
B.1.3.3 Virus genome composition. 
Certain components of a virus’ primary genomic structure are directly impacted by UV254 
irradiation. Nucleobases in the genome can be altered through direct photolysis, transforming the 
nucleic acids into photoproducts that may halt or inhibit translation, transcription, or replication of 
the viral genome and render the virus noninfectious. In particular, pyrimidine bases are about an 
order of magnitude more reactive with UV254 than purine bases.7 The predictors included in 
modeling that related to nucleobase composition were therefore exclusively focused on pyrimidine 
content. Pyrimidine dimers and photohydrates are widely considered the most common products 
resulting from UV irradiation of nucleic acid. Studies indicate pyrimidine dimers cause a large 
portion of the UV-induced damage to DNA,8–10 and the formation of thymine dimers, in particular, 
has been extensively studied.7,11–13 Research focused on RNA photolysis suggests pyrimidine 
hydrates are the primary lesions inducing UV damage,14 although the presence of pyrimidine 
dimers in UV-irradiated RNA has been observed.14,15 Research has also shown hydrate formation 
in DNA through UV exposure.16 Presence of flanking pyrimidines next to other pyrimidines is 
suggested to increase reactivity.9,10,13,17 Considering these findings related to nucleic acid 
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photoreactivity, we selected certain predictors related to the number of specific pyrimidine-based 
sequence combinations in the virus genome. Specifically, the number of uracil bases (U), cytosine 
bases (C), uracil doublets (UU), uracil triplets (UUU), uracil quadruplets (UUUU), uracil 
quintuplets (UUUUU), uracil-cytosine pairs (UC), and cytosine-uracil pairs (CU) were included 
as predictors for RNA viruses. DNA virus predictors included the number of thymine bases (T), 
cytosine bases (C), thymine doublets (TT), thymine triplets (TTT), thymine quadruplets (TTTT), 
thymine quintuplets (TTTTT), thymine-cytosine pairs (TC), and cytosine-thymine pairs (CT). We 
did not incorporate pyrimidine information including the number of CC, CCC, or CCCC in the 
genome, because past work indicates photoproducts resulting from these nucleobase combinations 
are not as prevalent as the other base sequences included in the model.18 Additionally, 
combinations of bases with purines flanking pyrimidines were not included because of the sparsity 
of data indicating which precise combinations may lead to photoproducts as well as for simplicity 
in genomic variable combinations. 
All nucleic acid composition values were determined using the same genome sequences used to 
assess viral genome length. For double-stranded genomes, these variables were counted on both 
the template and complement strands. 
B.1.3.4 Genome repair mode. 
Genome repair is a process by which genomic lesions in nucleic acid can be repaired through 
enzymatic activity. To our knowledge, dsDNA viruses are the only class of viruses that can 
undergo dark genome repair following UV254 treatment. Genome repair can be host-mediated or 
virus-gene controlled. Host cell mediated genome repair occurs for many dsDNA viruses. This is 
because genome repair enzymes in the host cell, meant to repair host dsDNA, can repair viral 
dsDNA once the virus genome is in the host cell. In contrast, certain viruses encode one or more 
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repair enzymes in their own virus genome (e.g., T-even and T5 phages); in these cases, genome 
repair is considered to be virus-gene controlled.19,20 Theoretically, it would be possible that host 
cell-mediated repair and virus-gene controlled repair occur simultaneously; in T-even phages 
known to encode genome repair genes, however, studies have shown that the virus destroys host 
cell repair mechanisms upon viral entry.20 No viruses are known to undergo simultaneous repair 
by these distinct genome repair modes, and therefore this combined repair mode was not 
considered in our models. It is also important to note that no genome photoreactivation was 
considered in modeling, because these processes only occur when samples are exposed to a 
nonionizing radiation source following the irradiation treatment.20 In all studies included in our 
data set, none of the samples were subject to photoreactivation steps. 
Based on knowledge of genome repair among viruses from the literature, a categorical predictor, 
namely genome repair mode, was developed for each virus. The four levels for this predictor were: 
0 = ‘host cell mediated,’ 1 = ‘virus-gene controlled using one repair system,’ 2 = ‘no repair,’ or 3 
= ‘virus-gene controlled using multiple repair systems.’ 
All viruses outside of the dsDNA virus Baltimore classification were designated as having no 
repair; to our knowledge, no evidence of genome repair in the (+) ssRNA, (-) ssRNA, dsRNA, or 
ssDNA virus classes has been observed. Many dsDNA viruses in our collected data set are known 
to undergo host cell mediated genome repair, including members of the Adenoviridae family, 
polyomavirus, and lambda phage. Unless past research had reported that a dsDNA virus undergoes 
virus-gene controlled repair, host cell mediated repair was assumed. This is because eukaryotic 
and prokaryotic hosts have dsDNA genome repair mechanisms, and there is no reason to believe 
a dsDNA virus genome would not benefit from these repair systems, unless other virus-mediated 
activities occur; only T-even phages are known to undergo virus-gene controlled genome repair. 
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As a result, only the T-even bacteriophages T2, T5, and T6 were categorized with ‘virus-gene 
controlled repair using one repair system.’ One virus, T4 bacteriophage, is known to undergo virus-
gene controlled repair with multiple repair systems. Beyond repair mode affecting genome repair 
capabilities, differences among host cell mediated repair do exist, and we evaluated these 
differences using another categorical predictor, host cell type.  
B.1.3.5 Host cell type. 
Virus diversity results in significant variability in viral hosts. These hosts differ considerably in 
several respects; in relation to evaluating UV254 inactivation of viruses, we are particularly 
concerned with the host cell’s ability to repair viral genome damage once the UV254-damaged virus 
has entered the host cell. The efficiency of repair depends on the host cell’s ability to repair 
genomic material. Eukaryotic and prokaryotic cells contain distinct sets of genes for encoding and 
producing repair enzymes. Among other dissimilarities, the number, function, and regulation of 
these repair genes differ.21 Even within the same host type, repair capabilities may differ. For 
example, studies have shown that in human cells from xeroderma pigmentosum patients, virus 
UV254 sensitivity is significantly increased (e.g., > 3x increase in measured rate constants) 
compared to in wild-type (i.e., normal) host cells for the same inactivated virus; this is because the 
cells are deficient in one or more of the common repair genes needed to effectively repair dsDNA 
inside the host.19,22–25 In addition, work has shown that genome repair systems in the cells of 
longer-lived mammals (e.g., human) are significantly upregulated compared to those in shorter-
lived mammals (i.e., mice).26 To incorporate these differences in host cell type that impact genome 
repair, we developed a categorical predictor for host cell type. Three different categories were 
used, including 0 = ‘prokaryotic cells’, 1= ‘eukaryotic cells with reduced repair’, and 2 = 
‘eukaryotic cells with wild-type repair.’ 
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All bacteriophages were assigned the category for ‘prokaryotic cells.’ Some experiments with 
human viruses were assayed in cell lines known to have reduced repair capabilities compared to 
wild-type human cell lines; these virus experiments were assessed as having ‘eukaryotic cells with 
reduced repair.’ The only virus in the modeling data set with this form of repair was human 
polyomavirus, assayed in SVG-A cells. A previous study showed reduced repair of DNA damage 
in SV-derived cells but not in other cells evaluated.25 While two adenoviruses in the data set were 
also evaluated in cell lines with reduced repair,22 these rate constants did not have associated errors 
and were therefore not included in modeling work. All other dsDNA human viruses were given 










where nv is the number of viruses in the data set, k+v is the inverse variance weighted mean 
inactivation rate constant for virus v, and SEv is the standard error of the inverse variance weighted 
mean inactivation rate constant for virus v. 
We employed weighted root mean squared relative prediction error (RMSrPE) to assess model 
prediction efficacy. Leave-one-virus-out cross-validation was used to determine each model’s 
RMSrPE. Specifically, data from the final curated data set were split into a training set and a 
validation set for each round of cross-validation so each virus was left out of the training set exactly 
one time. Weights for viruses in the training set were rescaled to sum to the number of viruses – 
1. The squared predicted error was determined for the held-out virus inactivation rate constant in 
each fold. The resulting relative errors for each virus were weighted by the inverse relative variance 
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weights and the weighted mean computed. The root of these values was then taken to obtain the 
RMSrPE for a particular model, as shown in the follow equation: 





where k8v is the predicted inactivation rate constant for virus v. The RMSrPE for each model was 
compared and top performing models were selected based on minimum RMSrPE values. The 
standard error associated with the relative RMSrPE was determined as the bias corrected weighted 
sample variance: 
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Pairwise comparisons of model performance were conducted using weighted least squares 
regression to compare the expected log ratio of the squared prediction errors. Specifically, for each 
virus the squared prediction error determined during cross-validation were transformed to the 
natural logarithm scale and differenced. A logarithm transform was used to stabilize the variance 
estimates of large individual prediction errors in some models. A weighted regression was then 
conducted using only an intercept as the predictor and the transformed squared error ratios as the 
dependent variable (i.e., a weighted one-sample t-test of the logarithm squared error ratios). The 
average squared error ratio (ASER) was determined by exponentiating the estimated intercept from 
this regression. Differences in model performance were considered significant if the exponentiated 
95% confidence interval of the ASER did not include 1. 
B.1.4 Virus propagation and enumeration. 
B.1.4.1 MHV. 
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MHV strain A59 was propagated and quantified in delayed brain tumor (DBT) cells (kindly 
provided by Dr. Julian Leibowitz at Texas A&M Health Science Center College of Medicine) 
according to published protocols with slight modifications.27,28 Briefly, DBT cells were grown in 
medium comprised of Dulbecco’s modified Eagle’s medium (DMEM) with 4.5 g/L glucose 
without L-glutamine (Cat. No. 12614F, Lonza), 10% horse serum (Cat. No. 26050088, Life 
Technologies), 1% penicillin streptomycin (Cat. No. 15140122, Invitrogen), and 1% L-glutamine 
(100X; Cat. No. 25030081, Invitrogen) at 37°C and 5% CO2. The medium was replaced every 48 
to 72 hours. 
MHV stocks were generated in 80% confluent DBT cell monolayers at a multiplicity of infection 
of approximately 0.01. Following 18 to 24 hours of incubation, infected DBT cells were 
centrifuged at 3,000 x g for 15 minutes at 4ºC and the supernatant was collected. MHV A59 stocks 
(~106 pfu/mL) were filter-sterilized with a 0.22 µm sterile polyethersulfone (PES) membrane (Cat. 
No. 229747, CELLTREAT Scientific) and stored in single-use aliquots at -80ºC. 
MHV was enumerated via plaque assay. Specifically, DBT cell monolayers were seeded in 12-
well plates (Cat. No. 353043, Corning) and incubated at 37°C and 5% CO2 prior to infection with 
MHV samples. Plaque assays were performed by inoculating 90% confluent cells with MHV 
samples diluted in DMEM2 (DMEM with 2% horse serum, 1% penicillin streptomycin, and 1% 
L-glutamine) for one hour. After inoculation, virus suspensions were removed and replaced with 
a 1:1 solution of 1.6% agarose (Cat. No. BP160-100, ThermoFisher) and 2xMEM (2x E-MEM 
(Cat No. 115073101, Quality Biological, Inc.), 5% horse serum, 10 mM HEPES (Cat. No. 17737E, 
Lonza), 1X MEM non-essential amino acids (Cat. No. 11140050, Invitrogen), 2% L-glutamine, 
and 2% penicillin streptomycin). Infected DBT cell monolayers were incubated for 48 hours. 
Plaques were enumerated using neutral red staining (Cat. No. N2889, Sigma-Aldrich) at a final 
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0.01% concentration in 1X phosphate buffered saline (PBS; Cat. No. 10010023, Invitrogen). 
Samples were enumerated in triplicate and negative media controls were plated with samples.  
B.1.4.2 HS2 bacteriophage. 
HS2 marine bacteriophage and its host Pseudoalteromonas 13-15 (kindly provided by Dr. Melissa 
Duhaime at the University of Michigan Department of Ecology and Evolutionary Biology) were 
propagated and enumerated using established methods with modifications.29 Briefly, HS2 
bacteriophage stock was generated using the soft agar overlay method. Specifically, soft seawater 
agar (5 g/L peptone, 1 g/L yeast extract, 10% Widdel salt solution, 0.6% agar) containing HS2 
bacteriophage and host bacteria was overlaid on hard seawater agar plates (1 g/L peptone, 0.2 g/L 
yeast extract, 10% Widdel salt solution, 1.2% agar) and incubated overnight at 25ºC. The soft 
seawater agar with virus was then scraped off and diluted with SM buffer (100 mM NaCl, 81.2 
mM MgSO4•7H2O, 50mM Tris-HCl (pH 7.5)). Chloroform was added to the agar solution (5 mL 
chloroform per 50 mL solution) and centrifuged at 3000 x g for 10 minutes. The supernatant was 
aerated to remove residual chloroform and filtered through a 0.45 µm PES membrane. The 
resulting HS2 bacteriophage stock (~ 1011 pfu/mL) was stored at 4ºC until use. HS2 infectivity 








Figure B.2 Percent error of the predicted inactivation rate constant from the mean experimental rate 
constant for each virus where the predicted constants were determined using the top performing (+) ssRNA 















































































































Figure B.3 Principal component analyses of virus genome attributes for (+) ssRNA viruses (a) and dsDNA 
viruses (b). Viruses included all viruses from the systematic review with full genome sequence information, 
and viruses used in predictions. Principal component analyses were conducted on standardized genome 
attributes, as described in methods.
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Figure B.4 Inactivation of MS2 following UV254 irradiation when MS2 was in the MHV experimental 
solution (a) and the HS2 experimental solution (b). Independent replicates (N = 3) are shown for each 
fluence. MS2 was spiked into the experimental solution at a final concentration of 109 pfu/mL. 
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B.3 Tables 
Table B.1 Experimental UV254 inactivation rate constants extracted from the systematic literature 
review and virus rate constants and weights used in modeling work. This table is provided as an 
external data file. 
Table B.2 Virus genome sequence sources and predictor information for all viruses used in 
training/validation and prediction. This table is provided as an external data file. 
Table B.3 Model performance metrics for top-performing models of each class for each subset of 
viruses used in the training and validation set. This table is provided as an external data file. 
Table B.4 Results of pairwise multiple linear regression model comparisons. This table is provided as 
an external data file. 
Table B.5 Results of pairwise model comparisons. This table is provided as an external data file. 
Table B.6 Predicted virus inactivation rate constants from the top performing dsDNA virus model 
and top performing (+) ssRNA virus model. This table is provided as an external data file. 
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Supplementary Information for Chapter 4 
C.1 Supplementary Text 
C.1.1 Preliminary work with the B cell culture system. 
Initial work to find an in vitro HuNoV culture system focused on evaluating HuNoV infectivity 
using a previously described B cell culture system.1 Various experiments were conducted with 
different HuNoV positive stool samples, and while some yielded moderate increased levels of 
RNA gene copies from 0 to 3 dpi (~ 6x to 15x increases in 3 to 0 dpi RNA gene copy levels), 
others did not. In many infections, bile was added to cells in an effort to increase virus replication. 
Unfortunately, no consistently successful infections resulted from the addition of bile, and the 
increases in RNA levels were not as great as desired. 
After two years of difficulties in establishing productive or consistent HuNoV infection of the B 
cells, we started working with the HIE cell culture system, which had recently been described.2 
C.1.2 Difficulties with the HIE cell culture system. 
Although the HIE system was ultimately used for our infectious HuNoV MPN assay and in 
preliminary UV254 inactivation experiments, work was delayed due to initial difficulties in 
identifying a stool sample that productively replicated in HIEs. Specifically, de-identified stool 
samples were frequently screened, however infection did not result in any of the initial samples 
tested (infection was defined by a > 3x increase in RNA gene copies from 0 to 3 dpi). These stool 
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samples ranged in genotype and age, and in certain cases the genotype or age was unknown (Table 
C.3). Similar to the B cell work, bile was added to infections in an attempt to promote viral 
replication, however no successful infections were observed. The inability of HIEs to support 
replication of certain HuNoV stool samples has been demonstrated by other laboratories, most 
prominently in a study that found only 20% of HuNoV positive stool samples could replicate in 
HIEs.3  
One prominent confounding factor in these initial HIE experiments was the lack of a positive 
control – that is, a HuNoV positive stool sample known to result in measurable 3 dpi RNA gene 
copy levels after HIE infection. This means it is also possible that the HIEs were not healthy 
enough to support replication of HuNoV. In this case, false negatives may have resulted, in which 
even stool samples that could have replicated in healthy HIEs would have appeared unable to infect 
cells. As a result, we cannot say with complete certainty that the HIEs did not support replication 
with these stool samples. After obtaining sufficient volume of HuNoV positive stool sample 
known to infect HIEs, a positive control infection was included in subsequent experiments. 
Yet another obstacle afflicting successful HuNoV infections with the HIE cell culture system is 
the difficulty in maintaining healthy HIEs. We experienced a visual change in cell health and a 
lack of successful HuNoV replication in HIEs at elevated passages in this study (i.e., > P37). 
Studies reporting HuNoV infection of HIEs often do not report the cell passage number used for 
infections.2,4,5 However, members in the Wobus laboratory have also noted a visual degradation 
of HIEs in both 3D culture and monolayers at around 35 or more passages. At this time, it is unclear 
what changes in HIEs occur at increased passages that would result in poor HuNoV replication. 
More research is needed to better understand the changes in these cell types through passage. 
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An additional hurdle in sustaining the growth of healthy HIE cells is that HIEs grow best with 
certain types of media that may be commercially made and extremely expensive. We often noted 
significant variability in HIE health from passage to passage when applying the laboratory made 
HIE growth media originally used for HuNoV culture system work. Improved HuNoV infection 
of HIEs has recently been reported by using commercial media, including the expensive cell 
culture media Intesticult.4 This means any slight change in media may result in poor growth of 
HIEs and decreased replication of HuNoV in HIEs during infection. In this work, these difficulties 
frequently manifested in the inability to obtain a confluent monolayer after passaging 3D cells into 
2D. To improve HIE health, the laboratory made media could be supplemented with Intesticult 
media. 
These complications aside, when the HIEs are growing well and a HuNoV sample of high titer has 
been identified that replicates well in the HIEs, HuNoV infections of HIEs proceeds smoothly and 
productively. As work continues to better understand the best conditions for optimal HIE growth 




Table C.1 Composition of media used in 2d and 3d HIE maintenance. 
Component Final Concentration 
Complete media without growth factors (CMGF-) 
Advanced DMDM/F12 (Invitrogen) - 
GlutaMax-100x (Invitrogen) 2 mM 
HEPES (Invitrogen) 10 mM 
Penicillin/Streptomycin (Invitrogen) 100 U/mL 
Complete media with growth factors (CMGF+) 
CMGF- - 
L-WNT3A-conditioned media (ATCC) 50% 
R-Spondin-conditioned media (Trevigen) 20% 
Noggin-conditioned media 10% 
B27 (Invitrogen) 1x 
N2 (Invitrogen) 1x 
N-acetylcysteine (Sigma-Aldrich) 1 mM 
Mouse recombinant EGF (Invitrogen) 50 ng/mL 
[Leu15]-Gastrin 1 (Sigma-Aldrich) 10 nM 
Nicotinamide (Sigma-Aldrich) 10 mM 
A-83-01 (Tocris) 500 nM 
SB202190 (Sigma-Aldrich) 10 EM 
Differentiation media 
CMGF- - 
Noggin-conditioned media 5% 
B27 (Invitrogen) 1x 
N2 (Invitrogen) 1x 
N-acetylcysteine (Sigma-Aldrich) 1 mM 
Mouse recombinant EGF (Invitrogen) 50 ng/mL 
[Leu15]-Gastrin 1 (Sigma-Aldrich) 10 nM 
A-83-01 (Tocris) 500 nM 
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Table C.2 Primers and probes used for the quantification of HuNoV RNA in one-step RT-qPCR. 
Primer or probe Sequence (5' to 3')a Reference 
QNIF2d ATGTTCAGRTGGATGAGRTTCTCWGA (Loisy et al. 2005) 
COG2R TCGACGCCATCTTCATTCACA (Kageyama et al. 2003) 
QNIFS FAM-AGCACGTGGGAGGGCGATCG-TAMRAb (Loisy et al. 2005) 
aDegenerate sequences include the following mixed nucleobases: R = A or G; W = A or T 
b6-FAM (6-Carboxyfluorescein) and TAMRA were used as reporter dye and quencher, 
respectively, for probe-based qPCR. 
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Table C.3. HuNoV positive stool samples used in screening for HIE infections. 
Stool Sample Identifier Genotype Source Year obtained 
GII.4 Sydney #1 GII.4 Sydney MI DHHS Unknown 
GII.4 Sydney #2 GII.4 Sydney MI DHHS Unknown 
GII.4 Sydney #3 GII.4 Sydney MI DHHS Unknown 
GII.4 Sydney #4 GII.4 Sydney MI DHHS Unknown 
GII.4 Sydney #5 GII.4 Sydney MI DHHS Unknown 
GII.6 GII.6 Unknown Unknown 
GII.4 #14 GII.4 CDC Unknown 
St. Judes Unknown 
St. Judes 
Hospital Unknown 
Cincinnati Unknown Cincinnati Unknown 
NIH A GII.4 NIH 2015 
NIH C GII.17B NIH 2015 
CL17 - 32 GII.4 MI DHHS 2017 
CL17 - 46 GII.4 MI DHHS 2017 
MI DHHS = Michigan Department of Health and Human Services; NIH = National 
Institutes of Health; CDC = Centers for Disease Control 
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Supplementary Information for Chapter 6 
D.1 Supplementary text 
D.1.1 FVM limit of detection. 
In this work, the limit of detection (LOD) of the FVM approach was defined as the lowest 
concentration of events in a sample that could be reliably detected above the background noise of 
the instrument. We established the LOD for a standard FVM protocol of analyzing 10 µL of sample 
at a flow rate of 1 µL s-1. To obtain the LOD, we determined the number of counts generated for 
replicate blank samples, and we calculated the standard deviation of those counts to capture the 
variability in the signal from the instrument background noise (standard deviation ~ 600 counts). 
We then computed the concentration of this standard deviation for a sample run with the standard 
protocol, which takes a total volume of 10 µL (concentration ~ 6 x 104 counts/mL). This can be 
taken as the number of counts needed to be confident that FVM analysis is detecting particles 
above the background noise of the instrument. This LOD can be improved by capturing events for 




Figure D.1 Heat map FVM dot plots of the signal from SG (0.5x final concentration) stained PBS (a), 
bacteriophage T4 (b), bacteriophage T3 (c), bacteriophage phi6 (d), bacteriophage phiX174 (e), and 





























































































































































































Figure D.2 Log10 reductions of FVM signal for samples containing bacteriophage T4 (a), bacteriophage T3 
(b), or secondary wastewater effluent (c), determined using the total FVM counts subtraction approach to 
FVM analysis. Turbidity and FVM counts were obtained for all samples, and infectivity was determined 
for T3 and T4-spiked samples. Samples in (a) and (b) consisted of bacteriophage spiked into secondary 
wastewater effluent at a 1:10 final concentration (~5 x 109 pfu/mL). The sample in (c) consisted of 
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secondary wastewater effluent. Error bars represent the standard error of two independent replicates. 
Arrows above bars indicate log10 reductions beyond detection limits. 
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D.2 Tables 
Table D.1 P-values from paired t-tests of the T4 counts enumerated via FVM using different stains, stain concentrations, and fluorescence channels. 




SGI (1x) 0.78 -
SGII (0.5x) 0.39 0.30 -
SGII (1x) 0.22 0.24 0.72 -
SG (0.5x) 0.73 0.46 0.064 0.27 -
SG (1x) 0.51 0.54 0.49 0.17 0.47 -
SYTO 11 (1 uM) 0.23 0.20 0.083 0.22 0.17 0.24 -
SYTO 11 (2 uM) 0.010 0.0013 0.010 0.031 0.0036 0.0085 0.18 -
SGI (0.5x) 0.12 0.47 0.33 0.20 0.84 0.36 0.25 0.0087 -
SGI (1x) 0.86 0.48 0.22 0.17 0.75 0.22 0.26 0.0034 0.96 -
SGII (0.5x) 0.34 0.29 0.28 0.96 0.13 0.39 0.081 0.027 0.31 0.23 -
SGII (1x) 0.21 0.22 0.51 0.19 0.25 0.18 0.21 0.046 0.20 0.17 0.76 -
SG (0.5x) 0.50 0.33 0.31 0.38 0.08 0.94 0.13 0.00039 0.35 0.30 0.30 0.31 -
SG (1x) 0.20 0.093 0.57 0.30 0.26 0.33 0.18 0.0034 0.12 0.077 0.43 0.25 0.67 -
SYTO 11 (1 uM) 0.43 0.37 0.14 0.30 0.39 0.40 0.008 0.085 0.47 0.49 0.13 0.28 0.23 0.30 -
SYTO 11 (2 uM) 0.014 0.0016 0.013 0.037 0.0051 0.010 0.27 0.00077 0.012 0.0040 0.033 0.053 0.00068 0.0042 0.12 -
SGI (0.5x) SGI (1x) SGII (0.5x) SGII (1x) SG (0.5x) SG (1x) SYTO 11 (1 uM)
SYTO 11 (2 
uM) SGI (0.5x) SGI (1x) SGII (0.5x) SGII (1x) SG (0.5x) SG (1x)
SYTO 11 (1 
uM)






























529 nm fluorescence channel 549 nm fluorescence channel
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Table D.2 P-values from paired t-tests of the signal-to-noise-ratios obtained via FVM using different stains, stain concentrations, and fluorescence 




SGI (1x) 0.022 -
SGII (0.5x) 0.23 0.15 -
SGII (1x) 0.017 0.020 0.055 -
SG (0.5x) 0.019 0.0017 0.031 0.00034 -
SG (1x) 0.025 0.004 0.040 0.0025 0.21 -
SYTO 11 (1 uM) 0.011 0.0017 0.020 0.0010 0.0074 0.0035 -
SYTO 11 (2 uM) 0.0065 0.00056 0.013 0.00015 0.00069 0.028 0.59 -
SGI (0.5x) 0.026 0.036 0.025 0.045 0.025 0.025 0.022 0.0208 -
SGI (1x) 0.0056 0.0050 0.0067 0.0047 0.0028 0.0026 0.0025 0.0026 0.22 -
SGII (0.5x) 0.012 0.011 0.018 0.011 0.0028 0.0024 0.0021 0.002 0.19 0.0028 -
SGII (1x) 0.015 0.014 0.023 0.016 0.0042 0.0028 0.0028 0.004 0.21 0.0037 0.53 -
SG (0.5x) 0.0043 0.0040 0.0056 0.0044 0.0029 0.0023 0.0023 0.00266 0.066 0.064 0.0059 0.0034 -
SG (1x) 0.035 0.038 0.041 0.043 0.023 0.020 0.019 0.0206 0.74 0.210 0.10 0.086 0.012 -
SYTO 11 (1 uM) 0.068 0.075 0.078 0.086 0.045 0.040 0.037 0.039 0.97 0.16 0.22 0.20 0.021 0.17 -
SYTO 11 (2 uM) 0.017 0.0171 0.026 0.022 0.0060 0.0037 0.0037 0.00497 0.213 0.0082 0.633 0.766 0.00166 0.0673 0.18 -
SGI (0.5x) SGI (1x) SGII (0.5x) SGII (1x) SG (0.5x) SG (1x) SYTO 11 (1 uM)
SYTO 11 (2 
uM) SGI (0.5x) SGI (1x) SGII (0.5x) SGII (1x) SG (0.5x) SG (1x)
SYTO 11 (1 
uM)
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Table D.3 Comparison of T4 counts obtained using the traditional FVM analysis approach and T4 counts 
obtained using the total FVM counts subtraction approach. 





















SYTO 11 (1 uM) 
0.0075 
(0.13) 
SYTO 11 (2 uM) 
1.0 
(0.26) 
aPercent error = (T4 counts using traditional 
FVM approach - T4 counts using total FVM 
count subtraction approach) / T4 counts using 
traditional FVM approach 
bCounts and resulting percent errors were 
determined using 549 nm fluorescence signal. 
Results were comparable between the 529 nm 
fluorescence channel and the 549 nm 
fluorescence channel. 
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Table D.4 FVM counts obtained for five bacteriophages using the total FVM counts subtraction method 
for SG and SGI stains. Infectious virus concentrations in the same samples are also shown. 
Bacteriophage Infectious virus (pfu/mL) 
Average FVM virus counts ± standard errora 
SGI (0.5x)  SG (0.5x) 
T4 4.5 x 104 1.4 x 105  ± 3.3 x 104 2.8 x 105  ± 9.2 x 104 
T3 5.0 x 104 BD 3.4 x 105  ± 2.6 x 105 
phi6 1.1 x 104 BD 3.7 x 105  ± 1.6 x 105 
phiX174 1.4 x 105 BD 4.4 x 105  ± 1.7 x 105 
MS2 1.2 x 105 BD 2.8 x 105  ± 1.5 x 105 
aFVM counts were obtained using the total FVM counts subtraction method, which takes the total 
stained virus signal and subtracting the stained blank signal. 
pfu = plaque forming unit; BD = below detection; SGI = SYBR Green I; SG = SYBR Gold 
 
